<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004253.pub4" GROUP_ID="BREASTCA" ID="542802111209043944" MERGED_FROM="" MODIFIED="2015-06-16 14:31:16 +1000" MODIFIED_BY="Melina L Willson" REVIEW_NO="52" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2015-06-16 14:31:16 +1000" MODIFIED_BY="Melina L Willson">
<TITLE>Psychological interventions for women with metastatic breast cancer</TITLE>
<CONTACT>
<PERSON ID="12750" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Adrian</FIRST_NAME>
<MIDDLE_INITIALS>GK</MIDDLE_INITIALS>
<LAST_NAME>Edwards</LAST_NAME>
<SUFFIX>B.Med.Sci MB BS MRCP MRCGP PhD</SUFFIX>
<POSITION>Research Professor in General Practice</POSITION>
<EMAIL_1>edwardsag@cardiff.ac.uk</EMAIL_1>
<EMAIL_2>adriangkedwards@btinternet.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Institute of Primary Care and Public Health, School of Medicine</DEPARTMENT>
<ORGANISATION>Cardiff University</ORGANISATION>
<ADDRESS_1>2nd Floor, Neuadd Meirionnydd</ADDRESS_1>
<ADDRESS_2>Heath Park</ADDRESS_2>
<CITY>Cardiff</CITY>
<ZIP>CF14 4YS</ZIP>
<REGION>Wales</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 29 2068 7192</PHONE_1>
<PHONE_2/>
<FAX_1>+44 29 2068 7193</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2015-06-16 14:29:29 +1000" MODIFIED_BY="Melina Willson">
<PERSON ID="14664120413200579247101004043815" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Mohammed</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Mustafa</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>MustafaMH@cardiff.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Institute of Primary Care and Public Health, School of Medicine</DEPARTMENT>
<ORGANISATION>Cardiff University</ORGANISATION>
<ADDRESS_1>2nd Floor, Neuadd Meirionnydd</ADDRESS_1>
<ADDRESS_2>Heath Park</ADDRESS_2>
<CITY>Cardiff</CITY>
<ZIP>CF14 4YS</ZIP>
<REGION>Wales</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="18533859989973524581101011013904" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Andrew</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Carson-Stevens</LAST_NAME>
<SUFFIX/>
<POSITION>Clinical Fellow</POSITION>
<EMAIL_1>andypcs@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Institute of Primary Care and Public Health, School of Medicine</DEPARTMENT>
<ORGANISATION>Cardiff University</ORGANISATION>
<ADDRESS_1>2nd Floor, Neuadd Meirionnydd</ADDRESS_1>
<ADDRESS_2>Heath Park</ADDRESS_2>
<CITY>Cardiff</CITY>
<ZIP>CF14 4YS</ZIP>
<REGION>Wales</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 78 5427 1884</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="83569236098323975406120309022034" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>David</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Gillespie</LAST_NAME>
<SUFFIX/>
<POSITION>Statistician</POSITION>
<EMAIL_1>gillespied1@cardiff.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>South East Wales Trials Unit, Institute of Translation, Innovation, Methods and Engagement</DEPARTMENT>
<ORGANISATION>Cardiff University</ORGANISATION>
<ADDRESS_1>4th Floor, Neuadd Meirionnydd</ADDRESS_1>
<ADDRESS_2>Heath Park</ADDRESS_2>
<CITY>Cardiff</CITY>
<ZIP>CF14 4YS</ZIP>
<REGION>Wales</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+412920687610</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12750" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Adrian</FIRST_NAME>
<MIDDLE_INITIALS>GK</MIDDLE_INITIALS>
<LAST_NAME>Edwards</LAST_NAME>
<SUFFIX>B.Med.Sci MB BS MRCP MRCGP PhD</SUFFIX>
<POSITION>Research Professor in General Practice</POSITION>
<EMAIL_1>edwardsag@cardiff.ac.uk</EMAIL_1>
<EMAIL_2>adriangkedwards@btinternet.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Institute of Primary Care and Public Health, School of Medicine</DEPARTMENT>
<ORGANISATION>Cardiff University</ORGANISATION>
<ADDRESS_1>2nd Floor, Neuadd Meirionnydd</ADDRESS_1>
<ADDRESS_2>Heath Park</ADDRESS_2>
<CITY>Cardiff</CITY>
<ZIP>CF14 4YS</ZIP>
<REGION>Wales</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 29 2068 7192</PHONE_1>
<PHONE_2/>
<FAX_1>+44 29 2068 7193</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2015-06-16 14:29:29 +1000" MODIFIED_BY="Melina Willson">
<UP_TO_DATE>
<DATE DAY="30" MONTH="6" YEAR="2011"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="6" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="12" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2004"/>
<LAST_CITATION_ISSUE ISSUE="6" YEAR="2013"/>
</DATES>
<WHATS_NEW MODIFIED="2015-06-16 14:31:16 +1000" MODIFIED_BY="Melina L Willson">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-06-16 14:31:02 +1000" MODIFIED_BY="Melina L Willson">
<DATE DAY="16" MONTH="6" YEAR="2015"/>
<DESCRIPTION>
<P>A typographical error was noted in the Excluded studies section</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-06-16 14:31:16 +1000" MODIFIED_BY="Melina L Willson">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-06-16 14:31:16 +1000" MODIFIED_BY="Melina L Willson">
<DATE DAY="30" MONTH="6" YEAR="2011"/>
<DESCRIPTION>
<P>Performed searches for new studies on 30 June 2011</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-06-16 14:31:16 +1000" MODIFIED_BY="Melina L Willson">
<DATE DAY="30" MONTH="6" YEAR="2011"/>
<DESCRIPTION>
<P>Five new studies included, adding 742 patients. New search strategies developed to include trial design</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-07-04 22:27:29 +1000" MODIFIED_BY="mohammed mustafa">
<DATE DAY="14" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Change to author by-line</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-07-04 22:28:42 +1000" MODIFIED_BY="mohammed mustafa">
<DATE DAY="26" MONTH="3" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-07-04 22:29:32 +1000" MODIFIED_BY="mohammed mustafa">
<DATE DAY="29" MONTH="1" YEAR="2008"/>
<DESCRIPTION>
<P>Review updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-03-26 11:53:24 +1100" MODIFIED_BY="Sharon  M Parker">
<DATE DAY="24" MONTH="2" YEAR="2004"/>
<DESCRIPTION>
<P>First published version</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2008-04-23 10:47:25 +1000" MODIFIED_BY="Sharon  M Parker">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2008-04-23 10:47:25 +1000" MODIFIED_BY="Sharon  M Parker">
<SOURCE MODIFIED="2008-04-23 10:47:25 +1000" MODIFIED_BY="Sharon  M Parker">
<NAME>Nil</NAME>
<COUNTRY CODE="NONE">Other</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-05-15 15:04:30 +1000" MODIFIED_BY="Mohammed Mustafa">
<SUMMARY MODIFIED="2013-05-07 19:03:26 +1000" MODIFIED_BY="Mohammed Mustafa">
<TITLE>Psychological interventions for women with metastatic breast cancer</TITLE>
<SUMMARY_BODY MODIFIED="2013-05-07 19:03:26 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Cancer that has spread beyond the breast (metastatic breast cancer) is frightening and distressing and can lead women to experience psychological symptoms, such as depression. There is a belief that these psychological symptoms can make the cancer worse.</P>
<P>Treatment for psychological symptoms is sometimes offered to women with metastatic breast cancer, either individually or in a group. In 1989 one study examined the effect of this treatment, offered to a group of women, and it found that it led to them feeling psychologically better and living longer. Subsequent studies did not seem to replicate the findings from the 1989 study, causing uncertainty about the effects of psychological treatments for women with metastatic breast cancer. </P>
<P>This review examined the studies to date to see what effect psychological treatments had on women with metastatic breast cancer. We found 10 studies with a total of 1378 women with metastatic breast cancer. Three of the studies used a psychological treatment known as cognitive behavioural therapy (CBT), four studies used supportive-expressive group therapy (SEGT), while the remaining three studies used treatments that were delivered on an individual basis and were neither CBT nor SEGT.</P>
<P>We performed statistical analysis and found that the odds ratio (a measure of association between an intervention and an outcome) for survival of women with metastatic breast cancer one year after receiving psychological treatment was 1.46, suggesting that there was an association between the psychological treatment and improved survival. This finding was not found when looking at the odds ratio of survival at five years. We also found some evidence that psychological treatments in the short term (for example, one year) may produce a small reduction in pain and improve some psychological symptoms. However, making comparisons across these studies was difficult as they differed in their conduct, treatments and measures used. Moreover, we cannot rule out that the psychological treatments could also cause psychological harm.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-05-15 15:03:10 +1000" MODIFIED_BY="mohammed mustafa">
<ABS_BACKGROUND MODIFIED="2013-05-07 18:50:45 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Psychological symptoms are associated with metastatic breast cancer. This is the basis for exploring the impact of psychological interventions on psychosocial and survival outcomes. One early study appeared to show significant survival and psychological benefits from psychological support while subsequent studies have revealed conflicting results. This review is an update of a Cochrane review first published in 2004 and previously updated in 2007.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-07-10 23:02:41 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>To assess the effects of psychological interventions on psychosocial and survival outcomes for women with metastatic breast cancer.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-05-15 15:03:10 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>We searched the Cochrane Breast Cancer Group Specialised Register, MEDLINE (OvidSP), EMBASE (OvidSP), PsycINFO (OvidSP), CINAHL (EBSCO), online trials and research registers in June/July 2011. Further potentially relevant studies were identified from handsearching references of previous trials, systematic reviews and meta-analyses. </P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-07-11 10:24:29 +1000" MODIFIED_BY="mohammed mustafa">
<P>Randomised controlled trials (RCTs) and cluster RCTs of psychological interventions, which recruited women with metastatic breast cancer. Outcomes selected for analyses were overall survival, psychological outcomes, pain, quality of life, condition-specific outcome measures, relationship and social support measures, and sleep quality. Studies were excluded if no discrete data were available on women with metastatic breast cancer. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-05-07 18:54:08 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Two review authors independently extracted the data and assessed the quality of the studies using the Cochrane Collaboration risk of bias tool. Where possible, authors were contacted for missing information. Data on the nature and setting of the intervention, relevant outcome data, and items relating to methodological quality were extracted. Meta-analyses was performed using a random-effects or fixed-effect Mantel-Haenszel model, depending on expected levels of heterogeneity.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-05-07 19:05:19 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Ten RCTs with 1378 women were identified. Of the seven RCTs on group psychological interventions, three were on cognitive behavioural therapy and four were on supportive-expressive group therapy. The remaining three studies were individual based and the types of psychological interventions were not common to either cognitive behavioural or supportive-expressive therapy. A clear pattern of psychological outcomes could not be discerned as a wide variety of outcome measures and durations of follow-up were used in the included studies. The overall effect of the psychological interventions across six studies, on one-year survival, favoured the psychological intervention group with an odds ratio (OR) of 1.46 (95% confidence interval (CI) 1.07 to 1.99). Pooled data from four studies did not show any survival benefit at five-years follow-up (OR 1.03, 95% CI 0.42 to 2.52). There was evidence of a short-term benefit for some psychological outcomes and improvement in pain scores.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-05-07 18:59:53 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Psychological interventions appear to be effective in improving survival at 12 months but not at longer-term follow-up, and they are effective in reducing psychological symptoms only in some of the outcomes assessed in women with metastatic breast cancer. However, findings of the review should be interpreted with caution as there is a relative lack of data in this field, and the included trials had reporting or methodological weaknesses and were heterogeneous in terms of interventions and outcome measures.  </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-05-15 15:04:30 +1000" MODIFIED_BY="Mohammed Mustafa">
<BACKGROUND MODIFIED="2013-05-07 19:35:13 +1000" MODIFIED_BY="Mohammed Mustafa">
<CONDITION MODIFIED="2013-05-07 19:17:40 +1000" MODIFIED_BY="Melina L Willson">
<P>Breast cancer is the most common cancer in women worldwide, comprising 13.7% of all female cancers and accounting for 485,503 deaths in 2008 (<LINK REF="REF-Ferlay-2010" TYPE="REFERENCE">Ferlay 2010</LINK>). The five-year survival from breast cancer presentation is approximately 70% to 90%, depending on country, and is improving (<LINK REF="REF-Kmietowicz-2000" TYPE="REFERENCE">Kmietowicz 2000</LINK>; <LINK REF="REF-McKenna-2002" TYPE="REFERENCE">McKenna 2002</LINK>). An important prognostic indicator is the stage of breast cancer at the time of diagnosis. Although metastatic breast cancer is incurable it is treatable and, as survival can be years, it may be regarded as a chronic relapsing and remitting disease (<LINK REF="REF-Leonard-2000" TYPE="REFERENCE">Leonard 2000</LINK>; <LINK REF="REF-Smith-2006" TYPE="REFERENCE">Smith 2006</LINK>).</P>
<P>Whether surviving a longer or shorter time, all women with advanced breast cancer, and their families, are not only living with uncertainty about the future, the burden of treatment, and the threat of dying, but also dealing with the existential, emotional, social and psychological difficulties their situation brings. Indeed, many believe psychological health can influence the outcome of cancer with 85% of cancer patients believing psychological functioning can predict disease progression (<LINK REF="REF-Lemon-2004" TYPE="REFERENCE">Lemon 2004</LINK>). This belief has been the basis of research exploring the impact of interventions on survival and psychological variables such as depression in patients with cancer.</P>
<SUBSECTION>
<HEADING LEVEL="3">Prevalence of psychological morbidity in cancer patients</HEADING>
<P>Up to a quarter (16% to 25%) of all newly diagnosed cancer patients experience depression or a clinically significant adjustment disorder with depressed mood using DSM-IV criteria (<LINK REF="REF-Sellick-1999" TYPE="REFERENCE">Sellick 1999</LINK>). <LINK REF="REF-Deflorio-1995" TYPE="REFERENCE">Deflorio 1995</LINK> reviewed 49 studies of the subsequent incidence of depression in cancer patients. The results showed a range in the incidence of depression from 1% to 53%, and this variability was considered to be due to methodological differences and variable diagnostic criteria. Different populations being studied may also account for some of the variation. The diagnosis of depression in cancer patients, particularly those with advanced cancer, is also made more difficult by the similarity between the somatic symptoms of depression and the symptoms of advanced cancer (<LINK REF="REF-Bottomley--1998" TYPE="REFERENCE">Bottomley 1998</LINK>; <LINK REF="REF-Lloyd_x002d_Williams-1999" TYPE="REFERENCE">Lloyd-Williams 1999</LINK>). </P>
<P>There are plausible explanations that implicate hypothalamo-pituitary-adrenal (HPA) axis activation with cancer progression (<LINK REF="REF-Reiche-2004" TYPE="REFERENCE">Reiche 2004</LINK>). The disruption of HPA axis activation may lead to cytokines and inflammatory molecules being involved in the functioning of the cellular immune system to enhance the malignant potential of tumours. Also, depression has been shown to increase pro-inflammatory cytokines that may influence cancer outcomes (<LINK REF="REF-Seruga-2008" TYPE="REFERENCE">Seruga 2008</LINK>). This appears to resonate with findings of immune response changes following psychological interventions (<LINK REF="STD-Larson-2000" TYPE="STUDY">Larson 2000</LINK>; <LINK REF="STD-van-der-Pompe-1997" TYPE="STUDY">van der Pompe 1997</LINK>).     </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Prevalence of psychological morbidity in women with breast cancer</HEADING>
<P>Many studies have examined the psychological well-being of women with early breast cancer. Most have focused on women at diagnosis, their reactions to mastectomy versus breast conserving surgery, or while undergoing adjuvant treatments. Up to 30% of women diagnosed with breast cancer will develop psychological morbidity, either an anxiety or depressive disorder, within one year of diagnosis (<LINK REF="REF-Bleiker-2000" TYPE="REFERENCE">Bleiker 2000</LINK>; <LINK REF="REF-Glanz-1992" TYPE="REFERENCE">Glanz 1992</LINK>; <LINK REF="REF-Irvine-1991" TYPE="REFERENCE">Irvine 1991</LINK>; <LINK REF="REF-Maguire-2000" TYPE="REFERENCE">Maguire 2000</LINK>).</P>
<P>Less work has been done on the psychological effects of metastatic breast cancer (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="REF-Fulton-1999" TYPE="REFERENCE">Fulton 1999</LINK>). The reason for this may be the difficulties involved in research with such a vulnerable group. There are ethical problems in engaging in research with patients who have limited life expectancy.</P>
</SUBSECTION>
</CONDITION>
<INTERVENTION MODIFIED="2013-05-07 19:24:33 +1000" MODIFIED_BY="Melina L Willson">
<SUBSECTION>
<HEADING LEVEL="3">Social support and psychological morbidity</HEADING>
<P>According to <LINK REF="REF-Helgeson-1996" TYPE="REFERENCE">Helgeson 1996</LINK> and <LINK REF="REF-Helgeson-1998" TYPE="REFERENCE">Helgeson 1998</LINK>, the advantageous effects of social support are thought to operate in two ways. First, network membership and social interaction directly increase positive thinking, emotions and behaviour (the 'main effect' hypothesis). Second, social networks help alleviate the damaging effects of stressful life events by providing potential coping resources such as emotional, informational and practical support (the 'stress-buffering' hypothesis).</P>
<P>These hypotheses contribute to the basis for many psychological interventions that have been proposed and sometimes evaluated in women with metastatic breast cancer. Marital or partner relationships may also be very important (<LINK REF="REF-Giese_x002d_Davis-2000" TYPE="REFERENCE">Giese-Davis 2000</LINK>). <LINK REF="REF-Pistrang-1995" TYPE="REFERENCE">Pistrang 1995</LINK> found that for women with breast cancer (not metastatic) even a good helping relationship with another person did not compensate for a poor helping relationship with a partner, and that high levels of empathy and low levels of withdrawal were associated with good communication in the marital relationship. These factors may lead to a specific pattern of psychological issues in women with metastatic breast cancer, and interventions to improve such problems may need to be different in this patient group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Psychosocial interventions for cancer patients</HEADING>
<P>The recognition of psychosocial need has led to the development of psychosocial interventions for cancer patients. <LINK REF="REF-Fawzy-1995" TYPE="REFERENCE">Fawzy 1995</LINK> reviewed the four main types of interventions: 1) education; 2) individual psychotherapy; 3) cognitive behavioural training; and 4) group interventions.</P>
<P>Educational interventions for individual patients with cancer aim to reduce feelings of inadequacy, confusion, helplessness and loss of control by providing information about the disease process, coping with the disease, and the resources available. <LINK REF="REF-Fawzy-1995" TYPE="REFERENCE">Fawzy 1995</LINK> found that in three of the five studies of educational interventions, patients in the intervention groups had decreased anxiety. In one study, levels of depression improved in the intervention sample, and in another, compliance and appointment keeping improved.</P>
<P>Individual psychotherapy is a one-to-one interaction between therapist and patient. Its aims are to decrease distress and increase morale, self-esteem and coping by increasing the patient's sense of mastery over the situation and helping to overcome the practical problems encountered by the patient. <LINK REF="REF-Fawzy-1995" TYPE="REFERENCE">Fawzy 1995</LINK> reviewed 13 studies where individual psychotherapy was at least part of the intervention. Ten of these suggested positive effects on coping, affect or quality of life.</P>
<P>
<LINK REF="REF-Jacobsen-1998" TYPE="REFERENCE">Jacobsen 1998</LINK> defined the cognitive behavioural method as involving the identification and correction of thoughts, feelings and behaviours that contribute to the development and maintenance of symptoms. These behavioural and cognitive techniques are then employed to try to achieve psychological change. The review by <LINK REF="REF-Jacobsen-1998" TYPE="REFERENCE">Jacobsen 1998</LINK> showed that four out of the five studies showed significant improvements in coping and emotional well-being or functioning in intervention participants compared with controls. Other reviews by <LINK REF="REF-Fawzy-1995" TYPE="REFERENCE">Fawzy 1995</LINK>, <LINK REF="REF-Meyer-1995" TYPE="REFERENCE">Meyer 1995</LINK> and <LINK REF="REF-Trijsburg-1992" TYPE="REFERENCE">Trijsburg 1992</LINK> all showed that psychological interventions, including cognitive behavioural interventions, have positive effects on emotional and functional adjustment in cancer patients.</P>
<P>Group interventions centre on two types of support groups, those led by patients and those led by professionals. <LINK REF="REF-Leszcz-1998" TYPE="REFERENCE">Leszcz 1998</LINK> proposed that group interventions offer an opportunity for the provision of social support, destigmatization, here-and-now practice of communication skills, instillation of hope, and added meaning in life through helping others. One of the principal manifestations of interventions on this basis is termed 'supportive-expressive group therapy' (<LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>), which includes building bonds, expressing emotions, detoxifying death and dying, redefining life priorities, increasing the support of friends and family, improving the doctor-patient relationship, and improving coping skills.</P>
<P>It is important to note, however, that only very few cancer patients attend available support programs when they are offered. <LINK REF="REF-Taylor-1986" TYPE="REFERENCE">Taylor 1986</LINK> found that less than 10% of patients attended support groups. Of these, the participants tended to be white and middle-class. <LINK REF="REF-Stalker-1990" TYPE="REFERENCE">Stalker 1990</LINK> found that of 200 patients nearly half said they would be interested in support groups, but only six had actually sought out group services. This raises significant questions about the generalisability of the evidence. It is equally important to note that these interventions have to date been almost exclusively theoretically or researcher driven and may not reflect approaches that women would find most important in addressing their psychological morbidity.</P>
</SUBSECTION>
</INTERVENTION>
<THEORY MODIFIED="2013-05-07 19:31:05 +1000" MODIFIED_BY="Melina L Willson">
<SUBSECTION>
<HEADING LEVEL="3">Psychological responses and survival</HEADING>
<P>Psychological responses to diagnosis and psychosocial therapies have been reported to be associated with differences in survival among cancer patients. <LINK REF="REF-Greer-1979" TYPE="REFERENCE">Greer 1979</LINK> reported on a prospective study of 69 patients with early breast cancer. The women's psychological response to diagnosis, assessed at three months post-operatively, appeared to be related to the five-year survival outcome. <LINK REF="REF-Watson-1999" TYPE="REFERENCE">Watson 1999</LINK> repeated the study with 578 women, this time assessing women at four to 12 weeks and at 12 months post-diagnosis. The results indicated a significantly increased risk of all-cause mortality at five years in women with high scores on scales for depression or helplessness and hopelessness, although no significant differences were found for fighting spirit. However, <LINK REF="REF-Buddeberg-1991" TYPE="REFERENCE">Buddeberg 1991</LINK> observed, during their prospective three-year longitudinal study involving 107 women with breast cancer, that indicators of coping were less predictive in regard to the course of the disease as women change their coping strategies over time. They felt it was difficult to say whether measuring a woman's psychological response on two occasions early in the course of her disease can be considered to predict her responses over the next five years.</P>
<P>
<LINK REF="REF-Petticrew-2002" TYPE="REFERENCE">Petticrew 2002</LINK> reviewed 26 prospective studies to investigate the association between psychological coping styles and survival. Any positive findings were typically confined to small or methodologically flawed studies. In a more recent meta-analysis of 25 prospective studies, <LINK REF="REF-Satin-2009" TYPE="REFERENCE">Satin 2009</LINK> found a 25% higher mortality rate for patients with cancer with depressive symptoms and a 39% higher mortality rate for those with major depression, after adjusting for prognostic factors. The evidence that was synthesised was however variable in terms of cancer types, and this was reflected in there being considerable heterogeneity in the findings.</P>
<P>Intervention studies have yielded conflicting results. <LINK REF="REF-Fawzy-1993" TYPE="REFERENCE">Fawzy 1993</LINK> and <LINK REF="REF-Richardson-1990" TYPE="REFERENCE">Richardson 1990</LINK> showed survival benefits for patients in the intervention group, as did the <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK> report of supportive-expressive group therapy for women with metastatic breast cancer. Other studies by <LINK REF="STD-Linn-1982" TYPE="STUDY">Linn 1982</LINK> (on male patients only) and <LINK REF="STD-Ilnyckyj-1994" TYPE="STUDY">Ilnyckyj 1994</LINK> (with patients with a range of disease types) failed to show a survival benefit. Possible explanations include the use of different types of interventions as well as issues surrounding the selection of patients, further limiting their generalisability.</P>
</SUBSECTION>
</THEORY>
<IMPORTANCE MODIFIED="2013-05-07 19:35:13 +1000" MODIFIED_BY="Melina L Willson">
<P>Despite conflicting results from studies to date, interest in this line of research has remained high. This may be partly because specific experiences in women with metastatic breast cancer (such as the effects on personal and body image and effects on relationships) are not replicated among the studies of patients with other types of cancer. Also, the effects of psychological interventions for women with metastatic breast cancer remain as yet uncertain. We therefore undertook a systematic literature review of the effects of psychological interventions for women with metastatic breast cancer.</P>
<P>The 2007 updated Cochrane review of psychological interventions for women with metastatic breast cancer, undertaken by <LINK REF="REF-Edwards-2008" TYPE="REFERENCE">Edwards 2008</LINK>, showed from the meta-analysis of five primary studies (511 women) that there was very limited evidence of benefit arising from group psychological therapies. There was evidence of a short-term benefit for some psychological outcomes, but they were not sustained at follow-up. There was no evidence of longer survival times in women allocated to receive a psychological intervention. <LINK REF="REF-Edwards-2008" TYPE="REFERENCE">Edwards 2008</LINK> found the relative lack of available data in this field as the main limitation of the review. There was also heterogeneity in the outcome measures and follow-up durations, and a lack of data in suitable format for combination.</P>
<P>This 2012 review is an update of the Cochrane review first published in 2004 and previously updated in 2007. For this 2012 update, we used a modified search strategy that included more search terms for the different topics and a randomised controlled trial (RCT) search string. We also devised a new search strategy for CINAHL as the database changed from being SP to EBSCOhost.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-07-10 23:02:42 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>To assess the effects of psychological interventions on key psychosocial outcomes and survival for women with metastatic breast cancer.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-05-09 09:38:13 +1000" MODIFIED_BY="Mohammed Mustafa">
<SELECTION_CRITERIA MODIFIED="2013-05-09 09:06:39 +1000" MODIFIED_BY="Mohammed Mustafa">
<CRIT_STUDIES MODIFIED="2013-05-08 10:55:45 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>We included published studies using a randomised controlled trial (RCT) design along with cluster-randomised controlled trials with the unit of randomisation as an institute or definable organisation (for example general practice, hospital, college).</P>
<P>Studies were included even if they were not 'intention to treat', owing to the nature of the patient group under study and the likely high loss of follow-up data (<LINK REF="REF-McWhinney-2002" TYPE="REFERENCE">McWhinney 2002</LINK>).</P>
<P>We excluded results of studies with other designs for the formal assessment of intervention effects. However, such studies and consumer literature were considered in interpreting the results of the review, and they informed the review authors' conclusions.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-05-08 10:57:10 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Studies involving women with metastatic breast cancer (that is stages three or four). This included women with metastatic disease present at first diagnosis ('contemporaneous' metastatic disease) and those in whom metastatic disease was diagnosed after the initial diagnosis and treatment phases of disease ('delayed' metastatic disease).</P>
<P>We excluded those studies involving patients with non-metastatic breast cancer (that is stages one or two) or where there were no separate data on the stage of breast cancer. Similarly, studies involving interventions for people with a range of conditions (that is including people with other cancers) were excluded if specific data regarding women with metastatic breast cancer could not be extracted.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-05-08 11:00:15 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>The intervention had to be based on one or more psychological or (broader) psychosocial categories as described in the <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK> to the review (<LINK REF="REF-Fawzy-1995" TYPE="REFERENCE">Fawzy 1995</LINK>). These were:</P>
<OL>
<LI>education;</LI>
<LI>individual psychotherapy;</LI>
<LI>cognitive behavioural training; and</LI>
<LI>group interventions.</LI>
</OL>
<P>The characteristics of these interventions are as described in the <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK> to the review. They provide the basis and details for the inclusion and exclusion criteria.</P>
<P>Studies were excluded if data from multi-faceted interventions were reported and it was not possible to extract specific data about the psychological or psychosocial intervention effects themselves.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-05-09 09:06:39 +1000" MODIFIED_BY="Mohammed Mustafa">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-05-09 09:06:39 +1000" MODIFIED_BY="Melina L Willson">
<P>The outcomes of interest were: (a) a change in participants in the intervention group according to psychological measures, and (b) survival. Survival was measured at one, five and 10 years after the intervention, if available.</P>
<P>Psychological outcome measures, duration and follow-up were according to what was reported as opposed to being set by a prior hypothesis. The range of psychological outcome measures used in this field of research is large (<LINK REF="REF-Deflorio-1995" TYPE="REFERENCE">Deflorio 1995</LINK>; <LINK REF="REF-Fawzy-1995" TYPE="REFERENCE">Fawzy 1995</LINK>; <LINK REF="REF-Petticrew-2002" TYPE="REFERENCE">Petticrew 2002</LINK>). Therefore, obtaining a uniform outcome measure was problematic. The review addressed the following categories of patient outcomes, as described below, and includes the types of measures most frequently reported in the included studies.</P>
<OL>
<LI>Generic psychological outcome instruments: Profile of Mood States (POMS); Center for Epidemiologic Studies Depression Scale (CESD-20); Mental Adjustment to Cancer Scale; Rationality/Emotional Defensive Scale; Courtauld Emotional Control Scale; Impact of Event Scale; Coopersmith Self-Esteem Inventory; Weinberger Adjustment Inventory; Stanford Emotional Self Efficacy Scale Cancer.</LI>
<LI>Quality of life: European Organisation for Research and Treatment of Cancer (EORTC) QLQ C30.</LI>
<LI>Symptom scores: Pain Rating Scale.</LI>
<LI>Condition-specific outcomes: Cancer Rehabilitation Evaluation System; Functional Living Index for Cancer.</LI>
<LI>Relationship and social support measures: Yale Social Support Index; Duke UNC Functional Social Support Questionnaire; Marlowe Crowne Social Desirability Scale; Perceived Emotional Support; Supportive Care Needs Survey.</LI>
</OL>
<P>To minimise problems of some studies contributing unduly to the overall review findings, we specified the principal outcome measures of this review to be Profile of Mood States (POMS) and survival data. Studies were excluded if they included unvalidated or subjective outcome measures. </P>
<P>We also sought to review any reported economic evaluation of the healthcare costs associated with the psychological or psychosocial intervention.</P>
</CRIT_OUTCOMES_PRIMARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-05-09 09:14:17 +1000" MODIFIED_BY="Mohammed Mustafa">
<ELECTRONIC_SEARCHES MODIFIED="2013-05-09 09:13:26 +1000" MODIFIED_BY="Melina L Willson">
<P>The search strategy for the review included the following, and involved the Trials Search Co-ordinator for the Cochrane Breast Cancer Group.</P>
<P>The search strategies from the original and updated (2007) review were modified and used to interrogate the following databases: </P>
<OL>
<LI>Cochrane Breast Cancer Group Specialised Register (June 2011);</LI>
<LI>MEDLINE (OvidSP) (1947 to June 2011), see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>;</LI>
<LI>EMBASE (OvidSP) (1947 to June 2011), see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>;</LI>
<LI>PsycINFO (OvidSP) (1806 to June 2011), see <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>;</LI>
<LI>CINAHL (EBSCOhost) (June 2011), see <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>.</LI>
</OL>
<P>There were no date or language limitations applied. These electronic databases were chosen as they were most likely to identify relevant studies.</P>
<P>The search strategy for the 2007 update was edited for several reasons: (A) each subject area of the core structure was expanded with more search terms; (B) search strings for RCTs were used for this additional search in accordance with <LINK REF="REF-SIGN-2011" TYPE="REFERENCE">SIGN 2011</LINK> (for EMBASE) and <LINK REF="REF-Eady-2008" TYPE="REFERENCE">Eady 2008</LINK> (for PsycINFO); (C) the search strategy for CINAHL could no longer be conducted on Ovid and so a separate strategy was created for EBSCO. As indexing in this field of literature is poor (<LINK REF="REF-Cook-2001" TYPE="REFERENCE">Cook 2001</LINK>), the original review (<LINK REF="REF-Edwards-2004" TYPE="REFERENCE">Edwards 2004</LINK>) and update (<LINK REF="REF-Edwards-2008" TYPE="REFERENCE">Edwards 2008</LINK>) search strategy centred on topic areas without restrictions for study design. That is, RCT filters were not used as early trials may not have been reliably indexed in this field and conventional search filters could have been inaccurate.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-05-09 09:14:17 +1000" MODIFIED_BY="Melina L Willson">
<OL>
<LI>Handsearching reference lists of previous trials, systematic reviews and meta-analyses. </LI>
<LI>Trials and research registers were also searched in July 2011. These included: (A) ClinicalTrials.gov (<A HREF="http://www.clinicaltrial.gov/">http://www.clinicaltrial.gov/</A>) (see <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>), Current Controlled Trials (http://www.controlled-trials.com/) (see <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal (<A HREF="http://www.who.int/trialsearch">www.who.int/trialsearch</A>) (see <LINK REF="APP-07" TYPE="APPENDIX">Appendix 7</LINK>).</LI>
</OL>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-05-09 09:38:13 +1000" MODIFIED_BY="Mohammed Mustafa">
<STUDY_SELECTION MODIFIED="2013-05-09 09:16:06 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>The initial selection of publications from search outputs was undertaken by two review authors independently (MM and ACS). Refer to <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> for details of the selection process during the 2012 review update. Titles and abstracts of studies generated by the search strategies were checked for possible inclusion against the eligibility criteria (see data extraction sheet, <LINK REF="APP-08" TYPE="APPENDIX">Appendix 8</LINK>). Disagreements over selection were resolved by discussion between MM and ACS, and AE if required. The full reports were retrieved for any study that appeared initially suitable for the review and further checked. If the full reports of the studies did not have the required level of data (for example separate data based on the type or stage of cancer) to decide on inclusion, or missing data could not be retrieved from author contact, the study was excluded on that basis. The reasons for non-inclusion of studies have been noted (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-05-09 09:18:30 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Using the data extraction sheet, all papers were appraised and analysed by two review authors (MM and ACS). The following information was extracted from each paper, where available.</P>
<OL>
<LI>General information: title, authors, year, country of origin, ethical approval, funding, duration.</LI>
<LI>Eligibility: RCT (type and method of randomisation), women with metastatic breast cancer, psychological intervention type.</LI>
<LI>Participants: sample size calculation, method of recruitment, inclusion and exclusion criteria, demographic descriptors, similarity of groups at baseline, the numbers through the process (including numbers eligible, excluded, withdrawn, lost to follow-up).</LI>
<LI>Interventions: description (including nature, duration, frequency), setting, type of provider, quality (including details of training for the providers and measures to gauge validity of intervention), details of the control group.</LI>
<LI>Outcome measures: primary and secondary outcomes as reported in the study, methods and timing of assessing effects, data on the validity of outcome measurement tools used, follow-up details.</LI>
<LI>Statistical methods used.</LI>
<LI>Results.</LI>
<LI>Risk of bias criteria (see below).</LI>
</OL>
<P>For included studies, if further information was required (for example stage of breast cancer, statistical outcome data), the designated author was contacted by e-mail for discrete data, where possible.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-05-09 09:23:24 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>The methodological quality of the studies was analysed according to the Cochrane Collaboration&#8217;s tool for assessing risk of bias (<LINK REF="REF-Higgins-and-Green-2011" TYPE="REFERENCE">Higgins and Green 2011</LINK>). It is a domain-based evaluation, as opposed to being a scale or a checklist. The following elements of each domain of bias were rated as &#8216;low risk&#8217;, &#8216;high risk&#8217; or &#8216;unclear risk&#8217;.</P>
<OL>
<LI>Random sequence generation (selection bias): assessment of the method used to generate the allocation sequence to produce comparable groups.</LI>
<LI>Allocation concealment (selection bias): assessment of the method used to conceal the allocation sequence to determine whether intervention allocations could have been foreseen in advance of, or during, enrolment.</LI>
<LI>Blinding of participants and personnel (performance bias): if applicable, assessment of measures used to blind study participants and personnel from knowledge of which intervention a participant received and whether it was effective.</LI>
<LI>Blinding of outcome assessment (detection bias): assessment of measures used to blind outcome assessors from knowledge of which intervention a participant received and whether it was effective.</LI>
<LI>Incomplete outcome data (attrition bias): assessment of the completeness of outcome data for each main outcome, including reporting of and reasons for attrition and exclusions from the analysis, and if there were any re-inclusions.</LI>
<LI>Selective outcome reporting (reporting bias): assessment of  the possibility of selective outcome reporting by the authors.</LI>
<LI>Other sources of bias.</LI>
</OL>
<P>The risk of bias of included studies was described, including statements to support the authors&#8217; judgement, in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. Owing to the nature of the intervention studies, assessing the blinding of treatment assignment was not appropriate.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-05-09 09:26:01 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Studies in this review derive from different psychological or psychosocial interventions, in particular the split between cognitive behavioural therapies and the (group) supportive-expressive therapies. Nevertheless, the essential characteristic of the interventions (based on psychological or psychosocial elements) renders data combination appropriate.</P>
<P>Studies were first examined for descriptions of the intervention and qualitative synthesis. In view of the large number of different outcome instruments used in this field (see <LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>), data for the following outcomes were combined from three or more studies for meta-analyses:</P>
<OL>
<LI>survival (one and five-year);</LI>
<LI>Profile of Mood States (POMS) full version (10 to 12 months);</LI>
<LI>pain (at one year).</LI>
</OL>
<P>These durations of follow-up were driven by what was available and reported, and not in relation to a priori hypotheses. We recognise that such analysis can be subject to data censoring, representing a potential weakness for conclusions to be drawn, but it reflects the nature and paucity of data available. Survival data were extracted at designated follow-up periods after randomisation, rather than from diagnosis of metastases, to evaluate effects subsequent to the intervention.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2013-05-09 09:26:55 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Intention-to-treat analyses were conducted. Wherever possible, authors were contacted for data that could not be imputed from the published reports. Thereafter, if no further useable data were available, the study was not included in analysis.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-05-09 09:29:36 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Statistical heterogeneity was assessed using the I<SUP>2 </SUP>statistic [(Q-df)/Q] x 100% with Q representing the Chi<SUP>2</SUP> statistic and df its degree of freedom (<LINK REF="REF-Higgins-and-Green-2011" TYPE="REFERENCE">Higgins and Green 2011</LINK>). This describes the percentage variability in effect estimates that is due to heterogeneity rather than chance (sampling error). </P>
<P>An I<SUP>2 </SUP>value greater than 50% suggests substantial heterogeneity. As an additional measure of the strength of evidence for heterogeneity, the observed I<SUP>2 </SUP>value was interpreted along with the P value (assuming significance at less than 0.05) from the Chi<SUP>2</SUP> test and the extent to which the confidence intervals (CIs) for individual studies overlapped when graphically depicted in forest plots. In cases of substantial heterogeneity, we attempted to explain the variation. Because of this, and in particular the disparate nature of the interventions (cognitive behavioural and supportive-expressive therapies), the random-effects model was employed. If the observed I<SUP>2 </SUP>value exceeded 80% then meta-analysis was not undertaken.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2013-05-09 09:32:12 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>An insufficient number of studies contributed to the outcomes so funnel plots were not constructed for inspection for signs of asymmetry, which is otherwise an indication of publication bias.   </P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-05-09 09:35:55 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>For meta-analyses, data were pooled from three or more RCTs if comparable measures were used. The effect size for studies was summarised as an odds ratio (OR). </P>
<P>Review Manager 5.1 software (<LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK>) was used to generate descriptive and inferential statistics. The software was used to calculate single study and pooled ORs for the dichotomous outcomes (for example survival) with 95% confidence intervals (CIs). ORs were calculated using the Mantel-Haenszel method and a random-effect model in cases where the I<SUP>2 </SUP>measure was 50% or more, or in the case where there was clear clinical heterogeneity (for example differences in psychological or psychosocial therapies). A random-effects model meta-analysis, which is more conservative than the fixed-effect model, assumes that the effect sizes varies across the different studies but that they still follow the same normal distribution. </P>
<P>An OR greater than one would suggest more participants benefited in the intervention group compared to the control group and was graphically represented on the right of the axis of the forest plot.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-06-25 22:14:13 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Potential clinical variations causing heterogeneity were explored by subgroup analysis stratified according to the type of psychological or psychosocial intervention (principally cognitive behavioural versus supportive expressive therapies). </P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-05-09 09:38:13 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>A sensitivity analysis was conducted to evaluate possible causes of methodological heterogeneity. This was based on repeated analysis excluding trials regarded at highest risk of bias. This analysis focused on two domains of the 'Risk of bias' tool in which weaknesses are especially likely to be significant in this field of palliative care research: (a) high post-randomisation attrition rate (more than 40%); and (b) unblinded outcome assessment. We also considered sensitivity analysis in the case of a high risk of selection bias consequent to poor randomisation.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-05-09 11:06:24 +1000" MODIFIED_BY="Mohammed Mustafa">
<STUDY_DESCRIPTION MODIFIED="2013-05-09 10:15:54 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Details of the included individual studies are summarised in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. The excluded studies are listed with reasons for their exclusion in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>. Studies are identified by the first author and publication year. </P>
<SEARCH_RESULTS MODIFIED="2013-05-09 09:40:39 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>In the 2012 review update, the electronic search strategies identified 860 new titles (see <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>) (for previous versions of this review refer to <LINK REF="REF-Edwards-2008" TYPE="REFERENCE">Edwards 2008</LINK>). Two further titles were identified from other references. Seven hundred and sixty-two titles were not relevant to this review and were excluded. Of the 100 remaining titles, 55 duplicates were excluded. Forty-five full text articles were further assessed for eligibility; 27 were excluded as they did not satisfy one or more of the inclusion criteria. Ten studies (18 publications) met the inclusion criteria. Seven studies were included in the meta-analyses. Outcomes that did not meet the criteria for meta-analysis were described from nine studies.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-05-09 10:15:54 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Ten studies published between 1989 and 2010 were included in the review, involving 1378 women with metastatic breast cancer. All 10 RCTs used individuals as the unit of randomisation. Individual studies are described in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, and a summary of the studies is presented in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Recruitment and setting</HEADING>
<P>Four studies were conducted in the United States of America (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>; <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>), three in Australia (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>), two in Canada (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>) and one in Austria (<LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>). The recruitment for eight studies was from secondary healthcare settings (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>; <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). Two studies also used media publicity in the wider community (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>) and one trial recruited from a larger, descriptive research study in which one of the authors already had involvement (<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>). It was unclear from where <LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK> or <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK> recruited patients.</P>
<P>Outpatient clinics were used to deliver the interventions in two studies (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>). One study each used a healthcare setting (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>), participants&#8217; home (<LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>), therapist&#8217;s office (<LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>) or a venue of the participants&#8217; choice (<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>). The intervention settings were unclear in four studies (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Intervention</HEADING>
<P>The interventions from seven studies fell into two categories: cognitive behavioural (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>), and supportive-expressive group therapies (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>); with a third reserved for three studies that did not have a common intervention type (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>; <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">Cognitive behavioural group interventions</HEADING>
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK> used a group-based intervention that comprised of three components. The first component was a course of 35 weekly group meetings (typically involving five to eight participants per group) lasting approximately two hours each, and covering issues including support, problem solving and emotional reactions to the disease. The second component was a 20-week course of cognitive behavioural assignments to be completed at home and then discussed in the group setting. These covered thought and behaviour monitoring and introduced substitutes for patterns identified as problematic or resistant to change. In the third component, participants were invited to an 'Intensive Weekend Coping Skills Training course', which addressed skills such as relaxation, stress control, positive affirmations and goal setting.</P>
<P>The trial by <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK> involved eight weekly sessions of Cognitive Behaviour Therapy (CBT) and a family night, followed by three further sessions one month apart. Participants were taught a range of cognitive and behavioural coping strategies, including thought monitoring, cognitive restructuring, use of coping statements, effective communication, goal setting and relaxation. Sessions comprised information sessions on one of these themes followed by group discussion. Homework was also set each week, to be discussed at subsequent meetings.</P>
<P>The intervention used by <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK> used cognitive and behavioural approaches and included such strategies as problem solving, regaining control, and setting new goals for the future. They focused on the patients&#8217; coping strategies, self-esteem and femininity, overcoming feelings of helplessness, negative thoughts and depression, and promotion of a fighting spirit. There were no set number of sessions or limits on their duration.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Supportive-expressive group therapy (SEGT)</HEADING>
<P>There were four separate studies in this category. For <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>, patients in the intervention group were invited to weekly group support sessions, lasting 90 minutes each, for one year. The topics and nature of the support covered: building bonds, expressing emotions, detoxifying death and dying, redefining life priorities, increasing the support of friends and family, improving the doctor-patient relationship, and improving coping skills. There were three groups in the intervention arm; one group was also selected to receive specific input regarding self-hypnosis for pain control.</P>
<P>
<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK> was modelled on the first trial (<LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>) with the intervention groups divided into three, each taking part in weekly, 90-minute group therapy for a year. However, the groups continued for &#8216;several years&#8217; and for as long as eight years. The supportive environment for participants included encouragement to express difficult emotions, confront problems, strengthen relationships with family and physicians, and find enhanced meaning in their lives. Self-hypnosis for pain was again included in this intervention. All participants also received educational materials after each assessment.</P>
<P>For <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>, the intervention comprised of weekly, 90-minute meetings for groups of eight to 12 women who had been asked to attend for at least one year. The therapy fostered support among the group members and encouraged expression of emotions and sharing of experiences about the effects of the illness on self and relationships with family or others. The participants also discussed strategies for coping and communicating. A monthly 90-minute session was available for family members and friends. All participants also received educational materials after each assessment.</P>
<P>
<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK> used an intervention that involved weekly, 90-minute group therapy for a year. The intervention aimed to improve relationships with family, friends and physicians, and to create a network of support and foster coping skills. The women were encouraged to have interactions outside of the group intervention setting. The women were also offered three further one-hour relaxation classes over consecutive weeks, annually.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Other interventions: individual-based</HEADING>
<P>For <LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>, the trial&#8217;s psycho-educational intervention comprised two components. The first was a one-hour face-to-face meeting with a breast cancer nurse who actively listened to the participant&#8217;s concerns, offered empathy and support, and elicited understanding of their situation (orientation). Information provided was tailored to the woman&#8217;s individual concerns (tailored response). Coaching and rehearsal of self-care, stress reduction and communication strategies to tackle the participant&#8217;s main problem were provided (coaching and practising self-care and communication strategies). Each woman was also given relevant information cards on self-care and communication strategies and a copy of her personal self-care plan. Women were provided with a relaxation CD. The second session was conducted over the telephone one week later to ask whether the suggested strategies had ameliorated the concerns; to elicit and respond to any concerns remaining; to reinforce or modify planned self-care strategies or introduce new ones; and to prompt for further questions or new concerns.</P>
<P>
<LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK> evaluated a weekly peer-delivered telephone intervention of four to eight sessions (one or two calls per week), each focusing on the quality of life and concerns as expressed by the participant. After the first session, participants were sent standardised information pamphlets.  </P>
<P>The <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK> trial employed an emotionally expressive writing intervention where the women, in a setting of their choice (for example home), would write about cancer-related emotions during four 20-minute sessions. The participants received information for the writing exercises beforehand. At the beginning of each session they were called by a research assistant, read the instructions, and then telephoned 20 minutes later to stop writing.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Control group</HEADING>
<P>Although it was unclear in one study (<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>), there was diversity among the remaining included studies concerning the nature of the comparator to the psychological intervention. Four studies described the control group as having standard care (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). In addition, <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK> offered a workbook as part of a home study cognitive behavioural package and two audiotapes for self-directed practice of relaxation and mental imaging; this constituted the material available to the intervention group as part of their &#8216;Intensive&#8217; weekend programme. However, the control group were not permitted to attend the course itself.</P>
<P>Although the control conditions were not specified in three studies (<LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>; <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>), it would be reasonable to assume standard care was provided.  </P>
<P>Educational material was provided in two studies (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>). <LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK> also offered one-year membership to a local consumer health library. Relaxation classes were offered in one study (<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>).</P>
<P>The studies did not report any difference between the trial groups except for the interventions.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Provider</HEADING>
<P>The intervention was delivered by a psychologist, psychiatrist or social worker in seven studies (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). For the telephone-based intervention study, a trained research assistant was used (<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>). Breast cancer nurses were the providers in <LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>. Counsellors in one study were mostly survivors of breast cancer recurrence (<LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>). A co-provider in one study also had a history of breast cancer (<LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Training of the provider</HEADING>
<P>Four studies referred to training the providers of the intervention, but they varied in their descriptions of duration, content, trainer, format and adherence to guidelines (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>). Breast care nurses attended two training days, delivered by a team including the authors, that included the medical and psychosocial management of women with advanced breast cancer and role playing scenarios (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>). Providers received training according to a published therapy manual (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>) as well as observation of training videotapes and attendance at a workshop, both by David Spiegel (<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>).</P>
<P>Only two studies reported monitoring the provider (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>). Providers were given feedback to &#8216;promote consistent delivery of the intervention&#8217; by reviewing videotaped sessions monthly and during two-day workshops every nine to 12 months that were attended by David Spiegel or his associate Catherine Classen (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>). Therapists and supervisors met fortnightly and also quarterly over six years to receive feedback about fidelity and to promote uniform application of the therapy (<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Survival outcome</HEADING>
<P>Six studies that published outcomes pertaining to survival presented the data at one and five-year follow-up (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>), and four also at 10 years of follow-up (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). Ten-year survival for two studies were from diagnosis of metastases rather than study entry or randomisation (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>).</P>
<P>Three studies described survival from randomisation (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>) and three from study entry (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Psychological outcomes</HEADING>
<P>Five studies used POMS (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). However, different versions of the scale were used: short version (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>) and full version (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). They also used a different duration of follow-up for evaluation: six months (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>), eight months (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>), 10 months (<LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>) and 12 months (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>).</P>
<P>Anxiety data were extracted primarily from the Tension-Anxiety subscale of the POMS. Two studies provided data: at six months (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>) and 12 months (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>).</P>
<P>Four studies used various other measures to evaluate generic psychological outcomes: Mental Adjustment to Cancer (MAC) scale, Rationally Emotional Defensiveness scale and Defensive Repression (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>); mini-MAC (<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>); Coopersmith Self Esteem Inventory adult form (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>); Weinberger Adjustment Inventory, Stanford Emotional Self Efficacy Scale Cancer, and Courtauld Emotional Control Scale (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>).</P>
<P>Impact of Event Scale (IES), a measure of trauma symptoms, was used in three studies (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>; <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>); although, in contrast to the two evaluating &#8216;total&#8217; IES scores, <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK> assessed the IES domain &#8216;intrusion&#8217;. Another patient-based outcome measure, Life Event Scale, was used by one study (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Quality of life</HEADING>
<P>Health-related quality of life was used in four studies: three studies used the EORTC C-30 measure (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>), and one study that measured quality of life using semi-structured interviews and the visual analogue scale (<LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>). </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Pain</HEADING>
<P>Pain was assessed in three studies (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK> and <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK> used a visual analogue scale ranging from zero (no pain) to 10 (worst imaginable pain). For <LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>, it relied on using the Likert-like scales for assessing pain at that moment, its constancy and frequency.  </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Condition-specific outcome measures</HEADING>
<P>Two studies used condition-specific outcome measures: Functional Living Index measure (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>) and Cancer Rehabilitation Evaluation System Short Form (<LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Relationship and social support measures</HEADING>
<P>Four studies used various measures to assess relationships and social support: Supportive Care Needs Survey (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>); Duke UNC Functional Social Support questionnaire, and Marlowe Crowne Desirability Scale (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>); Yale Social Support Index and Single Item Measure of Social Support (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>); and Perceived Emotional Support (<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Economic evaluation</HEADING>
<P>No studies described any cost-effectiveness analysis for their chosen psychological or psychosocial intervention.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Other</HEADING>
<P>One study used a symptom score: the Pittsburgh Sleep Quality Index (<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>). One study used the Hypnotic Induction Profile (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>). Two studies used measures to rate the intervention itself (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-05-09 10:45:02 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>The risk of bias in included studies has been summarised in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2012-07-09 17:38:24 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Three studies did not describe their methods of sequence generation and so were rated as unclear risk (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). Four studies provided insufficient information on allocation concealment and were similarly rated as having an unclear risk for selection bias (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). </P>
</ALLOCATION>
<BLINDING MODIFIED="2013-05-09 10:33:52 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Blinding of participants and providers of the intervention was not feasible in such trials. However, in terms of blinding outcome assessors, insufficient information was available to make judgements in all but two studies (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>) and so were described as unclear risk (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>; <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>). </P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-05-09 10:34:55 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>The data were not always clearly presented to establish what the numbers and reasons were for attrition and exclusions. For two studies there was insufficient information in the studies and related published articles to permit judgement on attrition bias (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). The method of follow-up was unclear (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>) and there were no discussions of the number of patients who completed follow-up questionnaires (<LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). As <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK> reported a dropout rate of 60% affecting the 20 patients randomised to the intervention, it was deemed that this could induce a clinically relevant bias in the intervention effect estimate and thus was judged as high risk of attrition bias.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2012-07-10 23:02:43 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>It was clear from all of the published reports that the studies&#8217; pre-specified expected outcomes of interest were reported. As a result they were all judged to be at low risk of reporting bias.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-05-09 10:45:02 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Several studies were judged to be &#8216;unclear&#8217; for bias that was not part of the criteria already described above, but could be grouped according to intervention fidelity, baseline differences and other.</P>
<SUBSECTION>
<HEADING LEVEL="4">Intervention fidelity</HEADING>
<P>There was a paucity of information concerning the fidelity of the interventions, not only in terms of method specificity but also the training in and maintenance of the intervention for all but two studies (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>). Fidelity of the intervention was attempted by videotaping the sessions and reviewing them weekly (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>) and by supervision throughout the study period (<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>). However, no trial provided information on what methods (for example scale) were employed to gauge the provider&#8217;s in-session proficiency or processes to address measures below particular thresholds of proficiency.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Baseline differences between intervention and control groups</HEADING>
<P>In <LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>, at study entry a greater proportion of patients in the intervention arm were undergoing current radiotherapy (93% versus 73%) and more patients in the usual care arm of the study had children who were minors (38% versus 14%).</P>
<P>In <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>, a potential risk of bias existed due to differences between the groups at the time of diagnosis. The intervention group were younger than those in the control group at the time of diagnosis (mean age 44.0 years versus 46.6 years) and were less likely to be postmenopausal (14.6% versus 33.8%). They were also more likely to have had involvement of axillary nodes (70.9% versus 50.7%). The tumours of the women in the intervention group were more likely to have had oestrogen receptors (69.0% versus 54.5%) and progesterone receptors (63.9% versus 42.9%), and the use of adjuvant chemotherapy was more common in the intervention group (75.9% versus 55.6%).</P>
<P>In the trial by <LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>, the arms were balanced at the time of randomisation but with two exceptions: more patients in the intervention group received chemotherapy (71% versus 57%) and more control patients received hormone therapy for recurrence (36% versus 49%).  </P>
<P>For <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>, there was a &#8216;nearly significant&#8217; difference in staging at initial diagnosis, with initial staging favouring the intervention group as it took place on average 59.8 months before the study began.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other</HEADING>
<P>For <LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>, it was unclear whether participants recruited from public hospitals would have different health seeking behaviours compared to those recruited from the private hospital. </P>
<P>In <LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>, they found a difference in terms of ethnicity in the samples at follow-up. There were more minority women in the control group, scoring higher for Suppression, Restraint, Repressive&#8211;Defensiveness, and Emotional Self-Efficacy. It was unclear whether women of different ethnic minority origins would have different health behaviours.</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-05-09 11:06:24 +1000" MODIFIED_BY="Mohammed Mustafa">
<SUBSECTION>
<HEADING LEVEL="3">Survival outcome: one year</HEADING>
<P>The pooled effect across six studies (n = 856) favoured the psychological interventions with an OR of 1.46 (95% CI 1.07 to 1.99) (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). A random-effects model was used as data from different intervention types were being pooled. There was no evidence of statistical heterogeneity (I<SUP>2 </SUP>= 0%). See <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Survival outcome: five years</HEADING>
<P>The meta-analyses of four studies (n = 666) did not indicate a survival benefit for the psychological intervention group compared to the control group at five years, OR 1.03 (95% CI 0.42 to 2.52) (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). A random-effects model was used as data from different intervention types were being pooled. There was evidence of statistical heterogeneity, I<SUP>2 </SUP>= 70%. Two studies were not considered in the meta-analysis of the five-year survival data as their data were from point of metastasis, not from point of randomisation (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>). See <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Survival outcome: 10 years</HEADING>
<P>The 10-year survival outcomes did not meet the criteria for meta-analysis as there were only two studies with survival data from study entry or randomisation (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>) (see <LINK TAG="EFFECT_MEASURES" TYPE="SECTION">Measures of treatment effect</LINK>). See below, 'Description of non meta-analysed outcomes'.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Psychological outcome: Profile of Mood States (POMS) full version 10 to 12 months</HEADING>
<P>Pooling three studies, all of supportive/expressive group therapy (SEGT) (n = 257), there was no statistically significant evidence of short-term outcome benefit from the intervention on psychological measures using POMS (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>), mean difference -11.54 (95% CI -28.68 to 5.60). There was evidence of heterogeneity (I<SUP>2 </SUP>= 71%) and a random-effects model was used. See <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pain at 12 months                                      </HEADING>
<P>Pooling three studies, all of the SEGT (n = 279), showed improved pain scores with a mean difference of -0.58 (95% CI -0.98 to -0.18) (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>) (<LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>). There was no evidence of heterogeneity (I<SUP>2 </SUP>= 0%) and a fixed-effect model was used. See <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis</HEADING>
<P>Two of the studies with outcomes that featured in the meta-analyses (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>) were found to have an unclear risk of selection bias. A sensitivity analysis was performed on the survival meta-analyses, removing data from both studies for the one-year analysis and removing Spiegel&#8217;s data from the five-year analysis.</P>
<P>While removing both sets of data from the survival meta-analysis at one-year increased the overall treatment effect (OR 1.74; 95% CI 1.21 to 2.48), removing <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK> at five years caused a decrease in treatment effect (OR 0.80; 95% CI 0.40 to 1.64).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Description of non meta-analysed outcomes</HEADING>
<P>The outcomes that did not meet the criteria for meta-analyses are described below and summarised in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Survival - mean and median</HEADING>
<P>
<LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK> found a highly significant difference between groups in terms of survival (P &lt; 0.0001), with mean survival times from study entry of 18.9 months (SD 10.8) for the control group and 36.6 months (SD 37.6) for the intervention group.</P>
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK> found no significant difference between treatment groups in terms of survival (P = 0.35), with median survival times from randomisation of 28.2 months (interquartile range (IQR) 25.8 to 51.7) for the control group and 23.6 months (IQR 18.9 to 34.9) for the intervention group.</P>
<P>
<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK> found no significant difference between treatment groups in terms of survival (P = 0.731), with median survival times from study entry of 33.3 months in the control group and 30.7 months in the intervention group.</P>
<P>
<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK> found no significant difference between treatment groups in terms of survival (P &gt; 0.1), with median survival times from recruitment of 1.07 years (IQR 0.63 to 1.48) for the control group and 0.97 years (IQR 0.59 to 1.46) for the intervention group.</P>
<P>
<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK> found no significant difference between treatment groups in terms of survival (P = 0.72), with median survival times from randomisation of 17.6 months in the control group and 17.9 months in the intervention group. The hazard ratio for death during the study in the intervention group compared to the control was 1.06 (95% CI 0.78 to 1.45, P = 0.72).</P>
<P>
<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK> found no significant difference between treatment groups in terms of survival (P = 0.60), with median survival times of 18.3 months in the control group and 24.0 months in the intervention group. The hazard ratio for death during the study in the intervention group compared to the control was 0.92 (95% CI 0.69 to 1.24, P = 0.60).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Psychological outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Anxiety</HEADING>
<P>
<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK> found no significant difference between treatment groups in terms of anxiety change scores at six months (P = 0.674), with mean changes of -0.28 (SD 6.90) for the control group and 0.39 (SD 5.56) for the intervention group.</P>
<P>
<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK> found a significant difference between treatment groups in terms of anxiety scores at 12 months, after adjusting for baseline scores (P = 0.002). The 12-month change score was 1.9 (SD 5.7) for the control group and -1.5 (SD 6.9) for the intervention group (favours the intervention group).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">The Centre for Epidemiologic Studies &#8211; Depression Scale (CES-D)</HEADING>
<P>
<LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK> found no significant difference between treatment groups in terms of reported depression at three months, adjusted for baseline scores (P = 0.50), with depressive symptoms exhibited in 40% of control patients and 47% of intervention patients (OR adjusted for baseline depression 0.80; 95% CI 0.41 to 1.54).</P>
<P>
<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK> found no significant difference between treatments groups in terms of reported depression at three months, with follow-up mean scores (adjusted for baseline scores) of 13.2 (SD 8.24) for the control group and 12.8 (SD 8.24) for the intervention group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Profile of Mood States (POMS)</HEADING>
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK> found no significant difference between treatment groups in terms of POMS (short version) change scores at eight months (P &gt; 0.05), with mean changes of 1.54 (SD 11.05) for the control group and 0.18 (SD 11.94) for the intervention group.</P>
<P>
<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK> found no significant difference between treatment groups in terms of POMS (full version) change over 12 months (P = 0.20), with mean slopes of -0.14 for the control group and -0.21 for the intervention group.</P>
<P>
<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK> found no significant difference between treatment groups in terms of POMS (full version) change scores at six months (P = 0.818), with mean changes of -0.15 (SD 28.55) for the control group and -1.87 (SD 30.36) for the intervention group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Self-esteem</HEADING>
<P>
<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK> found no significant difference between treatment groups in terms of self-esteem change scores at six months (P = 0.341), with mean changes of 2.97 (SD 12.86) for the control group and -0.42 (SD 14.87) for the intervention group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Rationality/Emotional Defensive scale (RED)</HEADING>
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK> found no significant difference between treatment groups in terms of RED change scores at eight months (P &gt; 0.05), with mean changes of 1.89 (SD 4.38) for the control group and 1.32 (SD 3.98) for the intervention group. The findings were similarly non-significant at four and 14 months.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Mental Adjustment to Cancer (MAC)</HEADING>
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK> found no significant difference between treatment groups in terms of MAC change scores for any of its domains (fighting spirit, helplessness, anxious pre-occupation, fatalism and anxiousness) at four, eight or 14 months.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Mini-Mental Adjustment to Cancer (Mini-MAC)</HEADING>
<P>
<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK> found there was reduced helplessness-hopelessness for SEGT at all five time points for the intervention group compared to the controls (F = 4.20, P = 0.004).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Courtauld Emotional Control Scale (CECS)</HEADING>
<P>
<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK> found a significant difference between treatment groups in terms of CECS (P = 0.01), with mean slopes of 0.03 (SD 0.86) for the control group and -0.29 (SD 0.78) for the intervention group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Impact of Event Scale (IES)</HEADING>
<P>
<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK> found a significant difference between treatment groups in terms of IES total change scores over 12 months (P = 0.03), with mean slopes of -0.29 for the control group and -0.61 for the intervention group.</P>
<P>
<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK> found no significant difference between treatment groups (for participants with data for at least two of the five time points &#8211; ranging from six to 24 months) in terms of IES total scores (F = 3.33, P = 0.07).</P>
<P>
<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK> found no significant difference between treatments groups in terms of the intrusion domain of the IES at three months, with follow-up mean scores (adjusted for baseline scores) of 10.1 (SD 0.96) for the control group and 8.7 (SD 0.94) for the intervention group.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Quality of Life</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">EORTC QLQ-C30</HEADING>
<P>
<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK> found no significant difference between treatment groups in terms of the global EORTC QLQ-C30 score at 12 months (P = 0.76), with mean scores of 58.8 (SD 23.5) for the control group and 59.7 (SD 20.2) for the intervention group. No significant differences between groups were observed for any of the domains.</P>
<P>
<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK> found no significant difference between treatment groups in terms of overall EORTC QLQ-C30 change scores (P &gt; 0.05), with mean changes of -26.2 (SD 42.7) in the control group and -28.1 (SD 36.1) in the intervention group at one month. Mean changes of -33.6 (SD 36.6) in the control group and -22.6 (SD 39.1) in the intervention group were observed at three months. No significant differences between groups were observed for any of the domains.</P>
<P>
<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK> found a significant difference between treatment groups (for participants with data for at least two of the five time points, ranging from six to 24 months) in terms of the social functioning domain of the EORTC QLQ-C30 (F = 4.56, P = 0.03) but found no significant differences in terms of the emotional (F = 2.00, P = 0.16) and physical (F = 0.18, P = 0.68) functioning domains of the EORTC QLQ-C30.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Visual analogue scale</HEADING>
<P>
<LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK> evaluated patients&#8217; and controls&#8217; judgement of quality of life by two visual analogue scales (health-related quality of life and non-medical aspects of quality of life) and did not find any significant differences at three or six months.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Condition-specific outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Functional Living Index for Cancer (FLIC)</HEADING>
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK> found no significant difference between treatment groups in terms of FLIC change scores at eight months (P &gt; 0.05), with mean changes of 2.48 (SD 24.06) for the control group and 2.91 (SD 24.48) for the intervention group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Cancer Rehabilitation Evaluation System Short Form Psychosocial Distress Score (CARES-SF)</HEADING>
<P>
<LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK> reported that 77% of control and 66% of intervention patients exhibited psychosocial distress at three months and that &#8220;in the multivariate model, there was no evidence that the intervention differentially impacted the outcome (OR 0.80; 95% CI 0.40 to 1.54)&#8221;.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Relationship and social support measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Supportive Care Needs Survey (SCNS)</HEADING>
<P>
<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK> found that after adjusting for baseline score, there were no significant differences between the intervention and standard care group for the change in SCNS domain score in any of the domains.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duke UNC Functional Social Support (DUFSS)</HEADING>
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK> found no significant difference between treatment groups in terms of DUFSS change score at eight months (P &gt; 0.05), with mean changes of -1.11 (SD 3.82) for the control group and -0.09 (SD 6.23) for the intervention group. The findings were similarly non-significant at four and 14 months.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Marlowe Crowne Social Desirability (MCSD)</HEADING>
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK> found no significant difference between treatment groups in terms of MCSD change score at eight months (P &gt; 0.05), with mean changes of 1.41 (SD 3.83) for the control group and 1.36 (SD 4.32) for the intervention group. The findings were similarly non-significant at four and 14 months.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Other</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Pittsburgh Sleep Quality Index (PSQI)</HEADING>
<P>
<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK> report adjusted mean scores for PSQI at three-months follow-up and revealed no effect for intervention versus control condition: mean 7.1 (standard error (SE) 0.51) versus 6.6 (SE 0.51) (P = 0.01).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-05-09 17:05:44 +1000" MODIFIED_BY="Mohammed Mustafa">
<SUMMARY_OF_RESULTS MODIFIED="2013-05-09 11:11:53 +1000" MODIFIED_BY="Mohammed Mustafa">
<SUBSECTION>
<HEADING LEVEL="3">Effects of psychological interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Survival</HEADING>
<P>The overall effect after meta-analysis suggests that psychological therapies for women with metastatic breast cancer exert a statistically significant albeit modest survival benefit at one year (OR 1.46, 95% CI 1.07 to 1.99). The finding is based on six studies involving 856 women. Subgroup analysis revealed that supportive-expressive therapies were also associated with survival benefit at one year (OR 1.56; 95% CI 1.07 to 2.28). The OR for cognitive behavioural therapies was consistent with a small benefit at one year, but this was not statistically significant (OR 1.14; 95% 0.61 to 2.15).</P>
<P>Pooled outcomes from four studies for survival at five-years follow-up did not show a statistically significant benefit from the interventions (OR 1.03; 95% CI 0.42 to 2.52).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Pain</HEADING>
<P>Meta-analyses of three studies for pain at 12 months showed improved pain scores with a mean difference of -0.58 (95% CI -0.98 to -0.18) favouring the psychological intervention (all were Supportive-Expressive Group Therapy (SEGT)). </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Psychological outcomes</HEADING>
<P>Three studies of group psychological therapies for women with metastatic breast cancer showed, according to the Profile Of Mood States (POM) (full version), evidence of a small benefit arising from these interventions at 10 to 12 months, but this was not statistically significant (mean difference -11.54; 95% CI -28.68 to 5.60).</P>
<P>In two Supportive-Expressive Group Therapy (SEGT) studies, there was some evidence of short-term benefit favouring the intervention group for some psychological outcomes, but which did not meet the review&#8217;s criteria for meta-analyses. <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK> found that there was reduced helplessness-hopelessness (a domain of the mini-Mental Adjustment to Cancer (mini-MAC)). They also found a significant difference in terms of the social functioning domain of the EORTC QLQ-C30. <LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK> found significant differences in terms of the Impact of Event Scale (IES) total change scores over 12 months and the Courtauld Emotional Scale (CECS).</P>
<P>The majority of other psychological, quality of life and social functioning outcome differences were not statistically significant between the intervention and control groups (see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-05-09 16:54:30 +1000" MODIFIED_BY="Melina L Willson">
<P>The trials were heterogeneous according to clinical and methodological characteristics and this could affect the direction and magnitude of effects. Therefore, further to the sample sizes, there are specific points to consider when comparing across trials in order to infer the effect attributable to psychological therapies with any degree of precision, including: (i) the intervention type and fidelity; (ii) participants&#8217; co-morbid state; (iii) type of control conditions; and (iv) quality of studies. </P>
<SUBSECTION>
<HEADING LEVEL="3">Psychological interventions, type and fidelity</HEADING>
<P>Confidence that psychological interventions are linked to the desired outcome can only be justified once there is adherence or fidelity to the intervention. The included trials had different types of psychological interventions and, where reported, there was a range of psychological intervention training and intervention quality maintenance methods making direct comparisons across the studies problematic. Studies were reviewed for evidence of both skill acquisitions that occurred in the training of providers and detailed information about what actually happened in the course of intervention delivery, but little information about the content of training, standardised training procedures, or methods for how supervision was rated to check the integrity of the intervention was available.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Participant characteristics</HEADING>
<P>Certain complications arise in the conduct of studies of this nature, which may make them particularly vulnerable to bias and wide variations in outcomes. One concerns the aggressiveness of the breast cancer. This would not be known when beginning a trial and cannot, therefore, be controlled for. Whilst the aim is that the complications should be evenly distributed by randomisation, any variations that do arise in disease aggression may particularly affect short-term outcomes between the intervention and control groups. Likewise, when numbers remaining in the study decline at long-term follow-up, the risk of underlying disease characteristics affecting the study outcome differentially between intervention and control groups is high, as found by <LINK REF="REF-Fox-1998" TYPE="REFERENCE">Fox 1998</LINK> when reviewing <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>.</P>
<P>There were other studies where such issues were also potentially important. For instance, <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK> refers to differences between the groups at the time of the initial diagnosis in terms of progesterone-receptor status and, as this was associated with survival, this favoured the intervention group (63.9% progesterone receptors versus 42.9%). However, at the time of randomisation they reported no baseline differences that seemingly affect prognosis. </P>
<P>Participants who are newly diagnosed with metastatic breast cancer are likely to be different to those who have been living with it for longer. Five studies have taken this into account, with descriptive statistics demonstrating no significant baseline difference in the trial groups in terms of duration of disease (<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>; <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>; <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>). Two studies specified particular durations since diagnosis of recurrence or progression of breast cancer as part of their inclusion criteria (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>). However, in three studies there were no reported data to characterise how long the women had lived with metastatic breast cancer and how they were represented in the trial groups, if at all (<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>).</P>
<P>Another consideration is that the period of recruitment, reported in all but two trials (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>), spans almost 30 years, from 1978 (<LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>) to 2007 (<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>). In that time, the management of patients with metastatic breast cancer has evolved substantially in terms of diagnosis and treatment, and this has to be considered when comparing trials conducted in different generations.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Control conditions</HEADING>
<P>The control group provision varied across the trials. Authors reported that they differed only in terms of the intervention, but they were not matched to the experimental condition in terms of frequency of contact, and this may be significant as intervention effectiveness could increase with contact time. Comparator conditions should allow for outcomes to be tested against the intervention content rather than the frequency of contact.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Quality of studies</HEADING>
<P>The total number of participants contributing to this review update is small (1378 participants). Most of these studies had methodological issues. This inevitably weakens the validity of their and this review&#8217;s findings. Although all of the studies were RCTs, three studies provided insufficient detail to judge whether they observed random sequence generation (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>), while four of the studies did not have enough information to decide on whether there was adequate allocation concealment, the other determinant of selection bias (<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>; <LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>). As the risk of selection bias was unclear for <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK> and <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>, a sensitivity analysis was undertaken by removing them from the meta-analyses. This increased the combined effect estimate for survival at one-year follow-up (OR 1.74; 95% CI 1.21 to 2.48), while removing <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK> from the five-year survival data decreased the effect (OR 0.80; 95% CI 0.40 to 1.64).</P>
<P>Although it was not possible to blind the participants or the providers, a lack of outcome assessment blinding may lead to detection bias. For all but two studies (<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>; <LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>) it was unclear whether there was any blinding of outcome assessment. Even though the response instruments are validated, the manner of follow-up (for example level of persistence) could be influenced by the knowledge of which treatment group the patient had been assigned to.</P>
</SUBSECTION>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-05-09 17:05:44 +1000" MODIFIED_BY="Melina L Willson">
<P>The review was conducted in keeping with the principles of the UK NHS Centre for Reviews and Dissemination (<LINK REF="REF-NHS-CRD-1996" TYPE="REFERENCE">NHS CRD 1996</LINK>) and the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-and-Green-2011" TYPE="REFERENCE">Higgins and Green 2011</LINK>). It comprised electronic database searches and manual follow-ups for further references to maximise recall.</P>
<P>This 2012 updated review differs from the previous Cochrane review in two ways. We undertook a comprehensive update of the literature using a modified search strategy that included more search terms for the different topics and strings for trial design (that is RCT). We also had to devise a new search strategy for CINAHL as the database changed from SP to EBSCO. Nevertheless, the conclusions of this updated review are similar to those of the original Cochrane review (<LINK REF="REF-Edwards-2004" TYPE="REFERENCE">Edwards 2004</LINK>), and also to the previously updated 2007 version of the review (<LINK REF="REF-Edwards-2008" TYPE="REFERENCE">Edwards 2008</LINK>).</P>
<P>As with all systematic reviews and meta-analyses, subjective judgement is involved at various points along the process, from identifying studies to data extraction and analysis. As a result, although the search strategies, data extraction and analysis were thorough, there is a possibility of missing relevant studies and data, and alternative analyses could be undertaken. </P>
<P>However, the main limitation of the review comes from the relative lack of data in this field. This is likely to give a lack of power to detect genuine effects that may arise from the interventions, and therefore the results of these meta-analyses must be interpreted with caution. However, a specific feature of the data available from the identified studies was the heterogeneity of the outcome measures, follow-up durations, and the lack of data in suitable format for combination. As described above, for example, some studies presented an analysis of longitudinal trends in psychological outcomes whereas this review uses essentially cross-sectional data (for example POMS score at one year). The paucity of data also affected how we could analyse the data. For instance, we could only use point-in-time meta-analyses to extract data from the reported survival curves. However, this method is problematic as it cannot take into account dropouts and censoring, both features of the included trials. For example, the dropouts are likely to account for the disparity between the median survival and proportion of participants surviving, as reported by <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>. They report median survival times from recruitment of 1.07 years (IQR 0.63 to 1.48) for the control group and 0.97 years (IQR 0.59 to 1.46) for the intervention group. Therefore, one could reasonably expect just over 50% of patients would survive approximately one year in the control group and just under 50% in the intervention arm. However, <LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK> further reported the proportions surviving one year to be 42/62 (68%) and 41/62 (66%) in the intervention and control groups respectively. See <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>. Thus this review is not able to utilise all the data currently available in the field for meta-analyses, a particular difficulty when the data are relatively sparse to begin with.</P>
<P>The apparent beneficial effects of the psychological interventions may also be influenced by bias from poor methodological quality. For instance, sequence generation or allocation concealment, or both, were unclear in four studies. Blinding of outcome assessment was unclear for eight of the studies, and may pose a high risk of bias, with the potential to overestimate the effect of the psychological intervention.</P>
<P>We did not report data on the socio-economic status, age or ethnicity of study participants, but participants were primarily Caucasian women and most studies were conducted in developed nations (USA, Australia and Canada). As such, it is not clear whether our findings generalise to women from different ethnic backgrounds or those in less developed countries.</P>
<P>We had insufficient studies to perform a meta-regression analysis, which could have determined some predictors of successful interventions. </P>
</POTENTIAL_BIASES>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-05-15 15:04:30 +1000" MODIFIED_BY="Mohammed Mustafa">
<IMPLICATIONS_PRACTICE MODIFIED="2013-05-09 17:08:19 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Psychological interventions appear to be effective in improving survival at 12 months but not at longer-term follow-up, and in reducing psychological symptoms in women with metastatic breast cancer only in some of the outcomes assessed. Given the extensive commitment of any breast cancer service required to provide group psychological therapies (either cognitive behavioural or supportive-expressive), the relative lack of evidence in its favour warrants a debate among patients, providers and commissioners of care (pending further clinical and economic evaluations) about whether to routinely offer such services to women diagnosed with metastatic breast cancer in comparison to other interventions for which there is evidence of benefit to patients.</P>
<P>It is, however, likely that group psychological therapies will continue to be offered to some women following diagnosis of metastatic breast cancer. It remains a common diagnosis and one that is accompanied by a devastating psychological effect that prompts patients to seek help, and healthcare professionals to offer help to meet patient needs.</P>
<P>The possibility of the interventions causing harm is not ruled out by the available data. As the wider palliative care literature indicates (<LINK REF="REF-Whatley-1998" TYPE="REFERENCE">Whatley 1998</LINK>), the confidence intervals for the outcome data identified include the possibility of adverse outcomes associated with the provision of the interventions.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-05-15 15:04:30 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Further research is needed in this field. Few studies were identified regarding educational, psychotherapy or cognitive behavioural therapies for individual women with metastatic breast cancer. Evaluating the effects of such therapies remains important as previous reviews have produced heterogeneous results (<LINK REF="REF-Devine-1995" TYPE="REFERENCE">Devine 1995</LINK>; <LINK REF="REF-Meyer-1995" TYPE="REFERENCE">Meyer 1995</LINK>). As described in the <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK> section, the association between psychosocial factors and breast cancer may be more modest than conventional wisdom suggests (<LINK REF="REF-McKenna-1999" TYPE="REFERENCE">McKenna 1999</LINK>), but there is some limited evidence of bio-medical changes arising from providing interventions to women with early stage cancer (<LINK REF="STD-Larson-2000" TYPE="STUDY">Larson 2000</LINK>; <LINK REF="STD-van-der-Pompe-1997" TYPE="STUDY">van der Pompe 1997</LINK>) and evidence that the adjustment process in breast cancer may have specific differences from those in other cancers (due to issues arising in body image, sexuality, effects on relationships etc). As such, there appears to be value in further assessing the effects of educational or psychological interventions at the individual level. We also share the view of <LINK REF="REF-Goodwin-2003" TYPE="REFERENCE">Goodwin 2003</LINK> that many of the psychological changes made by individuals in long-term interventions may elude conventional psychometric assessment. Further research, of a rigorous qualitative nature, is required to develop a clearer understanding of the experience of living and eventually dying of cancer within the context of a long-term intervention.</P>
<P>In terms of quantitative research, the general lack of evidence of the effects of the group psychological interventions may also be a Type 2 error, failure to identify a true effect. In this review this could stem from either the relative paucity of data or the difficulty of measurement. Further studies, with adequate power and follow-up to agreed stages with the outcome measures agreed as the most valid and relevant to assess effectiveness, would be helpful in identifying both the psychological and survival effects of the interventions. The failure to identify effects for most of the psychological outcomes measured may be particularly vulnerable to this criticism as different studies used a wide range of outcome instruments and data combination was difficult. The standardisation of outcomes and instruments to assess them is vital in further studies. Where possible, decisions about which measures and at which durations of follow-up to assess them should be made in the light of the methods of the existing trials, aiming to add to aspects on which some data have been accrued already (for example POMS or pain scales at one year). However, it is clear that the complexity of the emotional issues faced by women with metastatic breast cancer, including existential concerns, make it difficult for research studies to obtain valid measures of subtle aspects of emotional adjustment. The validity of instruments, including responsiveness to changes in individuals, requires attention in future research in this field. Any further trial should be complemented by a health economic (cost-effectiveness and cost-benefit) evaluation so that any effects can be interpreted in the light of the resources required to achieve them. This should also take account of carer outcomes, for which there are virtually no reliable data at present.</P>
<P>It is also important to note that the interventions have been usually theoretically or researcher driven to date. They may or may not reflect approaches that women would find most important in addressing their psychological morbidity. Inductive empirical research with women with metastatic breast cancer is needed to identify the required content for further interventions.</P>
<P>A further implication for research is the need, in all future studies, to take into account the biology of metastatic breast cancer, particularly as the evidence grows. There was evidence of inconsistencies in how these issues were addressed (or not) in some of the included studies. For instance, greater attention is needed to the biochemical factors that can influence the growth and proliferation of breast cancer (<LINK REF="REF-S_x00f8_rlie-2001" TYPE="REFERENCE">Sørlie 2001</LINK>; <LINK REF="REF-S_x00f8_rlie-2003" TYPE="REFERENCE">Sørlie 2003</LINK>). Oestrogen receptors and progesterone receptors are the most widely studied markers in breast tissue. When compared with hormone receptor&#8211;negative tumours, hormone receptor&#8211;positive breast cancers exhibit stronger clinical responses to hormonal treatment and confer better prognosis. Growth factors (epidermal growth factors, transforming growth factors &#945; and &#946;, and insulin-like growth factors I and II), and various cytokines and lymphokines are also known to influence the behaviour and phenotype expression of breast cells. A greater understanding of the molecular subtypes based on gene-expression patterns in breast tumour tissue will help to clarify whether breast cancers are aetiologically and clinically heterogeneous.</P>
<P>The questions of how psychological therapies work in women with metastatic breast cancer and which components are necessary remain unanswered. Future research should evaluate different components of the intervention to understand if there is an optimum treatment modality and also duration. In order to fully evaluate the intervention, reports of trials in this field should, therefore, pay greater attention to methodological quality for more comparable group characteristics including the biology of metastatic disease, explicitly describe the intervention delivered and its fidelity, and use sensitive and validated outcome measures. This would also help with implementing positive results, provided there is sufficient information to replicate the intervention. Longitudinal studies identifying psychological and physiological mediators of outcome may also have value, and could help shed light on the basic processes by which psychological treatments are effective for this patient group. Further research is required to explore whether the involvement of family members in treatment can predict outcomes. Similarly, the use of pharmacotherapy as a co-intervention to directly deal with psychological symptoms that meet diagnostic thresholds for depression and anxiety needs to be made explicit.</P>
<P>Several gaps in the available literature make our comment on the effectiveness or otherwise of interventions for certain scenarios impossible. These include psychological interventions for individuals, despite the three studies identified by this review (<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>; <LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>; <LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>), evaluation of online group support facilities that have flourished in recent years (for example <LINK REF="STD-Lieberman-2003" TYPE="STUDY">Lieberman 2003</LINK>) and complementary therapies (for example <LINK REF="STD-Laidlaw-2005" TYPE="STUDY">Laidlaw 2005</LINK>).</P>
<P>Uncertainty remains regarding the subgroups of patients who would benefit most from treatment and the characteristics of successful interventions. Considerable work remains outstanding to clarify these relationships and whether certain subgroups of women with metastatic breast cancer can be identified who may be most likely to benefit. Examples of the latter might include people with specific personality characteristics, and help-seeking behaviour patterns that might make interventions potentially more effective.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-05-07 20:59:49 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>The authors of this updated review gratefully acknowledge the contributions of Drs Melanie Maxwell and Stephen Hailey for the first published review (<LINK REF="REF-Edwards-2004" TYPE="REFERENCE">Edwards 2004</LINK>) and Drs Nicholas Hulbert-Williams and Richard Neal for the updated review (<LINK REF="REF-Edwards-2008" TYPE="REFERENCE">Edwards 2008</LINK>). The authors also thank the Breast Cancer Review Group editorial panel and Mr Fergus Tai, Trials Search Co-ordinator, for undertaking the search of the Specialised Register.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-05-07 21:00:35 +1000" MODIFIED_BY="[Empty name]">
<P>None declared</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-05-07 21:00:26 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Dr Mustafa and Dr Carson-Stevens were responsible for adapting, developing and implementing the search strategies. They selected the studies for inclusion, undertook quality assessment and extracted the data.</P>
<P>Analyses were performed by David Gillespie.</P>
<P>Dr Mustafa wrote the first draft of the updated review, with sections of the effects of intervention written by David Gillespie.</P>
<P>All co-reviewers were involved in providing critical comments about the manuscript.</P>
<P>Professor Edwards also provided supervision of the review process and is the guarantor of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2013-05-07 21:00:47 +1000" MODIFIED_BY="Sharon Parker">
<P>The review was updated in 2012 based on further literature searches done in June-July 2011. Five new studies were identified as a result of the updated searches.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-05-09 15:03:16 +1000" MODIFIED_BY="Mohammed Mustafa">
<STUDIES MODIFIED="2013-05-09 14:54:53 +1000" MODIFIED_BY="Mohammed Mustafa">
<INCLUDED_STUDIES MODIFIED="2013-05-09 14:44:12 +1000" MODIFIED_BY="Mohammed Mustafa">
<STUDY DATA_SOURCE="PUB" ID="STD-Aranda-2006" MODIFIED="2012-07-04 21:57:43 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Aranda 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-07-04 21:57:43 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Aranda S, Schofield P, Weih L, Milne D, Yates P, Faulkner R</AU>
<TI>Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial</TI>
<SO>British Journal of Cancer</SO>
<YR>2006</YR>
<VL>95</VL>
<PG>667-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Classen-2001" MODIFIED="2013-05-09 11:30:41 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Classen 2001" YEAR="1998">
<REFERENCE MODIFIED="2012-07-10 10:50:06 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Butler L, Koopman C, Neri E, Giese-Davis J, Palesh O, Thorne-Yocam K, et al</AU>
<TI>Effects of supportive-expressive group therapy on pain in women with metastatic breast cancer</TI>
<SO>Health Psychology</SO>
<YR>2009</YR>
<VL>28</VL>
<NO>5</NO>
<PG>579-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-10 10:50:20 +1000" MODIFIED_BY="Melina L Willson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Classen C, Butler L, Koopman C, Miller E, DiMiceli S, Giese-Davis J, et al</AU>
<TI>Supportive-expressive group therapy and distress in patients with metastatic breast cancer</TI>
<SO>Archives of General Psychiatry</SO>
<YR>2001</YR>
<VL>58</VL>
<PG>494-501</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-10 10:50:33 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giese-Davis J, Koopman C, Butler L, Classen C, Cordova M, Fobair P, et al</AU>
<TI>Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>2002</YR>
<VL>4</VL>
<PG>916-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-09 11:30:41 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Koopman C, Hermanson K, Diamond S, Angell K, Spiegel D</AU>
<TI>Social support, life stress, pain and emotional adjustment to advanced breast cancer</TI>
<SO>Psycho-Oncology</SO>
<YR>1998</YR>
<VL>7</VL>
<PG>101-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-10 10:50:53 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Speigel D, Butler L, Giese-Davis J, Koopman C, Miller E, DiMiceli S, et al</AU>
<TI>Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer. A randomized prospective trial</TI>
<SO>Cancer</SO>
<YR>2007</YR>
<VL>110</VL>
<PG>1130-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cunningham-1998" MODIFIED="2013-05-09 14:42:25 +1000" MODIFIED_BY="[Empty name]" NAME="Cunningham 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-05-09 14:42:06 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cunningham A, Edmonds C, Jenkins G, Pollack H, Lockwood G, Warr D</AU>
<TI>A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer</TI>
<SO>Psycho-Oncology</SO>
<YR>1998</YR>
<VL>7</VL>
<PG>508-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-09 14:42:25 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edmonds C, Lockwood G, Cunningham A</AU>
<TI>Psychological response to long term group therapy: a randomized trial with metastatic breast cancer patients</TI>
<SO>Psycho-Oncology</SO>
<YR>1999</YR>
<VL>8</VL>
<PG>74-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edelman-1999" MODIFIED="2013-05-09 14:43:19 +1000" MODIFIED_BY="[Empty name]" NAME="Edelman 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-05-09 14:42:52 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cocker K, Bell D, Kidman A</AU>
<TI>Cognitive behaviour therapy with advanced breast cancer patients: a brief report of a pilot study</TI>
<SO>Psycho-Oncology</SO>
<YR>1994</YR>
<VL>3</VL>
<PG>233-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-09 14:43:05 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edelman S, Bell, D, Kidman A</AU>
<TI>A group cognitive behaviour therapy programme with metastatic breast cancer patients</TI>
<SO>Psycho-Oncology</SO>
<YR>1999</YR>
<VL>8</VL>
<PG>295-305</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-09 14:43:19 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Edelman S, Lemon J, Bell, Kidman A</AU>
<TI>Effects of group CBT on the survival time of patients with metastatic breast cancer</TI>
<SO>Psycho-Oncology</SO>
<YR>1999</YR>
<VL>8</VL>
<PG>474-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goodwin-2001" MODIFIED="2013-05-09 11:29:30 +1000" MODIFIED_BY="[Empty name]" NAME="Goodwin 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-07-10 10:47:52 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bordeleau L, Szalai J, Ennis M, Speca M, Sela R, Doll R, et al</AU>
<TI>Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an explanation of missing data</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2003</YR>
<VL>21</VL>
<PG>1944-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown P, Goodwin P, Pritchard K</AU>
<TI>A multi-centre randomized trial of group psychosocial support in metastatic breast cancer: pilot results [abstract]</TI>
<SO>Quality of Life Research</SO>
<YR>1993</YR>
<VL>2</VL>
<PG>54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-10 10:48:15 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Goodwin P, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al</AU>
<TI>The effect of group psychosocial support on survival in metastatic breast cancer</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>345</VL>
<PG>1719-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-09 11:29:05 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goodwin P, Leszcz M, Koopmans J, Arnold A, Doll R, Chochinov H, et al</AU>
<TI>Randomized trial of group psychosocial support in metastatic breast cancer: the BEST study</TI>
<SO>Cancer Treatment Reviews</SO>
<YR>1996</YR>
<VL>22 Suppl A</VL>
<PG>91-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-09 11:29:30 +1000" MODIFIED_BY="mohammed mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goodwin P, Leszcz M, Quirt G, Koopmans J, Arnold A, Dohan E, et al</AU>
<TI>Lessons learned from enrolment in the BEST study - A multicenter, randomized trial of group psychosocial support in metastatic breast cancer</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2000</YR>
<VL>53</VL>
<PG>47-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gotay-2007" MODIFIED="2013-05-09 11:29:58 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Gotay 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-05-09 11:29:58 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gotay C, Moinpour C, Unger J, Jiang C, Coleman D, Martino S, et al</AU>
<TI>Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>15</NO>
<PG>2093-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kissane-2007" MODIFIED="2012-07-10 10:49:09 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Kissane 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-07-10 10:49:09 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kissane D, Grabsch B, Clarke D, Smith G, Love A, Bloch S, et al</AU>
<TI>Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial</TI>
<SO>Psycho-Oncology</SO>
<YR>2007</YR>
<VL>16</VL>
<PG>277-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Low-2010" MODIFIED="2012-07-04 17:24:35 +1000" MODIFIED_BY="[Empty name]" NAME="Low 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-04 17:24:35 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Low CA, Stanton AL, Bower JE, Gyllenhammer L</AU>
<TI>A randomized controlled trial of emotionally expressive writing for women with metastatic breast cancer</TI>
<SO>Health Psychology</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>4</NO>
<PG>460-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-09-19 04:38:52 +1000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scholten-2001" MODIFIED="2012-07-04 19:22:58 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Scholten 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-07-04 19:22:58 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Scholten C, Weinlander G, Krainer M, Frischenschalger O, Zielinski C</AU>
<TI>Difference in patient's acceptance of early versus late initiation of psychosocial support in breast cancer</TI>
<SO>Support Care Cancer</SO>
<YR>2001</YR>
<VL>9</VL>
<NO>6</NO>
<PG>459-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spiegel-1989" MODIFIED="2013-05-09 14:44:12 +1000" MODIFIED_BY="[Empty name]" NAME="Spiegel 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-07-04 17:24:22 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bloom J, Spiegel D</AU>
<TI>The relationship of two dimensions of social support to the psychological well-being and social functioning of women with advanced breast cancer</TI>
<SO>Social Science and Medicine</SO>
<YR>1984</YR>
<VL>19</VL>
<PG>831-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-04 17:24:13 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kogon M, Biswas A, Pearl D, Carlson R, Spiegel D</AU>
<TI>Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma</TI>
<SO>Cancer</SO>
<YR>1997</YR>
<VL>80</VL>
<PG>225-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-09 14:44:12 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Spiegel D, Bloom J, Kraemer H, Gottheil E</AU>
<TI>Effect of psychosocial treatment on survival of patients with metastatic breast cancer</TI>
<SO>Lancet</SO>
<YR>1989</YR>
<VL>2</VL>
<PG>888-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-04 17:23:55 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spiegel D, Bloom J, Yalom I</AU>
<TI>Group support for patients with metastatic cancer</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1981</YR>
<VL>38</VL>
<PG>527-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-04 17:23:48 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spiegel D, Bloom J</AU>
<TI>Group therapy and hypnosis reduce metastatic breast carcinoma pain</TI>
<SO>Psychosomatic Medicine</SO>
<YR>1983</YR>
<VL>45</VL>
<PG>333-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-04 17:23:42 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spiegel D, Yalom I</AU>
<TI>A support group for dying patients</TI>
<SO>International Journal for Group Psychotherapy</SO>
<YR>1978</YR>
<VL>28</VL>
<PG>233-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-04 17:23:37 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spiegel D</AU>
<TI>Psychological support for women with metastatic breast cancer</TI>
<SO>Psychosomatics</SO>
<YR>1979</YR>
<VL>20</VL>
<PG>780-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yalom I, Greaves C</AU>
<TI>Group therapy with the terminally ill</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1977</YR>
<VL>134</VL>
<PG>396-400</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-05-09 14:54:53 +1000" MODIFIED_BY="Mohammed Mustafa">
<STUDY DATA_SOURCE="PUB" ID="STD-Andersen-2007" MODIFIED="2012-07-10 10:52:15 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Andersen 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-07-10 10:52:15 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andersen B, Farrar W, Golden-Kreutz D, Emery C, Glaser R, Crespin T, et al</AU>
<TI>Distress reduction from a psychological intervention contributes to improved health for cancer patients</TI>
<SO>Brain, Behavior, and Immunity</SO>
<YR>2007</YR>
<VL>21</VL>
<PG>953-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Andersen-2008" MODIFIED="2012-07-10 10:52:29 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Andersen 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-07-10 10:52:29 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andersen B, Yang HC, Golden-Kreutz D, Emery C, Thornton L, Young D, et al</AU>
<TI>Psychologic intervention improves survival for breast cancer patients. A randomized clinical trial</TI>
<SO>American Cancer Society</SO>
<YR>2008</YR>
<VL>113</VL>
<NO>12</NO>
<PG>3450-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Antoni-2009" MODIFIED="2012-07-10 10:52:41 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Antoni 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-07-10 10:52:41 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Antoni M, Lechner S, Diaz A, Vargas S, Holley H, Phillips K, et al</AU>
<TI>Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer</TI>
<SO>Brain, Behavior, and Immunity</SO>
<YR>2009</YR>
<VL>23</VL>
<PG>580-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arathuzik-1994" MODIFIED="2012-08-01 21:48:21 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Arathuzik 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-08-01 21:48:21 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arathuzik D</AU>
<TI>Effects of cognitive-behavioral strategies on pain in cancer patients</TI>
<SO>Cancer Nursing</SO>
<YR>1994</YR>
<VL>17</VL>
<NO>2</NO>
<PG>207-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Badger-2005" MODIFIED="2012-11-26 16:45:00 +1100" MODIFIED_BY="Mohammed Mustafa" NAME="Badger 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-11-26 16:45:00 +1100" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Badger T, Segrin C, Meek P, Lopez A, Bonham E, Sieger A</AU>
<TI>Telephone interpersonal counseling with women with breast cancer: symptom management and quality of life</TI>
<SO>Oncology Nursing Forum</SO>
<YR>2005</YR>
<VL>32</VL>
<NO>2</NO>
<PG>273-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bahmani-2010" MODIFIED="2012-07-04 17:19:40 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Bahmani 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-04 17:19:40 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bahmani B, Etemadi A, Shafiabadi A, Delavar A, Motlagh AG</AU>
<TI>Cognitive-existential group therapy and cognitive instructional therapy for breast cancer patients</TI>
<SO>Journal of Iranian Psychologists</SO>
<YR>2010 Sept</YR>
<VL>6</VL>
<NO>23</NO>
<PG>201-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berger-2009" MODIFIED="2012-07-10 10:53:07 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Berger 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-07-10 10:53:07 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berger A, Kuhn B, Farr L, Lych J, Agrawal S, Chamberlain J, et al</AU>
<TI>Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue</TI>
<SO>Psycho-Oncology</SO>
<YR>2009</YR>
<VL>18</VL>
<PG>634-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brietbart-2010" MODIFIED="2012-07-10 10:53:20 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Brietbart 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-10 10:53:20 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Breitbart W, Rosenfeld B, Gibson C, Pessin H, Poppito S, Nelson C, et al</AU>
<TI>Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial</TI>
<SO>Psycho-Oncology</SO>
<YR>2010</YR>
<VL>19</VL>
<PG>21-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-2006" MODIFIED="2012-07-10 10:53:30 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Brown 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-07-10 10:53:30 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown P, Clark M, Atherton P, Huschka M, Sloan J, Gamble G, et al</AU>
<TI>Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?</TI>
<SO>American Journal of Clinical Oncology</SO>
<YR>2006</YR>
<VL>29</VL>
<NO>1</NO>
<PG>52-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carlson-2003" MODIFIED="2012-08-01 21:48:48 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Carlson 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-08-01 21:47:00 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carlson L, Speca M, Patel K, Goodey E</AU>
<TI>Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients</TI>
<SO>Psychosomatic Medicine</SO>
<YR>2003</YR>
<VL>65</VL>
<NO>4</NO>
<PG>571-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cerny-1999" MODIFIED="2013-05-09 14:46:06 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Cerny 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-05-09 14:46:06 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cerny T, Heusser P</AU>
<TI>Quality of life of patients with metastatic breast or intestinal cancer, treated with anthroposophic medicine or with mainstream medicine, the latter with or without psycho-oncologic or supplementary anthroposophic therapy</TI>
<TO>Untersuchungen der Lebensqualitat von Patienten mit metastasieren Brust&#8211; oder Darmkrebs, behandelt in der anthroposophischen Medizin oder in der Schulmedizin, letztere mit oder ohne psychoonkologische oder anthroposophische Zusatztherapie</TO>
<SO>Forschende Komplementarmedizin</SO>
<YR>1999</YR>
<VL>6 Suppl 1</VL>
<PG>35-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-2006" MODIFIED="2012-07-10 10:53:43 +1000" MODIFIED_BY="[Empty name]" NAME="Chan 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-07-10 10:53:43 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chan C, Ho R, Lee P, Cheng J, Leung P, Foo W, et al</AU>
<TI>A randomized controlled trial of psychosocial interventions using the psychophysiological framework for Chinese breast cancer patients</TI>
<SO>Journal of Psychosocial Oncology</SO>
<YR>2006</YR>
<VL>24</VL>
<NO>1</NO>
<PG>3-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chujo-2005" MODIFIED="2012-08-01 21:56:00 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Chujo 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-08-01 21:55:58 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chujo M, Mikami I, Takashima S, Saeki T, Ohsumi S, Aogi K</AU>
<TI>Afeasibility study of psychosocial group intervention for breast cancer patients with first recurrence</TI>
<SO>Supportive Care in Cancer</SO>
<YR>2005</YR>
<VL>13</VL>
<NO>7</NO>
<PG>503-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dirksen-2008" MODIFIED="2012-07-04 19:23:54 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Dirksen 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-07-04 19:23:54 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dirksen S, Epstein D</AU>
<TI>Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors</TI>
<SO>Journal of Advanced Nursing</SO>
<YR>2008</YR>
<VL>61</VL>
<NO>6</NO>
<PG>664-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Doorenbos-2006" MODIFIED="2012-07-10 10:54:02 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Doorenbos 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-07-10 10:54:02 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Doorenbos A, Given B, Given C, Verbitsky N</AU>
<TI>Physical functioning: effect of behavioral intervention for symptoms among individuals with cancer</TI>
<SO>Nursing Research</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>3</NO>
<PG>161-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edelman-2005" MODIFIED="2013-05-09 14:46:40 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Edelman 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-05-09 14:46:40 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edelman S, Lemon J, Kidman A</AU>
<TI>Group cognitive behaviour therapy for breast cancer patients: a qualitative evaluation</TI>
<SO>Psychology, Health &amp; Medicine</SO>
<YR>2005</YR>
<VL>10</VL>
<NO>2</NO>
<PG>139-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edgar-2001" MODIFIED="2012-07-01 21:17:21 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Edgar 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-07-01 21:17:21 +1000" MODIFIED_BY="mohammed mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edgar L, Rosberger Z, Collet JP</AU>
<TI>Lessons learned: Outcomes and methodology of a coping skills intervention trial comparing individual and group format for patients with cancer</TI>
<SO>International Journal of Psychiatry in Medicine</SO>
<YR>2001</YR>
<VL>31</VL>
<NO>3</NO>
<PG>289-304</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fukui-2000" MODIFIED="2012-07-10 10:54:56 +1000" MODIFIED_BY="[Empty name]" NAME="Fukui 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-07-10 10:54:56 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fukui S, Kugaya A, Okamura H, Kamiya M, Koike M, Nakanishi T, et al</AU>
<TI>A psychological group intervention for Japanese women with primary breast carcinoma</TI>
<SO>Cancer</SO>
<YR>2000</YR>
<VL>89</VL>
<PG>1026-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gellert-1993" MODIFIED="2012-08-01 22:00:09 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Gellert 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-08-01 22:00:08 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gellert G, Maxwell R, Siegel B</AU>
<TI>Survival of breast cancer patients receiving adjunctive psychosocial support therapy: a 10-yearfollow-up study</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1993</YR>
<VL>11</VL>
<PG>66-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Graves-2003" NAME="Graves 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Graves K, Carter C, Anderson E, Winett R</AU>
<TI>Quality of life pilot intervention for breast cancer patients: use of social cognitive theory</TI>
<SO>Palliative &amp; Supportive Care</SO>
<YR>2003</YR>
<VL>1</VL>
<NO>2</NO>
<PG>121-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Helgeson-1999" MODIFIED="2012-07-04 17:16:52 +1000" MODIFIED_BY="[Empty name]" NAME="Helgeson 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-07-04 17:16:52 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Helgeson V, Cohen S, Schulz R, Yasko J</AU>
<TI>Education and peer discussion group interventions and adjustment to breast cancer</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1999</YR>
<VL>56</VL>
<PG>340-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hong-2010" MODIFIED="2012-07-10 10:55:36 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Hong 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-10 10:55:36 +1000" MODIFIED_BY="mohammed mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hong Y, Wang JP, Mei YL, Zhang HW, Tang LL</AU>
<TI>Effects of group psychological intervention on the quality of life in breast cancer patients</TI>
<SO>Chinese Mental Health Journal</SO>
<YR>2010</YR>
<VL>24</VL>
<NO>12</NO>
<PG>903-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ilnyckyj-1994" MODIFIED="2012-08-01 22:03:18 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Ilnyckyj 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-08-01 22:03:17 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ilnyckyj A, Farber J, Cheang M, Weinerman B</AU>
<TI>A randomised controlled trial of psychotherapeutic intervention in cancer patients</TI>
<SO>Annals of the Royal College of Physicians and Surgeons of Canada</SO>
<YR>1994</YR>
<VL>27</VL>
<PG>93-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kissane-2003" MODIFIED="2012-08-01 22:28:00 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Kissane 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-08-01 22:28:00 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>*Kissane D, Bloch S, Smith G, Miach P, Clarke D, Ikin J, Love A, Ranieri N, McKenzie D</AU>
<TI>Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial</TI>
<SO>Psycho-Oncology</SO>
<YR>2003</YR>
<VL>12</VL>
<PG>532-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-08-01 22:27:50 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kissane D, Bloch S, Miach P, Smith G, Seddon A, Keks N</AU>
<TI>Cognitive-existential group therapy for patients with primary breast cancer - techniques and themes.</TI>
<SO>Psycho-Oncology</SO>
<YR>1997</YR>
<VL>6</VL>
<PG>25-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laidlaw-2005" MODIFIED="2012-08-01 22:10:04 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Laidlaw 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-08-01 22:10:00 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laidlaw T, Bennett B, Dwivedi P, Naito A, Gruzelier J</AU>
<TI>Quality of life and mood changes in metastatic breast cancer after training in self-hypnosis or Johrei: a short report</TI>
<SO>Contemporary Hypnosis</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>2</NO>
<PG>84-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lapid-2007" MODIFIED="2013-05-09 14:48:56 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Lapid 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-05-09 14:48:56 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lapid M, Rummans T, Brown P, Frost M, Johnson M, Huschka M, et al</AU>
<TI>Improving the quality of life of geriatric cancer patients with a structured multidisciplinary intervention: A randomized controlled trial</TI>
<SO>Palliative &amp; Supportive Care</SO>
<YR>2007</YR>
<VL>5</VL>
<PG>107-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Larson-2000" MODIFIED="2013-05-09 14:49:18 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Larson 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-05-09 14:49:18 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larson M, Duberstein P, Talbot N, Caldwell C, Moynihan J</AU>
<TI>A presurgical psychosocial intervention for breast cancer patients: psychological distress and the immune response</TI>
<SO>Journal of Psychosomatic Research</SO>
<YR>2000</YR>
<VL>48</VL>
<PG>187-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2006" MODIFIED="2012-07-04 17:16:23 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Lee 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-07-04 17:16:23 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee V, Cohen S, Edgar L, Laizner A, Gagnon A</AU>
<TI>Meaning-making intervention during breast or colorectal cancer treatment improves self-esteem, optimism, and self-efficacy</TI>
<SO>Social Science &amp; Medicine</SO>
<YR>2006</YR>
<VL>62</VL>
<PG>3133-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leon_x002d_Pizzaro-2007" MODIFIED="2012-07-10 10:56:07 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Leon-Pizzaro 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-07-10 10:56:07 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leon-Pizarro C, Gich I, Barthe E, Rovirosa A, Farrus B, Casas F, et al</AU>
<TI>A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients</TI>
<SO>Psycho-Oncology</SO>
<YR>2007</YR>
<VL>16</VL>
<PG>971-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lev-2000" MODIFIED="2012-07-04 17:15:56 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Lev 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-07-04 17:15:56 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lev E, Owen S</AU>
<TI>Counseling women with breast cancer using principles developed by Albert Bandura</TI>
<SO>Perspectives in Psychiatric Care</SO>
<YR>2000</YR>
<VL>36</VL>
<NO>4</NO>
<PG>131-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levine-2005" NAME="Levine 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levine E, Eckhardt J, Targ E</AU>
<TI>Change in post-traumatic stress symptoms following psychosocial treatment for breast cancer</TI>
<SO>Psycho-Oncology</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>8</NO>
<PG>618-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lieberman-2003" MODIFIED="2013-05-09 14:51:10 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Lieberman 2003" YEAR="2003">
<REFERENCE MODIFIED="2013-05-09 14:51:10 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lieberman M, Golant M, Giese-Davis J, Winzlenberg A, Benjamin H, Humphreys K</AU>
<TI>Electronic support groups for breast carcinoma: a clinical trial of effectiveness</TI>
<SO>Cancer</SO>
<YR>2003</YR>
<VL>97</VL>
<NO>4</NO>
<PG>920-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linn-1982" MODIFIED="2012-08-01 22:17:12 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Linn 1982" YEAR="1982">
<REFERENCE MODIFIED="2012-08-01 22:17:12 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linn M, Linn B, Harris R</AU>
<TI>Effects of counselling for late stage cancer patients</TI>
<SO>Cancer</SO>
<YR>1982</YR>
<VL>49</VL>
<NO>5</NO>
<PG>1048-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mantovani-1996" MODIFIED="2013-05-09 14:51:30 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Mantovani 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-05-09 14:51:30 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mantovani G, Astara G, Lampis B, Bianchi A, Curreli L, Orru W, et al</AU>
<TI>Evaluation by multidimensional instruments of health-related quality of life of elderly cancer patients undergoing three different "psychosocial" treatment approaches. A randomized clinical trial</TI>
<SO>Supportive Care in Cancer</SO>
<YR>1996</YR>
<VL>4</VL>
<NO>2</NO>
<PG>129-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marchioro-1996" MODIFIED="2013-05-09 14:52:36 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Marchioro 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-05-09 14:52:36 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marchioro G, Azzarello G, Checchin F, Perale M, Segati R, Sampognaro E, et al</AU>
<TI>The impact of a psychological intervention on quality of life in non-metastatic breast cancer</TI>
<SO>European Journal of Cancer</SO>
<YR>1996</YR>
<VL>32A</VL>
<NO>9</NO>
<PG>1612-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McArdle-1996" MODIFIED="2013-05-09 14:53:23 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="McArdle 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-05-09 14:53:23 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McArdle J, George W, McArdle C, Smith D, Moodie A, Hughson A</AU>
<TI>Psychological support for patients undergoing breast cancer surgery: a randomized study</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>312</VL>
<PG>813-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Michalec-2005" MODIFIED="2012-08-01 22:24:46 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Michalec 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-08-01 22:24:45 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Michalec B</AU>
<TI>Exploring the multidimensional benefits of breast cancer support groups</TI>
<SO>Journal of Psychosocial Oncology</SO>
<YR>2005</YR>
<VL>23</VL>
<NO>2</NO>
<PG>159-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nidich-2009" MODIFIED="2012-07-10 10:57:15 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Nidich 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-07-10 10:57:15 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nidich S, Fields J, Rainforth M, Pomerantz R, Cella D, Kristeller J, et al</AU>
<TI>A randomized controlled trial of the effects of transcendental meditation on quality of life in older breast cancer patients</TI>
<SO>Integrative Cancer Therapies</SO>
<YR>2009</YR>
<VL>8</VL>
<NO>3</NO>
<PG>228-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Northouse-2005" MODIFIED="2012-08-01 22:27:31 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Northouse 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-08-01 22:27:30 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Northouse L, Kershaw T, Mood D, Schafenacker A</AU>
<TI>Effects of a family intervention on the quality of life of women with recurrent breast cancer and their family caregivers</TI>
<SO>Psycho-Oncology</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>6</NO>
<PG>478-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rosenbaum-2004" MODIFIED="2013-05-09 14:54:05 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Rosenbaum 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-05-09 14:54:05 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosenbaum E, Gautier H, Fobari P, Neri E, Festa B, Hawn M, et al</AU>
<TI>Cancer supportive care, improving the quality of life for cancer patients: a program evaluation report</TI>
<SO>Supportive Care in Cancer</SO>
<YR>2004</YR>
<VL>12</VL>
<NO>5</NO>
<PG>293-301</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rummans-2006" MODIFIED="2012-08-01 22:43:59 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Rummans 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-08-01 22:43:20 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rummans T, Clark M, Sloan J, Frost M, Bostwick J, Atherton P</AU>
<TI>Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>2006</YR>
<VL>24</VL>
<NO>4</NO>
<PG>635-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salzer-2010" MODIFIED="2012-07-10 10:57:29 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Salzer 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-10 10:57:29 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salzer MS, Palmer SC, Kaplan K, Brusilovskiy E, Ten Have T, Hampshire M, et al</AU>
<TI>A randomized, controlled study of Internet peer-to-peer interactions among women newly diagnosed with breast cancer</TI>
<SO>Psycho-Oncology</SO>
<YR>2010 Apr</YR>
<VL>19</VL>
<NO>4</NO>
<PG>441-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sandgren-2007" MODIFIED="2012-05-04 20:52:35 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Sandgren 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-05-04 20:52:35 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sandgren A, McCaul K</AU>
<TI>Long-term telephone therapy outcomes for breast cancer patients</TI>
<SO>Psycho-Oncology</SO>
<YR>2007</YR>
<VL>16</VL>
<PG>38-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sloman-2002" MODIFIED="2012-07-04 17:14:02 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Sloman 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-07-04 17:14:02 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sloman R</AU>
<TI>Relaxation and imagery for anxiety and depression control in community patients with advanced cancer</TI>
<SO>Cancer Nursing</SO>
<YR>2002</YR>
<VL>25</VL>
<NO>6</NO>
<PG>432-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Targ-2002" MODIFIED="2013-05-09 14:54:53 +1000" MODIFIED_BY="[Empty name]" NAME="Targ 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-05-09 14:54:53 +1000" MODIFIED_BY="Melina L Willson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cotton S, Levine E, Fitzpatrick C, Dold K, Targ E</AU>
<TI>Exploring the relationships among spiritual well-being, quality of life, and psychological adjustment in women with breast cancer</TI>
<SO>Psycho-Oncology</SO>
<YR>1999</YR>
<VL>8</VL>
<PG>429-38</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-04 17:13:30 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Targ E, Levine E</AU>
<TI>The efficacy of a mind-body-spirit group for women with breast cancer: a randomized controlled trial</TI>
<SO>General Hospital Psychiatry</SO>
<YR>2002</YR>
<VL>24</VL>
<PG>238-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Traeger_x002d_Muney-2003" MODIFIED="2012-11-26 16:44:07 +1100" MODIFIED_BY="Mohammed Mustafa" NAME="Traeger-Muney 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-11-26 16:44:07 +1100" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="BOOK">
<AU>Traeger-Muney J</AU>
<SO>The relation of perceived social support to the effectiveness of psychosocial interventions for women with breast cancer</SO>
<YR>2003</YR>
<PB>Alliant International University, California School of Professional Psychology</PB>
<CY>San Francisco Bay, US</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-der-Pompe-1997" MODIFIED="2012-08-01 22:48:01 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="van der Pompe 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-08-01 22:48:00 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van der Pompe G, Duivenvoorden H, Antoni M, Visser A, Heijnen C</AU>
<TI>Effectiveness of a short term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study</TI>
<SO>Journal of Psychosomatic Research</SO>
<YR>1997</YR>
<VL>42</VL>
<PG>453-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006" MODIFIED="2012-07-10 10:58:14 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Wang 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-07-10 10:58:14 +1000" MODIFIED_BY="Mohammed Mustafa" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang HF, LI M</AU>
<TI>Group psychotherapy for cancer patients</TI>
<SO>Chinese Mental Health Journal</SO>
<YR>2006</YR>
<VL>20</VL>
<NO>12</NO>
<PG>817-9</PG>
<IDENTIFIERS MODIFIED="2012-05-04 20:09:53 +1000" MODIFIED_BY="Mohammed Mustafa"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-05-09 15:03:16 +1000" MODIFIED_BY="Sharon  M Parker">
<ADDITIONAL_REFERENCES MODIFIED="2013-05-09 15:03:16 +1000" MODIFIED_BY="Sharon  M Parker">
<REFERENCE ID="REF-Bleiker-2000" NAME="Bleiker 2000" TYPE="JOURNAL_ARTICLE">
<AU>Bleiker EM, Pouwer F, van der Ploeg HM, Leer JW, Ader HJ</AU>
<TI>Psychological distress 2 years after diagnosis of breast cancer: frequency and prediction</TI>
<SO>Patient Education and Counselling</SO>
<YR>2000</YR>
<VL>40</VL>
<PG>209-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bottomley--1998" MODIFIED="2012-07-04 17:12:59 +1000" MODIFIED_BY="[Empty name]" NAME="Bottomley  1998" TYPE="JOURNAL_ARTICLE">
<AU>Bottomley A</AU>
<TI>Depression in cancer patients: a literature review</TI>
<SO>European Journal of Cancer Care</SO>
<YR>1998</YR>
<VL>7</VL>
<PG>181-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Buddeberg-1991" MODIFIED="2012-07-10 10:59:48 +1000" MODIFIED_BY="[Empty name]" NAME="Buddeberg 1991" TYPE="JOURNAL_ARTICLE">
<AU>Buddeberg C, Wolf C, Sieber M, Riehl-Emde A, Bergant A, Steiner R, et al</AU>
<TI>Coping strategies and course of disease in breast cancer patients. Results of a 3-year longitudinal study</TI>
<SO>Psychotherapeutic Psychosomatics</SO>
<YR>1991</YR>
<VL>55</VL>
<PG>151-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cook-2001" MODIFIED="2013-05-09 14:56:30 +1000" MODIFIED_BY="Melina L Willson" NAME="Cook 2001" TYPE="JOURNAL_ARTICLE">
<AU>Cook A, Finlay I, Edwards A, Higginson I, Goodwin D, Hood K, et al</AU>
<TI>Efficiency of searching grey literature in palliative care</TI>
<SO>Journal of Pain and Symptom Management</SO>
<YR>2001</YR>
<VL>22</VL>
<PG>797-801</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deflorio-1995" MODIFIED="2012-07-04 19:25:01 +1000" MODIFIED_BY="[Empty name]" NAME="Deflorio 1995" TYPE="JOURNAL_ARTICLE">
<AU>Deflorio M, Massie M</AU>
<TI>Review of depression in cancer: gender differences</TI>
<SO>Depression</SO>
<YR>1995</YR>
<VL>3</VL>
<PG>366-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Devine-1995" NAME="Devine 1995" TYPE="JOURNAL_ARTICLE">
<AU>Devine E, Westlake S</AU>
<TI>The effects of psycho-educational care provided to adults with cancer: a meta-analysis of 116 studies</TI>
<SO>Oncology Nursing Forum</SO>
<YR>1995</YR>
<VL>22</VL>
<PG>1369-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eady-2008" MODIFIED="2012-07-01 20:51:40 +1000" MODIFIED_BY="mohammed mustafa" NAME="Eady 2008" TYPE="JOURNAL_ARTICLE">
<AU>Eady AM, Wilczynski NL, Haynes RB</AU>
<TI>PsycINFO search strategies identified methodologically sound therapy studies and review articles for use by clinicians and researchers</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2008</YR>
<VL>61</VL>
<NO>1</NO>
<PG>34-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fawzy-1993" MODIFIED="2012-07-10 10:59:42 +1000" MODIFIED_BY="[Empty name]" NAME="Fawzy 1993" TYPE="JOURNAL_ARTICLE">
<AU>Fawzy F, Fawzy N, Hyun C</AU>
<TI>Malignant melanoma: effects of an early structured psychiatric intervention, coping and affective state on recurrence and survival 6 years later</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1993</YR>
<VL>50</VL>
<PG>681-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fawzy-1995" MODIFIED="2012-07-04 17:12:04 +1000" MODIFIED_BY="[Empty name]" NAME="Fawzy 1995" TYPE="JOURNAL_ARTICLE">
<AU>Fawzy F, Fawzy N, Arndt L, Pasnau R</AU>
<TI>Critical review of psychosocial interventions in cancer care</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1995</YR>
<VL>52</VL>
<PG>101-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ferlay-2010" MODIFIED="2012-07-10 11:00:10 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Ferlay 2010" TYPE="OTHER">
<AU>Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM</AU>
<TI>GLOBOCAN 2008 v1.2 (2010) Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]</TI>
<SO>Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr, accessed on 15/06/12</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fox-1998" MODIFIED="2013-05-09 14:57:26 +1000" MODIFIED_BY="[Empty name]" NAME="Fox 1998" TYPE="JOURNAL_ARTICLE">
<AU>Fox B</AU>
<TI>A hypothesis about Spiegel et al's 1989 paper on psychological intervention and breast cancer survival</TI>
<SO>Psycho-Oncology</SO>
<YR>1998</YR>
<VL>7</VL>
<PG>361-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fulton-1999" MODIFIED="2012-07-04 17:11:34 +1000" MODIFIED_BY="[Empty name]" NAME="Fulton 1999" TYPE="JOURNAL_ARTICLE">
<AU>Fulton C</AU>
<TI>Patients with metastatic breast cancer: their physical and psychological rehabilitation needs</TI>
<SO>International Journal of Rehabilitation Research</SO>
<YR>1999</YR>
<VL>22</VL>
<PG>291-301</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Giese_x002d_Davis-2000" MODIFIED="2012-07-04 17:11:23 +1000" MODIFIED_BY="[Empty name]" NAME="Giese-Davis 2000" TYPE="JOURNAL_ARTICLE">
<AU>Giese-Davis J, Hermanson K, Koopman C, Weibel D, Spiegel D</AU>
<TI>Quality of couples' relationship and adjustment to metastatic breast cancer</TI>
<SO>Journal of Family Psychology</SO>
<YR>2000</YR>
<VL>14</VL>
<NO>2</NO>
<PG>251-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Glanz-1992" MODIFIED="2012-07-04 17:09:33 +1000" MODIFIED_BY="[Empty name]" NAME="Glanz 1992" TYPE="JOURNAL_ARTICLE">
<AU>Glanz K, Lerman C</AU>
<TI>Psychological impact of breast cancer: A critical review</TI>
<SO>Annals of Behavioural Medicine</SO>
<YR>1992</YR>
<VL>14</VL>
<NO>3</NO>
<PG>204-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goodwin-2003" MODIFIED="2012-07-04 17:09:01 +1000" MODIFIED_BY="[Empty name]" NAME="Goodwin 2003" TYPE="JOURNAL_ARTICLE">
<AU>Goodwin P, Black J, Bordeleau L, Ganz P</AU>
<TI>Health related quality of life measurement in randomized clinical trials in breast cancer - taking stock</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>2003</YR>
<VL>95</VL>
<PG>263-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greer-1979" MODIFIED="2013-05-09 14:58:47 +1000" MODIFIED_BY="[Empty name]" NAME="Greer 1979" TYPE="JOURNAL_ARTICLE">
<AU>Greer S, Morris T, Pettingale K</AU>
<TI>Psychological response to breast cancer: effect on outcome</TI>
<SO>Lancet</SO>
<YR>1979</YR>
<VL>2</VL>
<PG>785-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Helgeson-1996" MODIFIED="2012-07-04 17:08:44 +1000" MODIFIED_BY="[Empty name]" NAME="Helgeson 1996" TYPE="JOURNAL_ARTICLE">
<AU>Helgeson V, Cohen S</AU>
<TI>Social support and adjustment to cancer</TI>
<SO>Health Psychology</SO>
<YR>1996</YR>
<VL>15</VL>
<NO>2</NO>
<PG>135-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Helgeson-1998" MODIFIED="2013-05-09 14:59:17 +1000" MODIFIED_BY="[Empty name]" NAME="Helgeson 1998" TYPE="BOOK_SECTION">
<AU>Helgeson V, Cohen S, Fritz H</AU>
<TI>Social ties and cancer</TI>
<SO>Psycho-Oncology</SO>
<YR>1998</YR>
<PG>99-109</PG>
<ED>Holland, J</ED>
<PB>Oxford University Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-and-Green-2011" MODIFIED="2012-07-04 21:58:23 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Higgins and Green 2011" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</SO>
<YR>2011</YR>
<PB>The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Irvine-1991" MODIFIED="2012-07-04 17:08:20 +1000" MODIFIED_BY="[Empty name]" NAME="Irvine 1991" TYPE="JOURNAL_ARTICLE">
<AU>Irvine D, Brown B, Crooks D, Roberts J, Browne G</AU>
<TI>Psychosocial adjustment in women with breast cancer</TI>
<SO>Cancer</SO>
<YR>1991</YR>
<VL>67</VL>
<PG>1097-117</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jacobsen-1998" MODIFIED="2012-07-04 17:08:12 +1000" MODIFIED_BY="[Empty name]" NAME="Jacobsen 1998" TYPE="BOOK_SECTION">
<AU>Jacobsen P, Hann D</AU>
<TI>Cognitive-behaviour interventions</TI>
<SO>Psycho-oncology</SO>
<YR>1998</YR>
<PG>717-29</PG>
<ED>Holland J</ED>
<PB>Oxford University Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kmietowicz-2000" MODIFIED="2013-05-09 14:59:58 +1000" MODIFIED_BY="Melina L Willson" NAME="Kmietowicz 2000" TYPE="JOURNAL_ARTICLE">
<AU>Kmietowicz Z</AU>
<TI>Deaths from breast cancer fall dramatically in UK and US</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>320</VL>
<PG>1428</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lemon-2004" MODIFIED="2012-07-10 11:02:13 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Lemon 2004" TYPE="JOURNAL_ARTICLE">
<AU>Lemon J, Edelman S, Kidman AD</AU>
<TI>Perceptions of the &#8216;&#8216;Mind-Cancer&#8217;&#8217; relationship by members of the public, cancer patients and oncologists</TI>
<SO>Journal of Psychosocial Oncology</SO>
<YR>2004</YR>
<VL>21</VL>
<PG>42-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leonard-2000" NAME="Leonard 2000" TYPE="BOOK_SECTION">
<AU>Leonard R, Rodger A, Dixon J</AU>
<TI>Metastatic breast cancer</TI>
<SO>ABC of Breast Diseases</SO>
<YR>2000</YR>
<PG>65-71</PG>
<ED>Dixon M</ED>
<PB>BMJ Books</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leszcz-1998" MODIFIED="2012-07-04 17:07:49 +1000" MODIFIED_BY="[Empty name]" NAME="Leszcz 1998" TYPE="JOURNAL_ARTICLE">
<AU>Leszcz M, Goodwin P</AU>
<TI>The rationale and foundations of group psychotherapy for women with metastatic breast cancer</TI>
<SO>International Journal of Group Psychotherapy</SO>
<YR>1998</YR>
<VL>48</VL>
<NO>2</NO>
<PG>245-69</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lloyd_x002d_Williams-1999" MODIFIED="2012-07-04 17:07:20 +1000" MODIFIED_BY="[Empty name]" NAME="Lloyd-Williams 1999" TYPE="JOURNAL_ARTICLE">
<AU>Lloyd-Williams M</AU>
<TI>The assessment of depression in palliative care patients</TI>
<SO>European Journal of Palliative Care</SO>
<YR>1999</YR>
<VL>6</VL>
<NO>5</NO>
<PG>150-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maguire-2000" MODIFIED="2012-07-04 17:07:10 +1000" MODIFIED_BY="[Empty name]" NAME="Maguire 2000" TYPE="BOOK_SECTION">
<AU>Maguire P</AU>
<TI>Psychological aspects</TI>
<SO>ABC of Breast Diseases</SO>
<YR>2000</YR>
<PG>85-9</PG>
<ED>Dixon M</ED>
<PB>BMJ Books</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McKenna-1999" MODIFIED="2012-07-04 17:07:00 +1000" MODIFIED_BY="[Empty name]" NAME="McKenna 1999" TYPE="JOURNAL_ARTICLE">
<AU>McKenna M, Zevon M, Corn B, Rounds J</AU>
<TI>Psychosocial factors and the development of breast cancer: a meta-analysis</TI>
<SO>Health Psychology</SO>
<YR>1999</YR>
<VL>18</VL>
<PG>520-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McKenna-2002" MODIFIED="2013-05-09 15:00:47 +1000" MODIFIED_BY="[Empty name]" NAME="McKenna 2002" TYPE="JOURNAL_ARTICLE">
<AU>McKenna C</AU>
<TI>UK has highest reduction in deaths from lung and breast cancer</TI>
<SO>BMJ</SO>
<YR>2002</YR>
<VL>325</VL>
<PG>63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McWhinney-2002" MODIFIED="2013-05-09 15:01:06 +1000" MODIFIED_BY="[Empty name]" NAME="McWhinney 2002" TYPE="JOURNAL_ARTICLE">
<AU>McWhinney I, Bass MJ, Donner A</AU>
<TI>Evaluation of a palliative care service: problems and pitfalls</TI>
<SO>BMJ</SO>
<YR>2002</YR>
<VL>309</VL>
<PG>1340-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meyer-1995" MODIFIED="2012-07-04 19:25:28 +1000" MODIFIED_BY="[Empty name]" NAME="Meyer 1995" TYPE="JOURNAL_ARTICLE">
<AU>Meyer T, Mark M</AU>
<TI>Effects of psychosocial interventions with adult cancer patients</TI>
<SO>Health Psychology</SO>
<YR>1995</YR>
<VL>14</VL>
<NO>2</NO>
<PG>101-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NHS-CRD-1996" NAME="NHS CRD 1996" TYPE="BOOK">
<AU>UK National Health Service Centre for Reviews and Dissemination</AU>
<TI>Undertaking systematic reviews of research on effectiveness: CRD guidelines for those carrying out or commissioning reviews.</TI>
<SO>Report 4</SO>
<YR>1996</YR>
<PB>University of York</PB>
<CY>York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Petticrew-2002" MODIFIED="2013-05-09 15:01:31 +1000" MODIFIED_BY="[Empty name]" NAME="Petticrew 2002" TYPE="JOURNAL_ARTICLE">
<AU>Petticrew M, Bell R, Hunter D</AU>
<TI>Influence of psychological coping on survival and recurrence in people with cancer</TI>
<SO>BMJ</SO>
<YR>2002</YR>
<VL>325</VL>
<PG>1066-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pistrang-1995" MODIFIED="2012-07-04 17:04:49 +1000" MODIFIED_BY="[Empty name]" NAME="Pistrang 1995" TYPE="JOURNAL_ARTICLE">
<AU>Pistrang N, Barker C</AU>
<TI>The partner relationship in psychological response to breast cancer</TI>
<SO>Social Science and Medicine</SO>
<YR>1995</YR>
<VL>40</VL>
<NO>6</NO>
<PG>789-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reiche-2004" MODIFIED="2012-07-10 11:03:48 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Reiche 2004" TYPE="JOURNAL_ARTICLE">
<AU>Reiche EMV, Nunes SOV, Morimoto HK</AU>
<TI>Stress, depression, the immune system, and cancer</TI>
<SO>Lancet Oncology</SO>
<YR>2004</YR>
<VL>5</VL>
<PG>617-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2011" MODIFIED="2012-07-11 10:31:55 +1000" MODIFIED_BY="Melina L Willson" NAME="RevMan 2011" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Richardson-1990" MODIFIED="2012-07-04 17:04:10 +1000" MODIFIED_BY="[Empty name]" NAME="Richardson 1990" TYPE="JOURNAL_ARTICLE">
<AU>Richardson J, Shelter D, Krailo M, Levine A</AU>
<TI>The effect of compliance with treatment on survival among patients with haematologic malignancies</TI>
<SO>Journal of Clinical Oncology</SO>
<YR>1990</YR>
<VL>8</VL>
<NO>2</NO>
<PG>356-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Satin-2009" MODIFIED="2012-07-04 17:03:59 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Satin 2009" TYPE="JOURNAL_ARTICLE">
<AU>Satin JR, Linden W, Phillips MJ</AU>
<TI>Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis</TI>
<SO>Cancer</SO>
<YR>2009</YR>
<VL>115</VL>
<PG>5349-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sellick-1999" MODIFIED="2013-05-09 15:02:16 +1000" MODIFIED_BY="[Empty name]" NAME="Sellick 1999" TYPE="JOURNAL_ARTICLE">
<AU>Sellick S, Crooks D</AU>
<TI>Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions</TI>
<SO>Psycho-Oncology</SO>
<YR>1999</YR>
<VL>8</VL>
<PG>315-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Seruga-2008" MODIFIED="2012-07-10 11:04:16 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Seruga 2008" TYPE="JOURNAL_ARTICLE">
<AU>Seruga B, Zhang H, Bernstein LJ, Tannock IF</AU>
<TI>Cytokines and their relationship to the symptoms and outcome of cancer</TI>
<SO>Nature Reviews Cancer</SO>
<YR>2008</YR>
<VL>8</VL>
<PG>887-99</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-SIGN-2011" MODIFIED="2012-07-01 21:01:10 +1000" MODIFIED_BY="mohammed mustafa" NAME="SIGN 2011" TYPE="OTHER">
<AU>Scottish Intercollegiate Guidelines Network (SIGN)</AU>
<TI>Search Filters</TI>
<SO>Available from: http://www.sign.ac.uk/methodology/filters.html#random, accessed 31 May 2011</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-2006" MODIFIED="2012-07-10 11:04:30 +1000" MODIFIED_BY="Melina L Willson" NAME="Smith 2006" TYPE="JOURNAL_ARTICLE">
<AU>Smith I</AU>
<TI>Goals of treatment for patients with metastatic breast cancer</TI>
<SO>Seminars in Oncology 2006</SO>
<YR>2006</YR>
<VL>32</VL>
<PG>S2&#8211;6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stalker-1990" NAME="Stalker 1990" TYPE="JOURNAL_ARTICLE">
<AU>Stalker M, Johnson S, Cinima C</AU>
<TI>Supportive activities requested by survivors of cancer</TI>
<SO>Journal of Psychosocial Oncology</SO>
<YR>1990</YR>
<VL>7</VL>
<PG>21-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-S_x00f8_rlie-2001" MODIFIED="2012-07-10 11:05:00 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Sørlie 2001" TYPE="JOURNAL_ARTICLE">
<AU>Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al</AU>
<TI>Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications</TI>
<SO>Proceedings of the National Academy of Sciences</SO>
<YR>2001</YR>
<VL>98</VL>
<NO>19</NO>
<PG>10869-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-S_x00f8_rlie-2003" MODIFIED="2012-07-10 11:05:18 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Sørlie 2003" TYPE="JOURNAL_ARTICLE">
<AU>Sørlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al</AU>
<TI>Repeated observation of breast tumor subtypes in independent gene expression data sets</TI>
<SO>Proceedings of the National Academy of Sciences</SO>
<YR>2003</YR>
<VL>100</VL>
<NO>14</NO>
<PG>8418-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Taylor-1986" MODIFIED="2012-07-04 16:59:51 +1000" MODIFIED_BY="[Empty name]" NAME="Taylor 1986" TYPE="JOURNAL_ARTICLE">
<AU>Taylor S, Falker R, Shopton S, Lichtman R</AU>
<TI>Social support, support groups and the cancer patient</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1986</YR>
<VL>54</VL>
<PG>608-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Trijsburg-1992" NAME="Trijsburg 1992" TYPE="JOURNAL_ARTICLE">
<AU>Trijsburg R, van Knippenberg F, Rijpma S</AU>
<TI>Effect of psychological treatment on cancer patients: a critical review</TI>
<SO>Psychosomatic Medicine</SO>
<YR>1992</YR>
<VL>54</VL>
<PG>489-517</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Watson-1999" MODIFIED="2013-05-09 15:03:16 +1000" MODIFIED_BY="[Empty name]" NAME="Watson 1999" TYPE="JOURNAL_ARTICLE">
<AU>Watson M, Haviland J, Greer S, Davidson J, Bliss J</AU>
<TI>Influence of psychological response on survival in breast cancer: a population-based cohort study</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<PG>1331-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Whatley-1998" NAME="Whatley 1998" TYPE="BOOK">
<AU>Whatley R, Milne R</AU>
<SO>Psycho-social interventions in oncology: counselling services for women with breast cancer</SO>
<YR>1998</YR>
<PB>Wessex Institute for Health Research and Development: Development and Evaluation Committee</PB>
<CY>Southampton, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2012-07-11 10:31:55 +1000" MODIFIED_BY="Sharon  M Parker">
<REFERENCE ID="REF-Edwards-2004" MODIFIED="2012-07-10 11:11:11 +1000" MODIFIED_BY="Sharon  M Parker" NAME="Edwards 2004" TYPE="COCHRANE_REVIEW">
<AU>Edwards A, Hailey S, Maxwell M</AU>
<TI>Psychological interventions for women with metastatic breast cancer [review]</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2012-07-10 11:11:11 +1000" MODIFIED_BY="Sharon  M Parker">
<IDENTIFIER MODIFIED="2012-07-10 11:11:11 +1000" MODIFIED_BY="Sharon  M Parker" TYPE="DOI" VALUE="10.1002/14651858.CD004253.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Edwards-2008" MODIFIED="2012-07-10 11:09:32 +1000" MODIFIED_BY="Mohammed Mustafa" NAME="Edwards 2008" TYPE="COCHRANE_REVIEW">
<AU>Edwards AGK, Hulbert-Williams N, Neal RD</AU>
<TI>Psychological interventions for women with metastatic breast cancer [review]</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2. Art. No.: CD004253. DOI: 10.1002/14651858.CD004253.pub3</NO>
<IDENTIFIERS MODIFIED="2012-07-10 11:09:32 +1000" MODIFIED_BY="Mohammed Mustafa">
<IDENTIFIER MODIFIED="2012-07-10 11:09:26 +1000" MODIFIED_BY="Mohammed Mustafa" TYPE="DOI" VALUE="10.1002/14651858.CD004253.pub3"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2012-07-10 11:06:46 +1000" MODIFIED_BY="Melina L Willson">
<REFERENCE ID="REF-Aranda-2006" MODIFIED="2012-07-10 11:06:33 +1000" MODIFIED_BY="Melina L Willson" NAME="Aranda 2006" TYPE="JOURNAL_ARTICLE">
<AU>Aranda S, Schofield P, Weih L, Milne D, Yates P, Faulkner R</AU>
<TI>Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial</TI>
<SO>British Journal of Cancer</SO>
<YR>2006</YR>
<VL>95</VL>
<NO>6</NO>
<PG>667-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Savard-2006" MODIFIED="2012-07-10 11:06:46 +1000" MODIFIED_BY="Melina L Willson" NAME="Savard 2006" TYPE="JOURNAL_ARTICLE">
<AU>Savard J, Simard S, Giguere I, Ivers H, Morin C, Maunsell E, et al</AU>
<TI>Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects</TI>
<SO>Palliative &amp; Supportive Care</SO>
<YR>2006</YR>
<VL>4</VL>
<NO>3</NO>
<PG>219-37</PG>
<IDENTIFIERS/>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-06-16 14:29:59 +1000" MODIFIED_BY="Melina L Willson">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-05-09 11:25:02 +1000" MODIFIED_BY="Mohammed Mustafa" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-05-08 18:10:54 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Aranda-2006">
<CHAR_METHODS MODIFIED="2012-07-10 10:15:26 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-10 10:15:27 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>105 women with advanced breast cancer, English speaking, Australian</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-08 18:10:01 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Two components to the psycho-educational intervention; group (face-to-face) session followed by an individual (telephone) session a week later. The group session was designed around the FOCUS framework; family involvement, optimistic attitude, coping effectiveness, uncertainty reduction and symptom management. Telephone encounter involved asking whether the suggested strategies ameliorated the concerns, as well as addressing new concerns and self-help strategies</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-08 18:10:35 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>EORTC QLQ-30 version 2, supportive care needs survey. Data collected at baseline and then one month and 3 months post-baseline. Telephone follow-up was used to enhance response rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-08 18:10:54 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>No discussion of participant ethnicity</P>
<P>Intervention delivered by breast care nurses previously trained by study team. Quality assurance checks not described beyond initial training and analyses not undertaken for each breast care nurse</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-08 18:16:00 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Classen-2001">
<CHAR_METHODS MODIFIED="2012-07-10 10:17:04 +1000" MODIFIED_BY="mohammed mustafa">
<P>RCT (stratified)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-01 21:22:55 +1000" MODIFIED_BY="mohammed mustafa">
<P>125 women with metastatic breast cancer; recruited 1991-1996; USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-08 18:16:00 +1000" MODIFIED_BY="[Empty name]">
<P>Supportive-expressive group therapy: weekly meeting for at least 1 year; support to express difficult emotions, confront problems, strengthen relationships (social and professional), and find meaning in life. Control: educational materials for support and information</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Courtaulds Emotional Control Scale; Weinberger Adjustment Inventory; Stanford Emotional self-efficacy scale; Profile of Mood States; Impact of events scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-15 03:31:12 +1000" MODIFIED_BY="mohammed mustafa"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-08 18:19:11 +1000" MODIFIED_BY="mohammed mustafa" STUDY_ID="STD-Cunningham-1998">
<CHAR_METHODS MODIFIED="2012-07-10 10:15:46 +1000" MODIFIED_BY="mohammed mustafa">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-01 21:14:24 +1000" MODIFIED_BY="mohammed mustafa">
<P>66 women with metastatic breast cancer; recruited 1992-1994; Canadian</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-10 10:15:48 +1000" MODIFIED_BY="mohammed mustafa">
<P>Support + cognitive behaviour therapy sessions and homework exercises; including coping skills (relaxation and stress management); control group had home based CBT only, and regular phone contact to ensure compliance with study outcome evaluations</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-08 18:19:11 +1000" MODIFIED_BY="mohammed mustafa">
<P>Survival; Profile of Mood States; Functional Living Index; Mental Adjustment to Cancer Scale; rationality/emotional defensiveness; Marlowe Crowne social desirability; Defensive Repression</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-10 10:15:50 +1000" MODIFIED_BY="mohammed mustafa">
<P>Survival data from time of diagnosis of metastases not time of intervention</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-08 18:24:10 +1000" MODIFIED_BY="mohammed mustafa" STUDY_ID="STD-Edelman-1999">
<CHAR_METHODS MODIFIED="2012-07-10 10:16:03 +1000" MODIFIED_BY="mohammed mustafa">
<P>RCT (block randomisation)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-01 21:17:16 +1000" MODIFIED_BY="mohammed mustafa">
<P>124 women with metastatic breast cancer; recruited 1994-1997; Australian (English speakers)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-08 18:23:10 +1000" MODIFIED_BY="mohammed mustafa">
<P>Cognitive behaviour therapy-based; manual for cognitive skills; behavioural techniques at group sessions; home-work exercises; themes addressed: depression, communication, self-esteem, anxiety, self-image, relationships, anger management; control content uncertain</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-08 18:24:10 +1000" MODIFIED_BY="mohammed mustafa">
<P>Survival; Profile of Mood States (POMS); Coopersmith Self-Esteem Inventory</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-10 10:16:05 +1000" MODIFIED_BY="mohammed mustafa">
<P>Anxiety data from POMS component score</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-01 21:15:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goodwin-2001">
<CHAR_METHODS MODIFIED="2012-07-10 10:16:17 +1000" MODIFIED_BY="mohammed mustafa">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-01 21:15:20 +1000" MODIFIED_BY="mohammed mustafa">
<P>235 women with metastatic breast cancer; recruited 1993-1998; Canadian</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-10 23:14:51 +1000" MODIFIED_BY="mohammed mustafa">
<P>Group support, encouraged expression of emotions about cancer, effects of illness, relationships, strategies for coping and communicating<BR/>Control: educational materials and routine outcome assessments as per study protocol</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-10 10:16:19 +1000" MODIFIED_BY="mohammed mustafa">
<P>Survival; Pain, Profile of Mood States; Quality of Life</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-09-21 02:32:31 +1000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-09 11:25:02 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Gotay-2007">
<CHAR_METHODS MODIFIED="2012-07-10 10:16:28 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>RCT (stratified)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-01 21:15:51 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>305 women with metastatic breast carcinoma; recruited 1998-2002; USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-09 11:25:02 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Peer-delivered telephone intervention. The intervention content reflected the most common domains in multidimensional models of quality of life and the primary concerns expressed by breast cancer patients. Patients received four to eight counselling/ information sessions delivered by telephone at weekly intervals, with one to two calls per week. After the first session, patients were sent a standardized packet of information, primarily National Cancer Institute (NCI) pamphlets. All counsellors except one were breast cancer recurrence survivors at least 1 year post-recurrence, the exception being a bone marrow transplant recipient</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-08 21:41:38 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Primary: emotional well-being: CARES-SF; depressive symptom: CES-D.</P>
<P>Secondary: secondary analyses examined associations between baseline predictors and 3-month scores: CARES-SF psychosocial summary, CES-D, CARES-SF physical functioning, and CARES-SF global, using logistic regression</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-10 10:22:06 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Phase III trial. All counsellors except one were breast cancer recurrence survivors at least 1 year post-recurrence, the exception being a bone marrow transplant recipient</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-09 08:58:27 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Kissane-2007">
<CHAR_METHODS MODIFIED="2012-07-10 10:16:41 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-08 21:42:54 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>227 women with metastatic breast cancer; recruited 1996-2002; Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-10 10:16:43 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Supportive-expressive group therapy, weekly 90 minute sessions, encouraged to participate for a year</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-09 08:58:27 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Survival and Psychosocial (Monash Interview for Liaison Psychiatry (MILP), EORTC Quality of Life C-30, Impact of Event Scale, Mini-Mental Adjustment to Cancer Scale, Recording of details of self-help or other psychosocial treatments). Women were asked to rate their experience of SEGT and the relaxation classes. Assessment took place at baseline prior to randomisation and four follow-up points at 6-monthly intervals</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-08 21:45:03 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Low-2010">
<CHAR_METHODS MODIFIED="2012-07-10 10:18:03 +1000" MODIFIED_BY="[Empty name]">
<P>RCT (parallel groups)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-01 21:16:58 +1000" MODIFIED_BY="[Empty name]">
<P>62 women with metastatic breast cancer; recruited 2006-2009; USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-08 21:44:43 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Emotionally expressive writing during four 20 minute sessions within 3 weeks at participants convenience. A trained research assistant telephoned women at the beginning of each session to read the instructions to the participant then called again 20 minutes later to ask women to stop writing</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-08 21:44:55 +1000" MODIFIED_BY="[Empty name]">
<P>Centre for Epidemiologic Studies Depression Scale (CES-D); Impact of Event Scale (IES); negative somatic symptoms; The Pittsburgh Sleep Quality Index (PSQI); Perceived emotional support</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-08 21:45:03 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>This trial has attracted a particular type of patient (white, educated) including from another observational study. Payment of $80/participant</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-08 21:46:57 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Scholten-2001">
<CHAR_METHODS MODIFIED="2012-07-10 10:18:19 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>"Prospective" RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-10 10:22:57 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>43 women with metastatic breast cancer (group 2); Austria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-08 21:46:57 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Individual psychotherapy. Modeled upon crisis intervention with cognitive and behavioural approach. Self-hypnosis and progressive muscle relaxation therapies</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-10 10:18:21 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Quality of life assessed using semi-structured interview (study entry and 3 months) an visual analogue scale (4 time points: study entry, after the intervention, 3 months, 6 months)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-10 10:18:22 +1000" MODIFIED_BY="mohammed mustafa">
<P>Patients were divided into two groups according to their stage of breast cancer. 41 patients in group one had breast cancer stage 1 or 2. 43 patients in group two had metastatic breast cancer. Both group one and two were each randomised to control and intervention arms. The intervention was the same for both groups</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-05-08 21:49:44 +1000" MODIFIED_BY="mohammed mustafa" STUDY_ID="STD-Spiegel-1989">
<CHAR_METHODS MODIFIED="2012-07-10 10:18:29 +1000" MODIFIED_BY="mohammed mustafa">
<P>RCT (3:2 towards intervention)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-01 21:51:27 +1000" MODIFIED_BY="mohammed mustafa">
<P>86 women with metastatic breast cancer; recruitment started 1977; USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-05-08 21:48:51 +1000" MODIFIED_BY="mohammed mustafa">
<P>Group support including terminal illness problems, improving relationships and communication, discussing concerns, fears and living life to full; control group - assumed to be usual care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-08 21:49:21 +1000" MODIFIED_BY="mohammed mustafa">
<P>Survival at 1-10 years; Profile of Mood States; Health Locus of Control (HLC); self-esteem (Janis-Field); maladaptive coping response; denial measures; phobias</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-08 21:49:44 +1000" MODIFIED_BY="mohammed mustafa">
<P>1 of 3 intervention groups had self-hypnosis; other psychological outcomes reported as non-significant differences in HLC, denial or self-esteem; reduction in fear and maladaptive coping reported (no data)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>CARES-SF: Cancer Rehabilitation and Evaluation System Short Form <BR/>CBT: cognitive behavioural therapy<BR/>CES-D: Center for Epidemiologic Studies Depression scale<BR/>CG: control group<BR/>HLC: health locus of control<BR/>IES: impact of event scale<BR/>md: median<BR/>MILP: Monash Interview for Liaison Psychiatry<BR/>ns: non-significant<BR/>POMS: Profile of Mood States<BR/>PSQI: Pittsburgh Sleep Quality Index<BR/>QLQ: quality of life questionnaire<BR/>RCT: randomised controlled trials<BR/>SEGT: supportive-expressive group therapy<BR/>SESES-C: the Stanford Emotional Self-Efficacy Scale - Cancer<BR/>TG: telephone group<BR/>TMD: temporomandibular disorder <BR/>WAI: Weinberger Adjustment Inventory </P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-06-16 14:29:59 +1000" MODIFIED_BY="Melina L Willson" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-10-02 00:21:06 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Andersen-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 00:21:06 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Of the 227 participants, authors report 10% had Stage III breast cancer. However, there was not the required level of data with respect to that stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 10:45:52 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Andersen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 10:45:52 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Linked to <LINK REF="STD-Andersen-2007" TYPE="STUDY">Andersen 2007</LINK>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 00:23:47 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Antoni-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 00:23:47 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>The study had 3 patients with Stage III breast cancer. In addition to the small number, there was not the required level of data with respect to that stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 21:41:00 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Arathuzik-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 21:41:00 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Does address patients with metastatic breast cancer but is not a randomised controlled trial </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 21:44:26 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Badger-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 21:44:26 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not metastatic disease patients </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 10:45:53 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Bahmani-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 10:45:53 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Includes non-metastatic breast carcinoma</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 00:28:20 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Berger-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 00:28:20 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>The study had 31 patients with Stage III breast cancer. However, there was not the required level of data with respect to that stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 00:31:29 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Brietbart-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 00:31:29 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Study included patients with advanced cancer. However it did not present the data according to cancer type</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 00:46:58 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Brown-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 00:46:58 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Patients with advanced cancer involving brain, head and lung, ovarian, GI, and 'other'. There was not the required level of data with respect to cancer type</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 21:49:10 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Carlson-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 21:49:10 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Mixed cancer types not analysed separately</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 21:54:41 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Cerny-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 21:54:41 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Non-randomised study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 10:45:57 +1000" MODIFIED_BY="mohammed mustafa" STUDY_ID="STD-Chan-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 10:45:57 +1000" MODIFIED_BY="mohammed mustafa">
<P>Includes metastatic cancer patients but not analysed separately</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 21:56:26 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Chujo-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 21:56:26 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not metastatic disease patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 00:49:57 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Dirksen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 00:49:57 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Included 9 patients with Stage III breast cancer, but did not the required level of data with respect to that stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 00:58:22 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Doorenbos-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 00:58:22 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Included breast as a solid cancer site but there was not the required level of data with respect to stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 21:58:44 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Edelman-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 21:58:44 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not metastatic disease or randomised trial </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 10:46:01 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Edgar-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 10:46:01 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not the required level of data with respect to stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 10:46:01 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Fukui-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 10:46:01 +1000" MODIFIED_BY="Melina L Willson">
<P>RCT of group psychological intervention but predominantly for women with Stage 1 or 2 disease and other medical therapy (radiation, chemotherapy, hormonal); only 3 out of 50 recruited patients had Stage 3 disease</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-08 21:55:14 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Gellert-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-08 21:55:14 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Follow up of matched but non-randomised groups with or without 'ECaP&#8217; (Exceptional Cancer Patients) group psychosocial support therapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Graves-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not metastatic disease patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-07 21:06:59 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Helgeson-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-07 21:06:59 +1000" MODIFIED_BY="Melina L Willson">
<P>Aimed to recruit only patients with Stage 1 or 2 disease. In fact 6% of sample (approximately 19 women) with Stage 3 disease were recruited but results not reported separately and randomisation not stratified for disease stage</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 10:46:06 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Hong-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 10:46:06 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not the required level of data with respect to stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-08 21:55:52 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Ilnyckyj-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-08 21:55:52 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>RCT of psychological intervention for cancer patients, but breast cancer patients (for whom separate data are presented) were not randomised and disease status/metastatic status is not reported for this subgroup</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:08:18 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Kissane-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:08:18 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>RCT of psychological intervention for breast cancer patients but all patients had either Stage 1 or 2 disease</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-16 14:29:59 +1000" MODIFIED_BY="Melina L Willson" STUDY_ID="STD-Laidlaw-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-16 14:29:59 +1000" MODIFIED_BY="Melina L Willson">
<P>Excluded on methodological grounds although it was a (pilot) trial of a psychological intervention for women<BR/>with metastatic breast cancer. Small study with high loss to follow-up (23/37 participants = 62%, leaving 6, 5<BR/>and 3 participants in the study groups at this stage and insufficient information about characteristics to assess<BR/>bias). Only one outcome with data from the randomised design was POMS, and this was at 3 months, thus<BR/>not consistent with other outcome reporting/extraction for this review&#8217;s methods</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-08 21:56:56 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Lapid-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-08 21:56:56 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Included patients with newly diagnosed advanced cancer but there was not the required level of data with respect to cancer type other than brain, head and neck, lung, ovarian, GI and 'other'</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:13:18 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Larson-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:13:18 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Staging data only on 68% of sample, and of these 28 patients, only 3 had metastatic disease</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 01:08:51 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Lee-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 01:08:51 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Included 7 patients with at least Stage III breast cancer but there was not the required level of data with respect to those stages of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-08 21:57:27 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Leon_x002d_Pizzaro-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-08 21:57:27 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Included 10 patients with Stage III and IV gynaecologic and breast cancer but there was not the required level of data with respect to type or stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 01:20:11 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Lev-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 01:20:11 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Included 18 patients with breast cancer bu there was not the required level of data with respect to stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 01:20:52 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Levine-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 01:20:52 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Includes patients with metastatic cancer, but not analysed separately according to cancer site</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:15:55 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Lieberman-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:15:55 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not metastatic disease patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:17:28 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Linn-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:17:28 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Only male patients in study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 10:46:12 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Mantovani-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 10:46:12 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not the required level of data with respect to cancer type</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:21:58 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Marchioro-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:21:58 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Does not address patients with metastatic breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:23:31 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-McArdle-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:23:31 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Does not address patients with metastatic breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 01:22:02 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Michalec-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 01:22:02 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Includes patients with metastatic cancer, but not analysed separately according to cancer site</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 01:27:31 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Nidich-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 01:27:31 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Included women with stages II to IV breast cancer, but there was not the required level of outcome data with respect to stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:29:35 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Northouse-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:29:35 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Included metastatic disease patients, but not analysed separately</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:31:15 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Rosenbaum-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:31:15 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not randomised trial </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:44:28 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Rummans-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:44:28 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Mixed cancer types, breast cancer patients not analysed separately</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 10:30:52 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Salzer-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 10:30:52 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Includes non-metastatic breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-02 01:30:42 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Sandgren-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-02 01:30:42 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Included 23 women with Stage III breast cancer, but there was not the required level of outcome data with respect to that stage of breast cancer</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-11 10:30:56 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Sloman-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-11 10:30:56 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not the required level of data with respect to cancer type</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 10:46:16 +1000" MODIFIED_BY="mohammed mustafa" STUDY_ID="STD-Targ-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 10:46:16 +1000" MODIFIED_BY="mohammed mustafa">
<P>Entry criterion was within 18 months of diagnosis, not related to extent of disease; 80% of participants had Stage 1 or Stage 2 disease (non-metastatic); data for women with Stages 3 or 4 (metastatic) are not reported separately</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:46:45 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Traeger_x002d_Muney-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:46:45 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not randomised design </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-01 22:48:25 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-van-der-Pompe-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-01 22:48:25 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Only 6 out of 23 study patients had metastatic disease and effects of intervention on patients with metastatic<BR/>disease not reported separately</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-10 10:46:17 +1000" MODIFIED_BY="Mohammed Mustafa" STUDY_ID="STD-Wang-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-10 10:46:17 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>Not the required level of data with respect to cancer type</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-05-09 08:57:55 +1000" MODIFIED_BY="Mohammed Mustafa">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-05-09 08:57:55 +1000" MODIFIED_BY="Mohammed Mustafa" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:19:36 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Aranda-2006">
<DESCRIPTION>
<P>For each study site, an even number of folded intervention (20) and control (20) cards were thoroughly shuffled then placed in consecutively numbered, opaque, sealed envelopes. After baseline data collection, an envelope was sequentially drawn and opened by the breast care nurse/researcher</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-04 19:18:46 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Classen-2001">
<DESCRIPTION>
<P>"Participants were randomized by the project director..who used a computer-assisted adaptive randomization biased coin-design method to ensure comparability of medical status in treatment and control conditions"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-08 18:19:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cunningham-1998">
<DESCRIPTION>
<P>"Randomization was performed centrally, stratified for study center"</P>
<P>Comment: probably done especially in light of variation of randomization ratio needed by study site</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:08 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Edelman-1999">
<DESCRIPTION>
<P>"For every 20 patients that were recruited a block randomisation procedure took place, with ten being randomised to each treatment condition."</P>
<P>Comment: random sequence not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:20 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodwin-2001">
<DESCRIPTION>
<P>"Randomization, performed centrally with the use of sealed envelopes containing allocations from a computer-generated table of random numbers, was stratified according to the center (seven sites) and the presence or absence of visceral metastases."</P>
<P>Comment: probably done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:22:15 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Gotay-2007">
<DESCRIPTION>
<P>Random assignment was performed through the SWOG Web Registration Program, which automatically conveys treatment assignment, through a call to the SWOG Statistical Center. Assignment to the control group (CG) or telephone intervention group (TG) was dynamically balanced by the stratification factors (age, recurrence site, and time since diagnosis) according to Pocock and Simon&#8217;s method</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 08:57:55 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Kissane-2007">
<DESCRIPTION>
<P>Eligible consenting patients were independently allocated in a ratio of 2:1 to treatment and control arms respectively, by a stratified randomisation process (utilising an &#8216;adaptive biased coin design&#8217;) at the Statistical Centre of the Peter MacCallum Cancer Institute. Stratification ensured arms were balanced on three prognostic factors: (i) visceral or non-visceral metastases; (ii) less than three, or three or more visceral sites; and (iii) positive or negative oestrogen receptor status</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-04 01:32:11 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Low-2010">
<DESCRIPTION>
<P>"Randomization schedule was created by a biostatistician using a computerized random numbers generator"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-04 01:45:13 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Scholten-2001">
<DESCRIPTION>
<P>"The 43 patients were then randomized into one group of 20 patients who were to receive psychosocial support and another group of 23 patients who were to be the waiting list control group and who received no psychosocial support during the observation period."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-08 21:50:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Spiegel-1989">
<DESCRIPTION>
<P>"After written informed consent was obtained (protocol approved by Stanford Human Subjects Committee), a battery of psychological tests was administered. The subjects were then randomly assigned to either the intervention or control groups"</P>
<P>Comment: method of randomisation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-05-09 08:56:56 +1000" MODIFIED_BY="Mohammed Mustafa" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:15:36 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Aranda-2006">
<DESCRIPTION>
<P>As above - opaque, sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:17:12 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Classen-2001">
<DESCRIPTION>
<P>"Randomization was conducted for overall assignment to treatment versus control condition"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-08 18:19:56 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cunningham-1998">
<DESCRIPTION>
<P>"Using sealed envelopes containing allocations arising from computer-generated random numbers tables."</P>
<P>Comment: probably done (as above)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:09 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Edelman-1999">
<DESCRIPTION>
<P>"All patients were aware of the randomisation process and that therapy would be offered to only half of the participants. Whilst some did not mind which condition they would be randomised to, some had a clear preference to attend groups and were disappointed at having been randomised to the control group."</P>
<P>Comment: implies an open process of allocation, probably informed intervention group of condition too</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:21 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Goodwin-2001">
<DESCRIPTION>
<P>"No blinding was used in randomization or data collection."</P>
<P>Comment: uncertain how beneficial or otherwise this process would be for this psychological intervention; risk is dependant on differences between control and interventional groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:34 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Gotay-2007">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:51 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Kissane-2007">
<DESCRIPTION>
<P>See above - central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-04 01:32:20 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Low-2010">
<DESCRIPTION>
<P>"Participants were randomized to either the emotional or control writing condition and mailed a packet of sealed envelopes containing writing instructions as well as return envelopes and materials for the writing exercise."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-09 08:56:56 +1000" MODIFIED_BY="mohammed mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Scholten-2001">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:18:35 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Spiegel-1989">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-09-19 05:41:39 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-05-08 21:45:30 +1000" MODIFIED_BY="Mohammed Mustafa" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-10 10:29:16 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Aranda-2006">
<DESCRIPTION>
<P>No statement made by authors regarding information giving about the intervention or whether participants were informed which group they had been allocated. But review authors judge blinding as not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-10 10:36:59 +1000" MODIFIED_BY="mohammed mustafa" RESULT="YES" STUDY_ID="STD-Classen-2001">
<DESCRIPTION>
<P>Review authors judge blinding as not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-10 10:29:39 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cunningham-1998">
<DESCRIPTION>
<P>No evidence of blinding to participants or study group leaders. But review authors judge blinding as not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-10 10:29:57 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Edelman-1999">
<DESCRIPTION>
<P>Review authors judge blinding as not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-10 10:32:31 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodwin-2001">
<DESCRIPTION>
<P>"Women in the control group did not receive any psychological therapy as part of the study. Women in either group could participate in peer support groups, or therapist-led support groups for patients with various types of cancer that did not involve supportive&#8211; expressive therapy, and they could receive any necessary medical, surgical, or psychosocial care."</P>
<P>Comment: no formal group environment available for control group participants; therefore participants very aware which groups they were participating in</P>
<P>Review authors judge blinding as not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-10 10:32:52 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Gotay-2007">
<DESCRIPTION>
<P>Review authors judge blinding as not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-10 10:37:04 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Kissane-2007">
<DESCRIPTION>
<P>"For practical reasons, neither researchers nor participants were blinded to the randomization outcome."</P>
<P>Review authors judge blinding as not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-05-08 21:45:30 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Low-2010">
<DESCRIPTION>
<P>"Condition assignment was revealed to the assistant reading instructions during the first writing session. After each writing session, women mailed their essays to the research office."</P>
<P>Comment: no clear statement made by authors regarding control group details; no information regarding blinding of either participants or personnel. However, review authors deem this kind of blinding inappropriate for this type of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-10 10:18:25 +1000" MODIFIED_BY="mohammed mustafa" RESULT="YES" STUDY_ID="STD-Scholten-2001">
<DESCRIPTION>
<P>Review authors deem this kind of blinding inappropriate for this type of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-10 10:18:36 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spiegel-1989">
<DESCRIPTION>
<P>No blinding occurred. Those allocated to the Group Intervention attended three 90-minute sessions of group therapy. Review authors deem this kind of blinding inappropriate for this type of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2012-07-10 10:17:14 +1000" MODIFIED_BY="Mohammed Mustafa" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-10 10:15:38 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Aranda-2006">
<DESCRIPTION>
<P>A research assistant, not involved in the intervention delivery, administered all follow-up data collection</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-10 10:17:14 +1000" MODIFIED_BY="mohammed mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Classen-2001">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-10 10:15:59 +1000" MODIFIED_BY="mohammed mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Cunningham-1998">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-01 20:22:51 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Edelman-1999">
<DESCRIPTION>
<P>"Ninety-two participants who remained in the trial completed questionnaires in the pre- and post-therapy periods, with numbers diminishing in the subsequent 3 and 6 month assessments."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-10 10:16:23 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodwin-2001">
<DESCRIPTION>
<P>"Psychosocial questionnaires were scored by a research assistant who had no knowledge of the subjects&#8217; treatment assignment."</P>
<P>Comment: probably done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-10 10:16:36 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Gotay-2007">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-10 10:16:56 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Kissane-2007">
<DESCRIPTION>
<P>Insufficient information to judge</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-05-04 01:33:46 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Low-2010">
<DESCRIPTION>
<P>"An independent rater unaware of condition assignment read all transcribed essays in random order and recorded which condition instructions they most reflected. The rater correctly classified 94% of the essays, indicating excellent adherence to writing instructions."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-05-04 01:49:00 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Scholten-2001">
<DESCRIPTION>
<P>"The (semi-structured) interviews were tape recorded, and for each patient a descriptive rating was performed independently by the interviewer and by another experienced psychologist."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-01 20:33:44 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spiegel-1989">
<DESCRIPTION>
<P>"14 subjects assigned to group therapy were too weak or ill at initial interview to participate; 6 died after entry but before the groups began and 2 others moved away. 12 subjects were lost from the controls; 4 were too ill to participate, 2 died, 4 refused to participate, and we were unable to contact 2. 30 of the 34 women in the intervention group and all 24 control women survived long enough to respond to at least one follow-up questionnaire during the year of study."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-05-08 21:50:48 +1000" MODIFIED_BY="Mohammed Mustafa" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-08 18:14:13 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Aranda-2006">
<DESCRIPTION>
<P>Overall, 69% (72 out of 105) of patients completed the 1 month follow-up, 78% (36 out of 46) in the usual care arm and 61% (36 out of 59) in the intervention arm. Four of the 105 patients (4%) died prior to 1-month follow-up. Follow-up at 3 months was 57% (60/105), 65% (30/46) of usual care patients and 51% (30/59) intervention patients. Four of the 105 patients (9%) died prior to 3-month follow-up. Excluding the deaths, this represents overall response rates of 71% and 63% for the 1 and 3 month follow-ups, respectively</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-10 23:12:19 +1000" MODIFIED_BY="mohammed mustafa" RESULT="YES" STUDY_ID="STD-Classen-2001">
<DESCRIPTION>
<P>"The sample for each outcome slope of change n = 97, CECS; n = 62, WAI Restraint; n = 64, WAI Repressive-Defensiveness; n = 65, SESES-C) included in this article is reduced from the 125 women randomized at baseline for various reasons (2 women filling out the WAI were missing too many items on the Restraint Scale to score it). Because of the nature of the illness, many women died before they could complete a follow-up assessment, and some women declined to complete follow-ups because of illness-related factors (ns = 17, 35, 35, and 17 for the four scales, respectively)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-08 18:20:08 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cunningham-1998">
<DESCRIPTION>
<P>Method of follow-up for non-responders unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-08 18:27:10 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Edelman-1999">
<DESCRIPTION>
<P>"Only 92 patients were included in the analysis of the psychological outcome of the therapy, as patients who failed to complete post-therapy questionnaires were classified as &#8216;dropouts&#8217; in that analysis."</P>
<P>"The baseline psychological data that was available for 28 patients who dropped out of the study was compared with that of the 92 patients who were retained. Compared to patients who remained in the study, those who dropped out showed significantly higher levels of anxiety (MD 12 6s. 6.5, P = 0.008), confusion (MD 7.5 6s. 5, P = 0.014), TMD (MD 51.5 6s. 14, P = 0.010), and lower self-esteem (MD 66 6s. 80, P = 0.015) and vigour (MD 11 6s. 14.5, P = 0.026)."</P>
<P>"To examine the possibility that the failure to find a survival effect was related to the non-participation in therapy by patients in the intervention group, a further survival analysis (using time of recurrence as baseline) was conducted, with dropouts being excluded from the sample. Once again, only medical prognostic variables predicted survival outcome."</P>
<P>Comment: data presented and consideration of confounders discussed in papers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-08 18:29:25 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodwin-2001">
<DESCRIPTION>
<P>"The rate of completion of the psychosocial questionnaires did not differ significantly between the two groups (70.5% of the women in the intervention group and 65.3% of those in the control group completed at least one follow-up questionnaire, P = 0.43)."</P>
<P>"Thirty women (19.0%) dropped out of group therapy after a mean of 3.5 months, and eight women did not attend any sessions."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-10 10:16:36 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Gotay-2007">
<DESCRIPTION>
<P>Extent and reasons given for missing data, balanced across trial conditions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-10 10:17:01 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Kissane-2007">
<DESCRIPTION>
<P>Flowchart of randomised controlled trial of supportive-expressive group therapy for 227 women with metastatic breast cancer. Deaths and study withdrawals are recorded cumulatively down the chart. Treatment data were missing for 13 of the 227 (5.7%): five received treatment interstate and eight had medical records missing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-08 21:46:24 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Low-2010">
<DESCRIPTION>
<P>"One woman was not able to complete her writing sessions within the 3-week interval and was dropped from the study and the remaining 75 completed the writing...Eleven women died during the follow-up period, and two women did not return their questionnaires and could not be reached. Women who did not complete the project did not significantly differ on any demographic or cancer-related variable or on baseline levels of outcome variables."</P>
<P>"Women who did not complete the project did not significantly differ on any demographic or cancer-related variable or on baseline levels of outcome variables"</P>
<P>Comment: no statistical significance between categories following dropouts and deaths</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-08 21:48:21 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="NO" STUDY_ID="STD-Scholten-2001">
<DESCRIPTION>
<P>"Overall drop-out rate of 60%" from the intervention arm that originally comprised 20 women with metastatic breast cancer</P>
<P>"Three (15%) rejected the offer at study entry. After the first session, 5 (25%) further patients discontinued support. A further 6 (30%) discontinued therapy after three to five sessions."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-08 21:50:48 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Spiegel-1989">
<DESCRIPTION>
<P>"To examine between-group differences among those patients who where more actively involved, we did the same Cox regression analysis on the 54 patients who completed both a baseline and at least one of the three follow-up questionnaires during the year."</P>
<P>"We made phone contact with the 3 survivors. For other than the primary survival analysis, these 3 were treated as though their date of death was July 1, 1988, when all death records had been obtained. If there was any bias resulting from this decision, it would be in the direction of minimising the impact of intervention, since all 3 were in the treatment group."</P>
<P>Comment: no discussion of the number of patients who completed some or all follow-up questionnaires</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-05-07 21:08:26 +1000" MODIFIED_BY="Mohammed Mustafa" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-03 22:06:42 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Aranda-2006">
<DESCRIPTION>
<P>Hypothesis generated and reported on (main paper). "Those patients randomly allocated to the intervention group will report a decrease in psychological and informational needs and an increase in quality of life from baseline to follow-up compared to women receiving usual care."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:22:43 +1000" MODIFIED_BY="mohammed mustafa" RESULT="YES" STUDY_ID="STD-Classen-2001">
<DESCRIPTION>
<P>All primary and secondary outcome measures reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:00 +1000" MODIFIED_BY="mohammed mustafa" RESULT="YES" STUDY_ID="STD-Cunningham-1998">
<DESCRIPTION>
<P>Specified expected outcomes. All outcomes reported (analysis of survival data and psychological outcome data presented separately in two different publications)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:13 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Edelman-1999">
<DESCRIPTION>
<P>All outcomes reported (analysis of survival data and psychological outcome data presented separately in two different publications)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 21:08:26 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Goodwin-2001">
<DESCRIPTION>
<P>"Only progesterone-receptor status was associated with survival (P = 0.02); the imbalance in the distribution of this characteristic favoured longer survival in the intervention group (data not shown)."</P>
<P>Comment 1: important finding; unclear why authors did not include data in paper</P>
<P>Comment 2: otherwise, all outcome measures reported against</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-04 19:54:20 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Gotay-2007">
<DESCRIPTION>
<P>"The primary outcomes were specified a priori: patient reports of emotional well-being and depressive symptoms at 3 months post-study enrolment. Patients completed most assessments three times: baseline and 3 and 6 months. Three months was selected as the primary time point because most patients would be available for participation at that time, whereas considerable numbers would have progressed and become too ill to respond by 6 months. Therefore, this article reports outcomes data for baseline and 3 months only."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-15 03:19:28 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Kissane-2007">
<DESCRIPTION>
<P>"We report here on the impact of SEGT on survival, psycho-social outcomes and treatment adherence"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:18:17 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Low-2010">
<DESCRIPTION>
<P>All measures described in method reported in results</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-15 04:01:36 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Scholten-2001">
<DESCRIPTION>
<P>"The outcome measurements in our investigation was subjective self assessed quality of life"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-15 04:09:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spiegel-1989">
<DESCRIPTION>
<P>"Here we describe a 10 year follow-up of the effect of psychological intervention on disease progression and mortality"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2013-05-08 18:17:33 +1000" MODIFIED_BY="Mohammed Mustafa" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-07 21:09:22 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Aranda-2006">
<DESCRIPTION>
<P>The intervention and control groups were not comparable at baseline. A greater proportion of patients in the intervention arm were undergoing current radiotherapy (93% vs. 73%, P = 0.01). Proportionately more patients in the usual care arm of the study had minor children (38% versus 14%, P = 0.02)</P>
<P>Participants were recruited from 3 public and 1 private hospital - health seeking behaviours possibly different</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-08 18:17:33 +1000" MODIFIED_BY="mohammed mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Classen-2001">
<DESCRIPTION>
<P>"We found no significant treatment versus control differences at baseline on any of the demographic, medical, or outcome variables except for ethnicity in the samples with follow-ups. There were more minority women in the control group for Suppression, X2 (1, n = 97) = 10.79, P &lt; 0.10; Restraint, X2 (1, n = 62) = 6.33, P &lt; 0.01; Repressive&#8211;Defensiveness, X2 (1, n = 64) = 6.66, P &lt; 0.01; and Emotional Self-Efficacy, X2 (1, n = 65) = 12.46, P &lt; 0.01."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:02 +1000" MODIFIED_BY="mohammed mustafa" RESULT="YES" STUDY_ID="STD-Cunningham-1998">
<DESCRIPTION>
<P>Study appears free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:16:14 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Edelman-1999">
<DESCRIPTION>
<P>Study appears free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:21:39 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Goodwin-2001">
<DESCRIPTION>
<P>"Participation after randomization in support groups outside of the study was reported by 8.2% of the women in the intervention group (13 of 158 women) and 10.4% of those in the control group (8 of 77 women, P = 0.59)."</P>
<P>"Women in the intervention group were younger than those in the control group at the time of diagnosis (mean age, 44.0 years vs. 46.6 years; P = 0.04) and were less likely to be postmenopausal (14.6% vs. 33.8%, P = 0.001). They were also more likely to have had involvement of axillary nodes (70.9% vs. 50.7%, P = 0.002). The tumors of the women in the intervention group were more likely to have had estrogen receptors (69.0 vs. 54.5, P = 0.06) and progesterone receptors (63.9% vs. 42.9%, P = 0.01), and the use of adjuvant chemotherapy was more common in the intervention group (75.9% vs. 55.6%, P = 0.01)."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-15 03:15:38 +1000" MODIFIED_BY="mohammed mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Gotay-2007">
<DESCRIPTION>
<P>"More TG [intervention] patients received chemotherapy, whereas more CG [control] patients received hormone therapy for recurrence. Statistically significantly more patients in the CG progressed (progression also includes death) during the 6 months on study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-15 03:22:24 +1000" MODIFIED_BY="mohammed mustafa" RESULT="YES" STUDY_ID="STD-Kissane-2007">
<DESCRIPTION>
<P>Study appears free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:18:17 +1000" MODIFIED_BY="Mohammed Mustafa" RESULT="YES" STUDY_ID="STD-Low-2010">
<DESCRIPTION>
<P>Study appears free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-15 04:04:20 +1000" MODIFIED_BY="mohammed mustafa" RESULT="YES" STUDY_ID="STD-Scholten-2001">
<DESCRIPTION>
<P>Study appears free from other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-10 10:18:45 +1000" MODIFIED_BY="mohammed mustafa" RESULT="UNKNOWN" STUDY_ID="STD-Spiegel-1989">
<DESCRIPTION>
<P>Nearly significant difference in staging at initial diagnosis. Staging information, based on medical records at study entry, available for 70 of 86. Initial staging favoured intervention group taking place on average 59.8 months before study beginning</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2013-05-09 15:06:22 +1000" MODIFIED_BY="Mohammed Mustafa">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-05-09 11:25:47 +1000" MODIFIED_BY="Mohammed Mustafa" NO="1">
<TITLE MODIFIED="2013-05-08 22:01:28 +1000" MODIFIED_BY="Mohammed Mustafa">Summary of characteristics of included studies</TITLE>
<TABLE COLS="7" ROWS="11">
<TR>
<TH>
<P>Author, year</P>
</TH>
<TH>
<P>Recruitment</P>
</TH>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Setting</P>
</TH>
<TH>
<P>Control<SUP>a</SUP>
</P>
</TH>
<TH>
<P>Provider</P>
</TH>
<TH>
<P>Outcome</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>
</P>
</TD>
<TD>
<P>Hospital</P>
</TD>
<TD>
<P>Face-to-face</P>
<P>Telephone</P>
</TD>
<TD>
<P>Outpatients</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Nurse</P>
</TD>
<TD>
<P>EORTC QLQ-30</P>
<P>SCNS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>
</P>
</TD>
<TD>
<P>Hospital</P>
</TD>
<TD>
<P>CBT</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Standard care</P>
<P>Workbooks</P>
<P>Audiotapes</P>
<P>Telephone calls</P>
</TD>
<TD>
<P>Psychologist</P>
</TD>
<TD>
<P>Survival</P>
<P>POMS</P>
<P>FLIC</P>
<P>MAC, RED, DR DUFSS, MCDS</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>
</P>
</TD>
<TD>
<P>Hospital, Community</P>
</TD>
<TD>
<P>CBT</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Psychologist</P>
</TD>
<TD>
<P>Survival</P>
<P>POMS</P>
<P>Anxiety</P>
<P>Self esteem</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>
</P>
</TD>
<TD>
<P>Hospital</P>
</TD>
<TD>
<P>SEGT</P>
</TD>
<TD>
<P>Clinic</P>
</TD>
<TD>
<P>Educational material</P>
</TD>
<TD>
<P>Psychologist/</P>
<P>Psychiatrist/</P>
<P>Social worker</P>
</TD>
<TD>
<P>Survival</P>
<P>EORTC QLQ-30</P>
<P>POMS</P>
<P>Anxiety</P>
<P>Pain</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>
</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Peer delivered telephone intervention</P>
</TD>
<TD>
<P>Home</P>
</TD>
<TD>
<P>Unspecified</P>
</TD>
<TD>
<P>Breast Cancer survivor</P>
</TD>
<TD>
<P>CES-D</P>
<P>CARES-SF</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>
</P>
</TD>
<TD>
<P>Hospital</P>
</TD>
<TD>
<P>SEGT</P>
</TD>
<TD>
<P>Outpatients</P>
</TD>
<TD>
<P>Relaxation classes</P>
</TD>
<TD>
<P>Psychologist/</P>
<P>Psychiatrist/</P>
<P>Social worker</P>
</TD>
<TD>
<P>Survival</P>
<P>EORTC QLQ-30</P>
<P>IES</P>
<P>Mini-MAC</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>
</P>
</TD>
<TD>
<P>Hospital, Community</P>
</TD>
<TD>
<P>SEGT</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Educational material</P>
<P>1 year consumer health library membership</P>
</TD>
<TD>
<P>Psychologist/</P>
<P>Psychiatrist/</P>
<P>Social worker</P>
</TD>
<TD>
<P>Survival</P>
<P>POMS</P>
<P>Pain</P>
<P>CECS, WAI</P>
<P>SESESC</P>
<P>IES</P>
<P>HIP</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>
</P>
</TD>
<TD>
<P>Hospital,</P>
<P>Another study</P>
</TD>
<TD>
<P>Emotional expressive writing</P>
</TD>
<TD>
<P>Participant choice</P>
</TD>
<TD>
<P>Unspecified</P>
</TD>
<TD>
<P>Research Assistant</P>
</TD>
<TD>
<P>IES</P>
<P>CES-D</P>
<P>PSQI</P>
<P>PES</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>
</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>CBT</P>
</TD>
<TD>
<P>Therapists office</P>
</TD>
<TD>
<P>Unspecified</P>
</TD>
<TD>
<P>Psychologist/ psychiatrists</P>
</TD>
<TD>
<P>QoL</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>
</P>
</TD>
<TD>
<P>Hospital</P>
</TD>
<TD>
<P>SEGT</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Standard care</P>
</TD>
<TD>
<P>Psychiatrist/</P>
<P>Social worker,</P>
<P>Breast Cancer survivor</P>
</TD>
<TD>
<P>Survival</P>
<P>POMS</P>
<P>Pain</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a </SUP>Only difference between the trial groups was the intervention itself.</P>
<P>
<I>Interventions</I>: CBT (Cognitive Behavioural Therapy): SEGT (Supportive Expressive Group Therapy).</P>
<P>
<I>Outcomes</I>: CARES (Cancer Rehabilitation Evaluation System); CECS (Courtauld Emotional Control Scale); DR (Defensive Repression); DUFSS (Duke UNC Functional Social Support); EORTC C-30 (quality of life); FLIC (Functional Living Index for Cancer); HIP (Hypnotic Induction Profile); IES (Impact of Events Scale); MCDS (Marlowe Crowne Social Desirability Scale); MAC (Mental Adjustment to Cancer); PES (Perceived Emotional Support); POMS (Profile of Mood States); QoL (quality of life measure); RED (Rationally Emotional Defensiveness); SESESC (Stanford Emotional Self Efficacy Scale Cancer); SCNS (Supportive Care Needs Survey); WAI (Weinberger Adjustment Inventory).</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2013-05-09 15:06:22 +1000" MODIFIED_BY="Mohammed Mustafa" NO="2">
<TITLE MODIFIED="2012-06-25 23:16:00 +1000" MODIFIED_BY="Mohammed Mustafa">Summary of outcomes (not meta-analysed)</TITLE>
<TABLE COLS="18" ROWS="12">
<TR>
<TH ALIGN="LEFT" ROWSPAN="2">
<P>Author, year</P>
</TH>
<TH ALIGN="CENTER" ROWSPAN="2">
<P>Survival</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="10">
<P>Psychological outcome measures</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2">
<P>Condition specific</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="3">
<P>Realtionship &amp; social support</P>
</TH>
<TH ALIGN="CENTER">
<P>Other</P>
</TH>
</TR>
<TR>
<TH ALIGN="CENTER">
<P>Anxiety</P>
</TH>
<TH ALIGN="CENTER">
<P>CES-D</P>
</TH>
<TH ALIGN="CENTER">
<P>POMS</P>
</TH>
<TH ALIGN="CENTER">
<P>Self-esteem</P>
</TH>
<TH ALIGN="CENTER">
<P>RED</P>
</TH>
<TH ALIGN="CENTER">
<P>MAC</P>
</TH>
<TH ALIGN="CENTER">
<P>Mini MAC</P>
</TH>
<TH ALIGN="CENTER">
<P>CECS</P>
</TH>
<TH ALIGN="CENTER">
<P>QoL</P>
</TH>
<TH ALIGN="CENTER">
<P>IES</P>
</TH>
<TH ALIGN="CENTER">
<P>FLIC</P>
</TH>
<TH ALIGN="CENTER">
<P>CARES SF</P>
</TH>
<TH ALIGN="CENTER">
<P>SCNS</P>
</TH>
<TH ALIGN="CENTER">
<P>DUFSS</P>
</TH>
<TH ALIGN="CENTER">
<P>MCDS</P>
</TH>
<TH ALIGN="CENTER">
<P>PSQI</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Aranda-2006" TYPE="STUDY">Aranda 2006</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Cunningham-1998" TYPE="STUDY">Cunningham 1998</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Edelman-1999" TYPE="STUDY">Edelman 1999</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Goodwin-2001" TYPE="STUDY">Goodwin 2001</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P>&#8730;</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Gotay-2007" TYPE="STUDY">Gotay 2007</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Kissane-2007" TYPE="STUDY">Kissane 2007</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>&#8730;</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
<P>Emotional, physical</P>
<P>&#8730;</P>
<P>Social functioning</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Classen-2001" TYPE="STUDY">Classen 2001</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>&#8730;</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>&#8730;</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Low-2010" TYPE="STUDY">Low 2010</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
<P>Intrusion domain</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Scholten-2001" TYPE="STUDY">Scholten 2001</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P>X</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>
<LINK REF="STD-Spiegel-1989" TYPE="STUDY">Spiegel 1989</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>&#8730;</P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
<TD ALIGN="CENTER">
<P> </P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>X = no significant difference</P>
<P>&#8730; - significant difference</P>
<P>CARES (Cancer Rehabilitation Evaluation System); CES-D (depression measure); CECS (Courtauld Emotional Control Scale); DUFSS (Duke UNC Functional Social Support); FLIC (Functional Living Index for Cancer); IES (Impact of Events Scale); MCDS (Marlowe Crowne Social Desirability Scale); MAC (Mental Adjustment to Cancer); PSQI (Pittsburgh Sleep Quality Index); POMS (Profile of Mood States); QoL (quality of life measures); RED (Rationally Emotional Defensiveness); SCNS (Supportive Care Needs Survey).</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-05-25 16:11:23 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-05-25 16:11:23 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Psychological intervention versus usual practice</NAME>
<DICH_OUTCOME CHI2="4.240203882002263" CI_END="1.9872107582784113" CI_START="1.0748329599846245" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="OR" EFFECT_SIZE="1.461478573716931" ESTIMABLE="YES" EVENTS_1="379" EVENTS_2="235" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.2982439296681355" LOG_CI_START="0.03134097569932179" LOG_EFFECT_SIZE="0.1647924526837286" METHOD="MH" MODIFIED="2012-05-24 21:31:18 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5153761490556249" P_Q="0.40825625743444705" P_Z="0.015509413260316449" Q="0.6838740696565332" RANDOM="YES" SCALE="121.56333741221304" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="509" TOTAL_2="347" WEIGHT="100.0" Z="2.420260003730559">
<NAME>Survival at 1 year</NAME>
<GROUP_LABEL_1>Psychological input</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0918529769826098" CI_END="2.1506120472479466" CI_START="0.6094084471972511" DF="1" EFFECT_SIZE="1.1448148969318455" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="68" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.33256207429482465" LOG_CI_START="-0.21509153018271185" LOG_EFFECT_SIZE="0.058735272056056345" MODIFIED="2012-05-15 23:42:15 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7618345823385707" P_Z="0.674187320458181" STUDIES="2" TAU2="0.0" TOTAL_1="92" TOTAL_2="98" WEIGHT="23.75170879494299" Z="0.4204081445309078">
<NAME>Cognitive behaviour therapy</NAME>
<DICH_DATA CI_END="4.296924543284038" CI_START="0.41373260337009865" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="27" LOG_CI_END="0.6331577272647507" LOG_CI_START="-0.383280254048151" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2012-05-08 21:44:16 +1000" MODIFIED_BY="[Empty name]" ORDER="5687" O_E="0.0" SE="0.5970607016723521" STUDY_ID="STD-Cunningham-1998" TOTAL_1="30" TOTAL_2="36" VAR="0.35648148148148145" WEIGHT="6.895170201061275"/>
<DICH_DATA CI_END="2.273508126386616" CI_START="0.5088771550823632" EFFECT_SIZE="1.075609756097561" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="41" LOG_CI_END="0.35669651087829773" LOG_CI_START="-0.29338704538209154" LOG_EFFECT_SIZE="0.03165473274810307" MODIFIED="2012-05-15 23:42:15 +1000" MODIFIED_BY="[Empty name]" ORDER="5688" O_E="0.0" SE="0.3818622989128548" STUDY_ID="STD-Edelman-1999" TOTAL_1="62" TOTAL_2="62" VAR="0.14581881533101046" WEIGHT="16.856538593881712"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.392822119413638" CI_END="2.28489169562661" CI_START="1.0677516121068997" DF="3" EFFECT_SIZE="1.5619528774886202" ESTIMABLE="YES" EVENTS_1="313" EVENTS_2="167" I2="11.578034615075165" ID="CMP-001.01.02" LOG_CI_END="0.3588656192389238" LOG_CI_START="0.028470235803476285" LOG_EFFECT_SIZE="0.19366792752120005" MODIFIED="2012-05-15 23:42:17 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3349311574557081" P_Z="0.021576309249241855" STUDIES="4" TAU2="0.0181900829034818" TOTAL_1="417" TOTAL_2="249" WEIGHT="76.24829120505701" Z="2.2977449560897285">
<NAME>Supportive/expressive group therapy</NAME>
<DICH_DATA CI_END="4.975849334934541" CI_START="0.7743851018381018" EFFECT_SIZE="1.962962962962963" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="42" LOG_CI_END="0.6968672217637176" LOG_CI_START="-0.11104301088011405" LOG_EFFECT_SIZE="0.29291210544180174" MODIFIED="2012-05-08 21:47:34 +1000" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.0" SE="0.4745704698751369" STUDY_ID="STD-Classen-2001" TOTAL_1="62" TOTAL_2="56" VAR="0.22521713087750822" WEIGHT="10.913914402355799"/>
<DICH_DATA CI_END="2.997341474946729" CI_START="0.9554398707604731" EFFECT_SIZE="1.6922705314009663" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="46" LOG_CI_END="0.4767362231715721" LOG_CI_START="-0.019796639450022784" LOG_EFFECT_SIZE="0.22846979186077468" ORDER="5689" O_E="0.0" SE="0.29166586138123496" STUDY_ID="STD-Goodwin-2001" TOTAL_1="158" TOTAL_2="77" VAR="0.08506897469525776" WEIGHT="28.894206109178736"/>
<DICH_DATA CI_END="3.2929483425876485" CI_START="1.0054736237389017" EFFECT_SIZE="1.8196078431372549" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="51" LOG_CI_END="0.517584917864929" LOG_CI_START="0.0023706823769224544" LOG_EFFECT_SIZE="0.2599778001209257" MODIFIED="2012-05-08 21:46:34 +1000" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.0" SE="0.30263939227725223" STUDY_ID="STD-Kissane-2007" TOTAL_1="147" TOTAL_2="80" VAR="0.09159060175794456" WEIGHT="26.83681994837512"/>
<DICH_DATA CI_END="1.7969929918658027" CI_START="0.24732675444826388" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="28" LOG_CI_END="0.25454638339726254" LOG_CI_START="-0.606728901508625" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-05-15 23:42:17 +1000" MODIFIED_BY="[Empty name]" ORDER="5690" O_E="0.0" SE="0.5059173657351376" STUDY_ID="STD-Spiegel-1989" TOTAL_1="50" TOTAL_2="36" VAR="0.25595238095238093" WEIGHT="9.603350745147358"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.15619549276962" CI_END="2.5182331082102554" CI_START="0.4222378859549188" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0311612017295755" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="45" I2="70.46137993172981" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.40109592947461026" LOG_CI_START="-0.3744428015281835" LOG_EFFECT_SIZE="0.013326563973213334" METHOD="MH" MODIFIED="2012-05-16 18:27:10 +1000" MODIFIED_BY="Sharon  M Parker" NO="2" P_CHI2="0.017284079044133538" P_Q="1.0" P_Z="0.9462962598843238" Q="0.0" RANDOM="YES" SCALE="27.388690771340205" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.5222832335977625" TOTALS="YES" TOTAL_1="417" TOTAL_2="249" WEIGHT="100.0" Z="0.06735855833117158">
<NAME>Survival at 5 years</NAME>
<GROUP_LABEL_1>Psychological input</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.15619549276962" CI_END="2.5182331082102554" CI_START="0.4222378859549188" DF="3" EFFECT_SIZE="1.0311612017295755" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="45" I2="70.46137993172981" ID="CMP-001.02.01" LOG_CI_END="0.40109592947461026" LOG_CI_START="-0.3744428015281835" LOG_EFFECT_SIZE="0.013326563973213334" MODIFIED="2012-05-16 18:27:10 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.017284079044133538" P_Z="0.9462962598843238" STUDIES="4" TAU2="0.5222832335977625" TOTAL_1="417" TOTAL_2="249" WEIGHT="100.0" Z="0.06735855833117158">
<NAME>Supportive/expressive group therapy</NAME>
<DICH_DATA CI_END="2.3825150111853923" CI_START="0.5009070407889568" EFFECT_SIZE="1.0924369747899159" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="17" LOG_CI_END="0.3770356456186306" LOG_CI_START="-0.30024286379001874" LOG_EFFECT_SIZE="0.03839639091430597" MODIFIED="2012-05-08 21:55:55 +1000" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="0.3978367490093319" STUDY_ID="STD-Classen-2001" TOTAL_1="62" TOTAL_2="56" VAR="0.15827407886231415" WEIGHT="30.4942167331548"/>
<DICH_DATA CI_END="0.8388766858760408" CI_START="0.1885253735289414" EFFECT_SIZE="0.3976801988400994" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="17" LOG_CI_END="-0.0763018753806272" LOG_CI_START="-0.7246301900628968" LOG_EFFECT_SIZE="-0.400466032721762" ORDER="5693" O_E="0.0" SE="0.3808312613212814" STUDY_ID="STD-Goodwin-2001" TOTAL_1="158" TOTAL_2="77" VAR="0.14503244959955813" WEIGHT="31.099317321685657"/>
<DICH_DATA CI_END="2.649082804957411" CI_START="0.565496000924724" EFFECT_SIZE="1.2239467849223946" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="11" LOG_CI_END="0.4230955336743645" LOG_CI_START="-0.2475704619718878" LOG_EFFECT_SIZE="0.08776253585123835" MODIFIED="2012-05-08 21:55:18 +1000" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="0.3939525256928289" STUDY_ID="STD-Kissane-2007" TOTAL_1="147" TOTAL_2="80" VAR="0.155198592499759" WEIGHT="30.63264782324004"/>
<DICH_DATA CI_END="334.4932954569339" CI_START="1.0708455954680032" EFFECT_SIZE="18.925925925925927" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="0" LOG_CI_END="2.524387417245132" LOG_CI_START="0.029726854706318737" LOG_EFFECT_SIZE="1.2770571359757255" MODIFIED="2012-05-15 23:42:07 +1000" MODIFIED_BY="[Empty name]" ORDER="5694" O_E="0.0" SE="1.4653759632042418" STUDY_ID="STD-Spiegel-1989" TOTAL_1="50" TOTAL_2="36" VAR="2.147326713536759" WEIGHT="7.77381812191951"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.324793156613609" CI_END="1.9574825608512265" CI_START="0.5939581707945795" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0782684087023433" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="24" I2="43.65978336127708" I2_Q="75.95286996602889" ID="CMP-001.03" LOG_CI_END="0.2916979016317341" LOG_CI_START="-0.22624413891233175" LOG_EFFECT_SIZE="0.032726881359701185" METHOD="MH" MODIFIED="2012-05-09 00:24:14 +1000" MODIFIED_BY="Sharon  M Parker" NO="3" P_CHI2="0.14950172939801598" P_Q="0.041426188727078705" P_Z="0.8043773271831004" Q="4.158500405608947" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="204" TOTAL_2="190" WEIGHT="100.0" Z="0.24768604890211576">
<NAME>Survival at 10 years</NAME>
<GROUP_LABEL_1>Psychological input</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.2251292424416356" CI_END="1.3891786624853566" CI_START="0.27432399791260415" DF="1" EFFECT_SIZE="0.617320860256534" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" I2="18.375958604413167" ID="CMP-001.03.01" LOG_CI_END="0.14275810401100036" LOG_CI_START="-0.5617361985743199" LOG_EFFECT_SIZE="-0.2094890472816598" NO="1" P_CHI2="0.2683564552308848" P_Z="0.24376278321201583" STUDIES="2" TAU2="0.0" TOTAL_1="92" TOTAL_2="98" WEIGHT="72.9958269715244" Z="1.1656332388236332">
<NAME>Cognitive behaviour therapy</NAME>
<DICH_DATA CI_END="3.4983093955753195" CI_START="0.3066349943173737" EFFECT_SIZE="1.0357142857142858" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.5438582164774277" LOG_CI_START="-0.5133782833639541" LOG_EFFECT_SIZE="0.015239966556736905" ORDER="5695" O_E="0.0" SE="0.6210259534119051" STUDY_ID="STD-Cunningham-1998" TOTAL_1="30" TOTAL_2="36" VAR="0.38567323481116583" WEIGHT="24.442232736535125"/>
<DICH_DATA CI_END="1.2497175553064093" CI_START="0.13235288384958124" EFFECT_SIZE="0.40669856459330145" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.0968118705822204" LOG_CI_START="-0.8782665913757428" LOG_EFFECT_SIZE="-0.39072736039676126" ORDER="5696" O_E="0.0" SE="0.5727659152703386" STUDY_ID="STD-Edelman-1999" TOTAL_1="62" TOTAL_2="62" VAR="0.32806079369546864" WEIGHT="48.553594234989276"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.37948958592357035" CI_END="6.210039357588382" CI_START="0.8699191050935846" DF="1" EFFECT_SIZE="2.324270182347402" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="6" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.7930943526289619" LOG_CI_START="-0.06052113111116839" LOG_EFFECT_SIZE="0.3662866107588968" MODIFIED="2012-05-09 00:24:14 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5378768450026116" P_Z="0.09256068803171473" STUDIES="2" TAU2="0.0" TOTAL_1="112" TOTAL_2="92" WEIGHT="27.0041730284756" Z="1.6820420406648462">
<NAME>Supportive/expressive group therapy</NAME>
<DICH_DATA CI_END="5.746667306110541" CI_START="0.6960556070031624" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.7594160550939034" LOG_CI_START="-0.15735606376594102" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2012-05-09 00:24:14 +1000" MODIFIED_BY="[Empty name]" ORDER="28" O_E="0.0" SE="0.5385164807134505" STUDY_ID="STD-Classen-2001" TOTAL_1="62" TOTAL_2="56" VAR="0.29000000000000004" WEIGHT="24.412641655740288"/>
<DICH_DATA CI_END="107.43866405522604" CI_START="0.26929853462596554" EFFECT_SIZE="5.378947368421053" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.0311605994647297" LOG_CI_START="-0.5697660097729996" LOG_EFFECT_SIZE="0.730697294845865" ORDER="5697" O_E="0.0" SE="1.5277971650606" STUDY_ID="STD-Spiegel-1989" TOTAL_1="50" TOTAL_2="36" VAR="2.3341641775672057" WEIGHT="2.591531372735309"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.759680040857104" CI_START="-1.4196800408571035" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.67" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2008-04-23 10:54:35 +1000" MODIFIED_BY="Sharon  M Parker" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.2894275638290177" Q="0.0" RANDOM="NO" SCALE="28.246579621616778" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="32" UNITS="" WEIGHT="100.0" Z="1.0593782562915135">
<NAME>Anxiety at 6 months</NAME>
<GROUP_LABEL_1>Psychological input</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.759680040857104" CI_START="-1.4196800408571035" DF="0" EFFECT_SIZE="1.67" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.01" NO="1" P_CHI2="1.0" P_Z="0.2894275638290177" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="32" WEIGHT="100.0" Z="1.0593782562915135">
<NAME>Cognitive behaviour therapy</NAME>
<CONT_DATA CI_END="4.759680040857104" CI_START="-1.4196800408571035" EFFECT_SIZE="1.67" ESTIMABLE="YES" MEAN_1="7.39" MEAN_2="5.72" ORDER="5698" SD_1="5.56" SD_2="6.9" SE="1.5763963344368086" STUDY_ID="STD-Edelman-1999" TOTAL_1="31" TOTAL_2="32" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="24.842567492959876" CI_START="-4.282567492959878" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="10.28" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2008-04-23 10:53:40 +1000" MODIFIED_BY="Sharon  M Parker" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.16648809241827198" Q="0.0" RANDOM="NO" SCALE="109.38857920842739" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="32" UNITS="" WEIGHT="100.0" Z="1.3835767470820173">
<NAME>Profile of Mood States (full version) at 6 months</NAME>
<GROUP_LABEL_1>Psychological input</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="24.842567492959876" CI_START="-4.282567492959878" DF="0" EFFECT_SIZE="10.28" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.01" NO="1" P_CHI2="1.0" P_Z="0.16648809241827198" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="32" WEIGHT="100.0" Z="1.3835767470820173">
<NAME>Cognitive behaviour therapy</NAME>
<CONT_DATA CI_END="24.842567492959876" CI_START="-4.282567492959878" EFFECT_SIZE="10.28" ESTIMABLE="YES" MEAN_1="21.13" MEAN_2="10.85" ORDER="5699" SD_1="30.36" SD_2="28.55" SE="7.43001790228165" STUDY_ID="STD-Edelman-1999" TOTAL_1="31" TOTAL_2="32" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="9.48411530435112" CI_START="-4.264115304351121" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.6099999999999994" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2008-04-23 10:54:53 +1000" MODIFIED_BY="Sharon  M Parker" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.4567740268211157" Q="0.0" RANDOM="NO" SCALE="32.718769911722994" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="32" UNITS="" WEIGHT="100.0" Z="0.7441693618976061">
<NAME>Self-esteem at 6 months</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="9.48411530435112" CI_START="-4.264115304351121" DF="0" EFFECT_SIZE="2.6099999999999994" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.01" NO="1" P_CHI2="1.0" P_Z="0.4567740268211157" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="32" WEIGHT="100.0" Z="0.7441693618976061">
<NAME>Cognitive behaviour therapy</NAME>
<CONT_DATA CI_END="9.48411530435112" CI_START="-4.264115304351121" EFFECT_SIZE="2.6099999999999994" ESTIMABLE="YES" MEAN_1="83.58" MEAN_2="80.97" ORDER="5700" SD_1="14.87" SD_2="12.86" SE="3.507266132731654" STUDY_ID="STD-Edelman-1999" TOTAL_1="31" TOTAL_2="32" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="5.17406325113644" CI_START="-5.9340632511364415" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3800000000000008" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2008-04-23 10:55:02 +1000" MODIFIED_BY="Sharon  M Parker" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.8933254313544245" Q="0.0" RANDOM="NO" SCALE="29.49707981168839" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="36" UNITS="" WEIGHT="100.0" Z="0.13409755713041766">
<NAME>Profile of Mood States (short version) at 8 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.17406325113644" CI_START="-5.9340632511364415" DF="0" EFFECT_SIZE="-0.3800000000000008" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.01" NO="1" P_CHI2="1.0" P_Z="0.8933254313544245" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="36" WEIGHT="100.0" Z="0.13409755713041766">
<NAME>Cognitive behaviour therapy</NAME>
<CONT_DATA CI_END="5.17406325113644" CI_START="-5.9340632511364415" EFFECT_SIZE="-0.3800000000000008" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="11.88" ORDER="5701" SD_1="11.05" SD_2="11.94" SE="2.8337578113405058" STUDY_ID="STD-Cunningham-1998" TOTAL_1="30" TOTAL_2="36" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="9.820391929292198" CI_START="-13.680391929292183" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.9299999999999926" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2008-04-23 10:55:12 +1000" MODIFIED_BY="Sharon  M Parker" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.7475104442655742" Q="0.0" RANDOM="NO" SCALE="67.99635768267403" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="36" UNITS="" WEIGHT="100.0" Z="0.3219237718132991">
<NAME>Functional Living Index at 8 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="9.820391929292198" CI_START="-13.680391929292183" DF="0" EFFECT_SIZE="-1.9299999999999926" ESTIMABLE="YES" I2="0.0" ID="CMP-001.08.01" NO="1" P_CHI2="1.0" P_Z="0.7475104442655742" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="36" WEIGHT="100.0" Z="0.3219237718132991">
<NAME>Cognitive behaviour therapy</NAME>
<CONT_DATA CI_END="9.820391929292198" CI_START="-13.680391929292183" EFFECT_SIZE="-1.9299999999999926" ESTIMABLE="YES" MEAN_1="113.68" MEAN_2="115.61" ORDER="5702" SD_1="24.06" SD_2="24.48" SE="5.995208086463721" STUDY_ID="STD-Cunningham-1998" TOTAL_1="30" TOTAL_2="36" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-3.866787041746121" CI_START="-4.533212958253884" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.200000000000003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2008-04-23 10:55:21 +1000" MODIFIED_BY="Sharon  M Parker" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="7.44244513506393" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="41" UNITS="" WEIGHT="100.0" Z="24.70446761195952">
<NAME>Courtauld Emotional Control Scale at 8 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-3.866787041746121" CI_START="-4.533212958253884" DF="0" EFFECT_SIZE="-4.200000000000003" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.01" NO="1" P_CHI2="1.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="56" TOTAL_2="41" WEIGHT="100.0" Z="24.70446761195952">
<NAME>Supportive/expressive group therapy</NAME>
<CONT_DATA CI_END="-3.866787041746121" CI_START="-4.533212958253884" EFFECT_SIZE="-4.200000000000003" ESTIMABLE="YES" MEAN_1="44.8" MEAN_2="49.0" ORDER="5703" SD_1="0.78" SD_2="0.86" SE="0.17000973532280325" STUDY_ID="STD-Classen-2001" TOTAL_1="56" TOTAL_2="41" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.0344913815620247" CI_START="-2.6344913815620226" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.29999999999999893" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2012-04-12 18:54:42 +1000" MODIFIED_BY="Sharon  M Parker" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.8011412671395254" Q="0.0" RANDOM="NO" SCALE="13.230165573045436" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="102" TOTAL_2="45" UNITS="" WEIGHT="99.99999999999999" Z="0.25187036457105566">
<NAME>Anxiety at 1 year</NAME>
<GROUP_LABEL_1>Psychological input</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.10.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Cognitive behaviour therapy</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.0344913815620247" CI_START="-2.6344913815620226" DF="0" EFFECT_SIZE="-0.29999999999999893" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.02" MODIFIED="2012-04-12 18:54:42 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.8011412671395254" STUDIES="1" TAU2="0.0" TOTAL_1="102" TOTAL_2="45" WEIGHT="99.99999999999999" Z="0.25187036457105566">
<NAME>Supportive/expressive group therapy</NAME>
<CONT_DATA CI_END="2.0344913815620247" CI_START="-2.6344913815620226" EFFECT_SIZE="-0.29999999999999893" ESTIMABLE="YES" MEAN_1="9.8" MEAN_2="10.1" MODIFIED="2012-04-12 18:54:42 +1000" MODIFIED_BY="[Empty name]" ORDER="5704" SD_1="5.8" SD_2="7.0" SE="1.1910889179475712" STUDY_ID="STD-Goodwin-2001" TOTAL_1="102" TOTAL_2="45" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.8464267246615655" CI_END="5.601524919091965" CI_START="-28.676248524812344" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-11.53736180286019" ESTIMABLE="YES" I2="70.7876812177689" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2012-05-25 16:11:23 +1000" MODIFIED_BY="Sharon  M Parker" NO="11" P_CHI2="0.03260762415792806" P_Q="1.0" P_Z="0.18703997471951236" Q="0.0" RANDOM="YES" SCALE="58.432030295853515" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="157.99638917938003" TOTALS="YES" TOTAL_1="165" TOTAL_2="92" UNITS="" WEIGHT="100.00000000000001" Z="1.3193863742182685">
<NAME>Profile of Mood States (full version) at 10-12 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.8464267246615655" CI_END="5.601524919091965" CI_START="-28.676248524812344" DF="2" EFFECT_SIZE="-11.53736180286019" ESTIMABLE="YES" I2="70.7876812177689" ID="CMP-001.11.01" MODIFIED="2012-05-09 01:42:57 +1000" MODIFIED_BY="Sharon  M Parker" NO="1" P_CHI2="0.03260762415792806" P_Z="0.18703997471951236" STUDIES="3" TAU2="157.99638917938003" TOTAL_1="165" TOTAL_2="92" WEIGHT="100.00000000000001" Z="1.3193863742182685">
<NAME>Supportive/expressive group therapy</NAME>
<CONT_DATA CI_END="2.801967652321826" CI_START="-25.76196765232183" EFFECT_SIZE="-11.48" ESTIMABLE="YES" MEAN_1="17.13" MEAN_2="28.61" MODIFIED="2012-05-09 01:42:57 +1000" MODIFIED_BY="[Empty name]" ORDER="29" SD_1="27.33" SD_2="35.04" SE="7.286852087577203" STUDY_ID="STD-Classen-2001" TOTAL_1="47" TOTAL_2="33" WEIGHT="36.22362470545576"/>
<CONT_DATA CI_END="14.017638063308286" CI_START="-10.21763806330829" EFFECT_SIZE="1.8999999999999986" ESTIMABLE="YES" MEAN_1="33.4" MEAN_2="31.5" MODIFIED="2012-04-12 18:55:43 +1000" MODIFIED_BY="[Empty name]" ORDER="5705" SD_1="27.3" SD_2="37.3" SE="6.182582006042289" STUDY_ID="STD-Goodwin-2001" TOTAL_1="102" TOTAL_2="45" WEIGHT="38.969442527376444"/>
<CONT_DATA CI_END="-8.705561502232896" CI_START="-56.7544384977671" EFFECT_SIZE="-32.73" ESTIMABLE="YES" MEAN_1="1.21" MEAN_2="33.94" MODIFIED="2012-05-09 01:39:59 +1000" MODIFIED_BY="[Empty name]" ORDER="5706" SD_1="37.56" SD_2="29.48" SE="12.257591816619492" STUDY_ID="STD-Spiegel-1989" TOTAL_1="16" TOTAL_2="14" WEIGHT="24.806932767167805"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="7.3122146132008785" CI_START="-5.512214613200867" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.9000000000000057" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2008-04-23 10:56:03 +1000" MODIFIED_BY="Sharon  M Parker" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.7832433242233403" Q="0.0" RANDOM="NO" SCALE="29.49707981168839" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="145" TOTAL_2="70" UNITS="" WEIGHT="99.99999999999999" Z="0.27509490753078775">
<NAME>Quality of Life (EORTC QLQ-C30 score) at 1 year</NAME>
<GROUP_LABEL_1>Psychological input</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours intervention</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.3122146132008785" CI_START="-5.512214613200867" DF="0" EFFECT_SIZE="0.9000000000000057" ESTIMABLE="YES" I2="0.0" ID="CMP-001.12.01" MODIFIED="2008-04-23 10:51:49 +1000" MODIFIED_BY="Sharon  M Parker" NO="1" P_CHI2="1.0" P_Z="0.7832433242233403" STUDIES="1" TAU2="0.0" TOTAL_1="145" TOTAL_2="70" WEIGHT="99.99999999999999" Z="0.27509490753078775">
<NAME>Supportive/expressive group therapy</NAME>
<CONT_DATA CI_END="7.3122146132008785" CI_START="-5.512214613200867" EFFECT_SIZE="0.9000000000000057" ESTIMABLE="YES" MEAN_1="59.7" MEAN_2="58.8" ORDER="5707" SD_1="20.2" SD_2="23.5" SE="3.2715981843439996" STUDY_ID="STD-Goodwin-2001" TOTAL_1="145" TOTAL_2="70" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.1301762233390742" CI_END="-0.17522742590973" CI_START="-0.9845260493319217" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5798767376208258" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.13" MODIFIED="2012-05-15 19:06:53 +1000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.5683102261048496" P_Q="1.0" P_Z="0.0049742357099691594" Q="0.0" RANDOM="NO" SCALE="3.1089406376032045" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="175" TOTAL_2="104" UNITS="" WEIGHT="100.00000000000003" Z="2.808697527257493">
<NAME>Pain at 1 year</NAME>
<GROUP_LABEL_1>Psychological input</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.1301762233390742" CI_END="-0.17522742590973" CI_START="-0.9845260493319217" DF="2" EFFECT_SIZE="-0.5798767376208258" ESTIMABLE="YES" I2="0.0" ID="CMP-001.13.01" MODIFIED="2012-05-15 19:06:38 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5683102261048496" P_Z="0.0049742357099691594" STUDIES="3" TAU2="0.0" TOTAL_1="175" TOTAL_2="104" WEIGHT="100.00000000000003" Z="2.808697527257493">
<NAME>Supportive/expressive group therapy</NAME>
<CONT_DATA CI_END="0.4369414363239814" CI_START="-0.9729414363239819" EFFECT_SIZE="-0.26800000000000024" ESTIMABLE="YES" MEAN_1="2.065" MEAN_2="2.333" MODIFIED="2012-05-15 19:06:38 +1000" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="1.682" SD_2="1.563" SE="0.35967060715628946" STUDY_ID="STD-Classen-2001" TOTAL_1="46" TOTAL_2="36" WEIGHT="32.94970524336829"/>
<CONT_DATA CI_END="0.15097226177778145" CI_START="-1.550972261777782" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="3.0" MODIFIED="2011-05-11 20:49:17 +1000" MODIFIED_BY="[Empty name]" ORDER="5708" SD_1="2.6" SD_2="2.3" SE="0.4341774994286335" STUDY_ID="STD-Goodwin-2001" TOTAL_1="99" TOTAL_2="44" WEIGHT="22.611366212278483"/>
<CONT_DATA CI_END="-0.14298836383976232" CI_START="-1.3570116361602378" EFFECT_SIZE="-0.75" ESTIMABLE="YES" MEAN_1="0.02" MEAN_2="0.77" MODIFIED="2012-05-15 19:04:44 +1000" MODIFIED_BY="[Empty name]" ORDER="5709" SD_1="1.42" SD_2="0.83" SE="0.30970550527880514" STUDY_ID="STD-Spiegel-1989" TOTAL_1="30" TOTAL_2="24" WEIGHT="44.438928544353246"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-05-09 15:04:53 +1000" MODIFIED_BY="Mohammed Mustafa">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-05-08 22:03:59 +1000" MODIFIED_BY="Mohammed Mustafa" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram for 2012 review update.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAgsAAAKWCAYAAADHp9pTAABQRUlEQVR42u2dAWRX3///PyRJksh8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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-05-09 08:57:56 +1000" MODIFIED_BY="Mohammed Mustafa" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: Review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVIAAAKBCAIAAACK9bSkAAAd8ElEQVR42u3dv64cSRnG4SMhIQIH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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-05-09 15:04:03 +1000" MODIFIED_BY="Mohammed Mustafa" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Psychological intervention versus usual practice, outcome: 1.1 Survival at one year.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAzQAAAGQCAMAAABPvtWUAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2013-05-09 15:04:18 +1000" MODIFIED_BY="Mohammed Mustafa" NO="4" REF_ID="CMP-001.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Psychological intervention versus usual practice, outcome: 1.2 Survival at five years.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAzQAAAEQCAMAAABRDsFMAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAAA2kElEQVR42u19CZhc1XXmqb2qq7u6bi1qtRZQt1gGQ+IlEzCRSSBg
exgrGU8+snxk4nxOFDwzzoRxYj47cfJ5RPiw5QRswDaLLIvNODYGHBCBGMW2EBjcNnKIsRNaqFvq
vdXV71Z3V1dV1zr3bfX2qldLV1W3zo+aesu95567nHvOXc67DgIIBKIeOLEIEAgUGgQChQaBQKEx
gvK4Pm/xzvrO+oHhsYSMzw4/ER91BkZ0Dw/7aqS8nsgwjnwxTcKa9Fn5Oan3uHx73Ndm/hrM1bUs
V/GquaLUV8lVxtsNuXIFuqPwskACAy/FCubvApZ3DIGAafiARc5SKRtZnr3dvXLdHY8XtU8f1EU1
sLKOiJXAUfT8YjatSliTPivB8o//7gmZ5TsZr4FAt8vM7D2Tqb/1pmLVchWA5JNyrlKr3ZCrbjLP
TsMM60qoy5d30xjEqIcLuqjQDRGfiwCwu7IYkl31AuR9rn7W7bB/XK/T6R2B/E0u6iWKGqA04nWF
2U/Y5c0LPRTrjdn/arOye7E3ch1Zk1OilHj3ED4+u/R7AFh6wfYWTjrxgMcTPJJiuXb3s/u819Mv
dL18ecmBroJ5mPVTp/uwxCvjlLp6u1dodi/2RTzBxRWWHVZRACNed0jSqt6Kng/AHMTZE09EyVXb
y797xzRR6Jsvf3/uo37I8f89MtV30dwSe77Wl1iA8lRwV5IvUrhrKjg0WYbwXF9OjHfeZGh6/j3Q
83ixd35FTTAXSqT4FtY3H5KelJgI2lF8o8Ivn+YkH5X7lyNvI2LUwDyUJ/v6psptLZp3wn8DOMVK
pX+u91Z2H5rv4dWyWF4V6wW2wvl+Mr2wT+IVQpO7eie7V2qy8BawfyxX83286P/a/PMlPldz5WOs
PlW5WnqWTJ+9RM5VB8q/O82zAHfeMikswr2P09/ppf4ipH78Zwn66UCRvVv+dLavPJj48a37PWUW
8mg6efP+3nIxQ/9iPwTYg2KabmEBSy/0vb6aDoj6Pcu/Wfp0lr9funm/j48oPrSRZQ7uFn4rabof
yo4GRApcBNxpuveeoVQ7zbPpDOPoAMsNy3XwHgiU0/TPWebF8hJLMJstbA2liy9882vzaYnXQCFN
/+/+7aluFRqhnA9kM4GzIGSnlLnlb9kPZO79Fr29kqsbkuniPznuWF2U61Aq/05x7eiSxU3eZIp5
pyNkaRFifck9R3p9V75MxX6F/2F/wk+0pLmSnksBQ2e2Hr1MvpPDmf3UxJ4j5UglaXVKwhNwLton
1SqTYJFxxDliRS0vUnmJrJIl13yk//Q2Llt5L3HarUIjlLNJrt52BGL/fJ2Uq7GBOZarQdo1ueoe
84yQYiYCNDG0I7EMIehbfB1irCdSEAcuL/LLnnPgYD95ye6VAqZg9lJT2nmOBYmyX7vMhOAiOU3O
pIwc/OO3t7V4/HABwAnwsmxwnJDlEf5HKi+p5+k9u5ONDKczGk5HIN615tlP+FztBg+fK74uLxEz
R58Z3p54v5yr8+f5XM1kOlr+XWqeCb++W176Ys7tTCRTkPN84amHQtP9RUkn9yw/GEzG19jVF556
8O6k19GzvP3QimBvBZcfHv/r/uKvjP72FUlQm2eSQbbli0mSd6UhuszCZjIHarJz+Bsffv7+2Ztf
Y2neJabJE7puNHNAIB5cfuiu5JqjnebZxL35Vz/7Tn84HVh5OPIUBPwrR+5guZHKSyrBtVBu5v70
Y3csVXgtZR96JHnf890qNP3O3FoJrllJ9yw//FWWndLKQ3cKuYr9x23BkpyrvrnkfWKu+MoT6lso
fxQakZHI+/9XbiCWfvEeiLvg1qdWp25YSktNdu5QZi22wl/d+lR6JuyA9G+e9CejZeHVxL39q65b
jx52LZsJDVkJvXiw3zX05Jch0J+8r1hbaMirt7jIPQeVNPm/FP3ZuEB8Dv7RHc23dcr5jhcf+cwX
3eEEpMnUv7Ke4QffzPhYK5LKSy7B3tmxBddUaJnn9X6+t6FfXc1Fn+5aTZN+8Wtc7k9fYrmKZAIs
V2my5ue7vRuO3Rvqr+Tqz797KDiY4Kv2vseFXEnlf66PaXTjw77AwhtX1RT4Al3zb12zMV7CXamI
TS80NOboTdYeBa3Ox9yhhdrUoiWsaMRmFxoEoouBGzYRCBQaBAKFBoFAoUEgNonQjARc1Ol/SfBZ
UKGK+8JIj5O6/HEbIeuH4EhhTjBybTOkVP40Rs8N8wQP+2pSVfGkpToCHAvGwQh1G95LV9r8sNAj
kKFq55JKDJ3PjL1a4vxOZzAPeZHfj9MQQCAilYWXugL5dfZQYanmIWKZIer0xurL0FwPdfaMyBkK
CRkicoaczp71zpB6cfPh2ZGvhycfL/E+CypUWcF7ZKbcRyaunKwdsn7wjhQWnhMzP68vnUBA8MqQ
oPKnMXhuWCT4oJkLjpaqiict1SPZg6wGH808ngwX5Ii6kNr8ZAGOZKNLoHIuqVDU+czYq6W7Zwd9
EwO5GN3mZkn/0HnFZDwj7nU8/ph75f6Jj722vou0LEM7st6kVYYCZNJdqitDX572Ryefyn/vgUEP
y1CB+1wp7xQcciD+y/PzD5yJFNd51VmlafLwAaCkUPFZYH+i74aHxiAudpSiHwOl13v4uxz8DXDk
ZTk0QMjtzcOIzx0SnFl8XsUfRfJvIU7vbB3cEcr38T4a7mV9Cyf5xwgeMVo/EnsQ/HGE2DHB58RM
p1A/+7+fHg46aS+n9qM57nVSX9ycai+4+CCiz4fudQ4KEGV/OfBxQeoKckK5+gVPIJae1x02ePjE
c7DHersY7zMj8S/5C0m+KJK/EaX9Xhrqd7lkTtaAjrE2mAPBgkh4XoGMX3zzvkRfhJIH1t2c2cJS
32KtCaHI2oyT94QSy5tl6Lx+IUOCLxClYY+r3L/HLa+OTENgnGXnWhAMgMTgAoQl55qVI9+JcGRt
vfOjEho3nPFmBIeFytqN6LvhY/K0BnxBV/wYXp3nX++DT3k1jaTUOx+Cq+eeF1tzcFXxR5GbUGh+
dz2afcvcLMzObSlMDn1n+jwQ/WMEjxitH4ktiP44QuzlAJle+IpJmA8PzMYhPzvwf6b6hif5Yqj4
0XxyfuFCwbdHB9G3p8gHEX0+dO+vgN9jBbjGKtlNpob6ph4RynW2T6zZj/YvpAwePt4r4Dtey2zw
3iUV/gV/IckXpeJvVDwDZ4pTCZmTRX43a4m1zBRl3czeuIN7+2nxzbvgzbaMAdwFyLss30ZYO3pP
T+mi+WWpvCE0v1QQMiT5Au0PJ5K3ji7InlJRPkOXM2VyGfVxEIvF8mvjcr9/aZvHNKtxmM/6R7Q6
cuxKVons9/cEoXHD+AswyC5OCbKyj8U45Vf19xNjrHGsQUjcdvuWh4U9Og6rSoBJvs+rYyjSAxfC
Z6AnA2PvEiJOJEDcAbAAA3vL9fWRKl5yTwevgCNmCfohDWEIZOCFU8Dr1sJVUrhXYTB3Mmek+hdw
egzE4UpuMng+vKJ9HX0yfwCOwVx+IZpww9gY3CGV64vC66kFMO5o8DwZS3jUXGl4zA6GFP6F8piG
sUl1/iZYDb01WMnfNvjH3UxyIBb55txvwpWjQXLlLip0ZEcg0hah8Z+NLQQsM3Rq6z7IzfzZEiTk
8s7B+KTY2sYFDq9cEP7kkvLC7t18Occ+PzS3DYIng3/p30U/Lmid9mRIvSOA25VegK1rsteI4t7g
hGl/jDek9X4kHPGw1puz9lsx8UexuadFTIPbslD+jVcXYouisaaQUfxIbBNT8dJ/evCFy3T+MFKC
ccj6IOEAfYLhlQRE+2kNqrLPhzLymdk+PZj1z26f3pahFaKqcjS45VC4aPTGxy4aVXyJlM1zis9M
hX9duVfKWomUD80M/tKrfPVxDv4ZtyXjn9pZAMlHB9Z7cx6FC08Ozl540iJDhz+4dTYSOjPYe1Kf
IW0pqTLUl9t3qFwSMsS3Ji7+ysdGOT6DrkQ7MqSZco4sn90luZxIvid7RfcG3+IfCYrG4McQcZw9
HwqiYhT+z/utXML7vcjmecUfRfSMGeHqYy/ih8EjgciVUCZEUw4aPxJ7UPxxeO8MCz0eKST6FouR
SwwJJhe+vW1xzBhB8GtxyFQz+tdepgd8zKTKMg0WUxHlqhTEQuyxSxYMXbKccdFnRs1/lC93Tf60
iitDsq+4ZW4Bdns9/DiAr1e4uC2aJrE3F0tYZejDu+Z2QgpmRtVlKhSPg8+XyeDOky09oFLFMOy/
/MiC4PzsgZ+12Tzz0KOROWZfsjpg/B7na/cnMMzb4M/AY4LuZGbk0BCcUWxVSiJuxuleMTTrRYdZ
K1mGE+GKYoZdQ9DDch4TbHm4ZrjOeQ0Kc+zvdRiepT5VmYLP8UwScvUZCbArxnjhLeI4XLTLclg6
G+VgBYZiSoKs74CbHBccM6vBO+G6YdZvxCyoegSjYQszj17iSy9GvWI5Du/QtBFtpD8GQYWqxVZp
bstbMrPalAIQ36nkzzBt63XOksUe8NLYCaHrW/0ePw7g33wHVrij1Lf+rezEotc6Q0sDU3EH/GxI
3dMM8wNYVqpD4DdmyLcnHoZnWb4yu4X8pt+CWPxKYZ4K3scR6m+j0KQH30+D2/bBvfBfIBT7/eeE
/Cx/mp8UYxUrtPWJT59O7VR8f36wbYkubUvBvtg1z4lStLLlGHx/4I8qo76JHasrO5ehL0b/Vgww
fkPStrzwHZNnB2zzMDLj27dWXML7olshdONlqYHBurIq8RJiA+ne2MmSRYLR7eCNwuSO1MnBygTG
z+G3Yd/gr124NWyM9Ac7UuNhh8BT7yWcYTI4EYUtHljYAtFLYWLnCrf1JUFtbV3hnRVV+dEgBMaG
HFVkZPGPtPwnty67lfwZsOTcvryLQmjryffvYEOFjOMKfhwgTMTtLjnev/34+guNBzxV3q7BSih6
terrXccGVvh2SXeurOww+RBAcHLUf/51ENoXXNoxwWdoEIKjgtAk/IXY0vaVdo5pLOcE+3rO+u0r
iD0/Pd2XMnVzQccWeXWsQC8eHahHUR6/plB/Msd/Pd+1RZAJNcBb7OKXu4F3O0LjBEeojiXWyEpx
cbA3YUZoEYVGQDj0etS96qnHtqQNLNf5e7iuLYKGePMdvWqjCA0CgUAgEKhpEJsRtDtbJ7oGIBAo
NAhEO4XGJ06SxXxO5awY6ZnOd8YaGbODUUZc9SrmxjwiuuP8EsS5IzRx35x4kcxPX/hYn/bZr06v
kv7Zi2pTzM7xS7+6h8veOvkijVmz2XmsUkQ7hWZUPrygUBochVntM53vTOXMl/Ae3q1F8bMRvEOo
U+uXAh/0cj0uGuTi1Auchx6X4gk+N5wYhj+T5KYR2W+FPxeNUbieZoR4graq7adDRdeUjNdNgOul
TsF7xe9R/E/4cF4ahzz1Yt0jGoT6s7SRmf2VnWH3JePCRo1IKic++5OXv9vfnwGofOq1NzAVK2Th
7m9OxfPlswO+Cb8jC6uTn80CgWxmYO68dJ4b+M7UQOTMXQ5wPP/PDw+Qia8m/YtbvzDz8O9I8bIw
QF1fEsMEzpY/8PvfLI7+ZPWxCXcxC1tedbvi3x+4R4jHL55/bfb4o8Knm1mc8tk4mRhYqzAT7Jk6
zGQ3ICQOA32TntKXJoee+fuv5hihyQOFHpj5q9SkGM693LtGlu59Hiu/65HtzqPc1Jomo+xvipwG
8SSgjLxsvW+LzndmckzYMHnlGEzr/Wx4JaPxS+Hyl97BO5Nkgb49lRI21wnxBJ+bXjFMCQZ+o5xT
/FZ6WPw0+KV4AHX46UwtwFmo+OAwnir+J3y4BfhlRus2bJKIBqFdp5E3h8UuPrJrSfdM8LYx9Z2J
ltR+NuKbssYvJfZbDwij82gJyknYmVJ7oUi+vvKZJJLfCqMQgzX/u59xSPE0x9RY+umofC+cig+O
2n+GhXMlelPxAtZ992MjrdPkLz41bPDsjSzrfGdGBO8M4aQY43khWr+U3GOiM0kJ8u7YJZN5OZ6A
t4thpDNJKn4rkT9f7E28FJHiAdTvp6N4r1T8T4RwXqbcfNgiEa0Y04gDFpoN9J3xCUfrZKUjK/hX
7sVt+4O0v3jd6I+fEI6zGPhakrBBye7fopG8+rwW6QgRbn8quvi58vJDfdPhovPph4WzZsLF0NxA
bokfCwnxhAiF5Qf5MNKZJDe996/33RMvsTfH+hbA7ZLiMQ5KK7/5bfkgDencmL70zvBT/KOnvpgU
jl6QEgfxzJoX7rxZ/NJKn3i6iRTugW+k4AeHse5xTNMyoWF/0Qkum80q57zwr159YpVzkRXXqush
WhDPfPmzuw9m4SfjW5dd6vNa+PNf2MXnoivh22H+UHpqMJQuf8X12KHVqRt+PnB66+paaO7HXxbj
CRHmD2X4MNnoGf5Mknu/dejA1n7+TBpXYGVbCcR4/DLPy9/8l9ySJDTSuTH9rizTHexR5PQNb/Bh
pPNLxONsJr7R/7KYRMgtnNkihftWXyZ+CFskCk1rxjR1WJsqj+/Go9eF5v10pM8AQDyxm8MWiWOa
tguN+H0MV6Kx+I3Ea95PRwznSmzpWcIGiULTdqFBIM5ZocENmwgECg0CgUKDQKDQIBAoNAjEOQQ3
FgGia+ESd+iGulpoqHjqg/2ZPjmC5medZwp1ibWBAJWCV41AxdfmVA1JVkKT+ourEl5PVdyqakhC
xZDmbSUufsSxCaGh9dagFEH7A+vrbqxLrA0EpG3YUCNnxLoITZKUQ1NSt8xYUzVPQiVllRtNXIIO
4g0LjVCcch2a6hDxh1YOhyDmjXJd64C0iIh9bVrJT7XmrXpHavPchC62W7xmSZDWlmJrzIZq5pmd
QKSjQqPmwVSHVFQJqVbr3a/q6zNHiL2WXrFNbRFX2UlknToNuhGqojqHy93Zoty1M0OsnjTbZzZl
oTUXnbZ+7FW9Q9GLkhiSCB50zQ8paBWGrAdERPDRw/FMy4QGKsd2qct2c9i+ZD2JEqvXmgasDl1d
b9tIWZC8unNJmhsZotAYuyJ5QC8VqvLT2k6/E4qmUTrrk9UWjABJxzOxXih2/4ZNofqUUqWKaqFW
lsA5JDPNjGhpfePflqRMq+YZ58uagP7DGpV1GirOo5nPnlX0kWw7t3GdRpdmYxRI7XUXU+Vbe9xt
Y51GVa5yUdcv7cbKUT8zvNXUl8XbLpyxQX8aROfaWI2ZPxSaRs0zxIaXmrZGQ/MMgUBNg5oGgUCh
QSBQaBCIDQj0p0G0GdKGstBmERrLtQ/1iIyaLu20c6WGVOXVTsz6Fnrs+NPISyDmoYzlQpXdnfXu
TNDvIbXwpzErJ4M/jbiLB/efNS409nYiEZMo7fSooXXwahazqueLdbQae++0PYeJ1GnLpZKJuv1p
1HxT3QPNZjKTcjL400g9CM45Nyw0ij+NXn2otgEIldxJjxoVcdJQTEoaTbDWngBiFYoYKa17O6Wd
FIVqSdtxkiEbRmgq/BrUBzVpH53yqFHtjWvQE6VOw86mP00VmTGWi6W12zq5IJ0ULVJ7TLOBLUJ3
FYNZVQbCTjTxP0OOO7QC1fiO+oovSxsrzlzCW+VPU3+3j440LRQasmH2VJAmI7bXlcRCwpvyp7EV
y8LbprYDLqIO82xdqm4zoGnrrOX2Ea173qYxEq1FaMO3hCr+NDoFTwSThmx8maGbJUn+dETSXNK2
SCCqaRrZ0NU6OVsoeLlOhEA6t+h22DsNJ9V+XnVp6Ra9SJ3f+dC7wGiIW70VHyg3OKZpArjL+dww
INGfZp3MM8SGl5oNY7CipkEgUNMgEAgUGgQChQaB6BDQnwbR5eg+/xvDLue69qqbfhWNf7HOHz5r
bPFdtaW+ke+e2fsAuv3zaTQbyBsaHts5n0abTbPzaepdKEK4TWqE1FN7Bmea9f7ms8YTpG5xU37t
kzB+ZrRmWdR6qdpAvs7n0xCTGOoreTEb0bjQULPPM+rOpal0V6RWV7geaOFOeps+aLIbDm0tz6TZ
XJCqdKiJS4PZyQVdAFr1TfcdUuOuYr9YnEtTc3twe2qi/kZMdDFt8knWpVpo286nsUiANnkIYzv6
QYH17vO/cVs3d6WxVDlGoiNdVTeuedXYzKUfNoidT9P+NNVGW9XPp5F6Pzxqo1mhUezrqufSdIUF
TEl3iVwN/at3XVGpr3VyayF2XqO8NC00qr3/mnNpdN/KqOGru+49V+UrKw2mRKGLDjNqyt/YzrQe
Jd2upGug+/xvnCZWhtmEETWfUOqccda4J0gHfEjoepaERS1QO1oWp81aMBEgn+5czaOGqNYFOuBM
Q7vzBNaqhaB9qXZnqd+fRjUoEktCUyBWHjOydqaSpdgBp6LNA9zlvImA/jSdMc8QG1pqusp6RE2D
QKCmQU2DQKDQIBAoNAhEN6AXhQaBqA/pu6wnAqSDW2qMwqhmp6H5+TRtGB42nlTd59NUopHar6uF
Uvm22PSn0WfVzING719j6kFj4oSknG3Ttf403TIRQKM9KdWtwQnNah+5eQuw2A69vjlQJ9wQSCME
aO3mXasEiEmxVfWn0WfVzIPG4C1j5kFj4oSkOtsG/WkM4LdWq/bvLC4+fLO50CgFrZxIU+kQKdGf
wUU71fvQbuy+iOllc4lbZZXUCmTo+TbswkKnxNmlT/tDqjJ0m/aGxOhgqO9rO1YNpBUVQdazmkld
MtPsOT91bZlt67FS3VHbjWsaJW3nYthhYZ4ReUxjfkJN1SGCysreCBWxHtqG1rHRX7Opr9aQQrNB
jNaWTFMhtoyBppkZtFurtTKjdw0wOYa2evlKezlpZZNg93dgZN3oUlLPpzrk0DXFjKo/YE6oklYd
bAHRpiMPiSh+IMAGdqYAqk0EVGtgpGYTxE059Q6n6jOTSIOpqLo95Rhb+zJ+rkMrM+brNNRkBsdC
2XShT2dnxpa0jazTRmMorkTSFWqZRmA+pqmc3azxpzFzvjA43mza82lqhK+Dar3+NAYfGbNELDxo
TGNYnG2DsAmH3ckX/PzCBrH3Gqkw9KdpWNNU1fEoM5u3WaGRVh+cdkabhLeAEV0I0uQiT00qnUP+
aK8vuscXJBluI5hnCEQnwQUGCoXCYnRRvI0ubnV+9JB7AYUGgTBBPL//k7mE+Su3y+VNdJt5NhJw
Uaf/pYqhK1q6x32VAJFrQfcy7GWxKO3NQ57ygBD9OMBHDkvhfdQZGOHDesJdkdkRp8j2tfwihchw
04j5nPT6PG9OuBg1zu90Bue0IfxULNseVko9Qonwoa938lea8rIHH5Vqy0mDeTh+LaXeuFglVEVf
4ue410n9eSlmxs/qV0xdzLzEe0vKoem6yfT3XEtHxz80YyEYC7NTZ046Pdf3Z/JdpGl8c29cRcbi
hcroUL/9wnDJbfGtBmaGy+M7U2RsW4Y92TPKFWfPE3OVCXpnTvzS1jUWtvyeZyJdIDTBKZ7t2V1z
YkYip258rvmZlNL0L5wczAKUk4yqVBpqoUrNsuc907sc4ztWg1ND5dNCQQlX29Pq8rLXFS9LzPdM
n+9kKQVmLvypX6gzvkoU+hI/7lLEMcpzx8Nz9qJ/829d4wcxYm3JvHfYNSC/hQsUz4qWmGyRVf2N
uT/3/56+tHMtSqVp8vABoKQgaBGh7wm5PSNUmFsJumgvH5RCnGkPj8zu0IIP1oCOQYZF9vBPXlko
w4U9cg57I9eRNWGkeWSoG3R/Tuz5y5LpvBz9UfNEC6XBUZhlpfce/i7Hl0ZW/f5kUahmGB9jRZWF
sXEQ9MIaf5XXlJctjJYrtXWaL/cMSVyqVKJCX+KnUEq8yXMnPiKsvvIim141750Tl1h/r9edGkvm
mMxEARajYOc3MfexscscvmA4M9JpoXHDGW9G/a4YPPtrwk6Lu6aCQ5PlEn+59CyZPnuJFOB3YR6u
BI71alCAFPUvgiN+Jff2cbkGR2VKfIPpPFZFvfI3kvm0a+HzrTGRh/h2GvoZf5ngS6OkfvmJef7/
UxCJsOdl/ud1/kGJv7pcU162sG1VuricJ8BLkPvUlkq7V+hL/MjcKaxeKdQspPb4Fg1v24nFSLnn
Gt/J05Pz/Ah/sYG/uanx7IXuP+2PtH12zRWoXGb706sF8oODWQiwBh/IwtLee7xl/u5oOnnz/l7h
svhPjjtWF4VLgH9NB+Gynz5yVzITcO30hyZPvtU39od/MHdXvo+XEQ7uloQn8In9qUDHZSaWflBg
e+SA8MM9UN5/sBV0I+MwkD3+/DxPNbLyzg/QjDqvrwmpcXyZZgKcWLRC4bCrxbK6vOwpNpcYH/5N
pMjk9KHpk2+JxQwKfYkfgMP3Me5UrN52hBc0f+Rjh/lYAu9SlPbihke9xbXxpsn09P6851OuzgmN
K/GgN516vFgRmrsPslrh7xbh7gPZgCAp/WPBZEF8Ktb8v0cn/b5guZhKz+z/aWAtcOQzfStkme8C
rxvNHJCE5kA2Wu640BSXPFLrEH4Ojsa+1BJZ/E+j5y/B18sZnmom+hX/1Zw2r/zz60ZZmUbLvWn2
s3eSH9NkhDavLi+bUOUhG2PxDsyycpceKPQlfuD4f88w7uSZgHJ617cE0SunH+ZjMd53LUFHhOZg
Zq2wlHk03Bv0ZSDKLJy6/3oj5OWHHeOOTLtlRrO4GVk+u4vZvFEQDV/gOGaLixY5uxQ9Ck7DjGLC
RZnYeLJs2CLtK+BDD3sWFhKC2ROCi+SAXbE8NZel6sXvtDgKa9os504NLwPMnhKIs9LIvmKyy+JH
wOVZWTv4gpwUeijgRgTLSCmv+jAAI5VSjVWmdSr0JX5GrnYML1dY7X33t5dU0g75i08NL3WySiJc
cjVbumh34Ma4MF4RLK/avzFXeNeFa4XV5as8HWFbJTQeejQyB/vYo4w4mXLeCfDBXtbi74Rdw2zU
wmSH/V20qxJjH/TBTc5YeLEHvHuOD7NwbOAQhF+cFWrxr6K/x4XpTfxlH/g6LzTCtgZlmqgIZ1tB
td9RoApxr3OWLJoM7D1wIs7KwA/DJ9i4h1J2Pfw+YTSulFcdYAT+Dt47zOh598TEchfnOCr0JX6u
gSkK8gpB+N1vfli88dLYCRa4/9VCN+ygWeBWnyuU3+jb8YkoSOMVy9+BwXD4ZDHvWEp4Osewyjxb
iz7E9ZN7Dva7hp78Mm+eRZ92rbhS9P7irU+lZ8IO6HfdWewfTLiWQTLPTiV3ZL/wyKR7IAlkx5+6
on99ECLvfgPgs728jX6YvHqLO3wPP0aK0Wg3zASoTRtWB8FWkIxOcNlsVraPUoG/z21JGhOdP/jg
zPYl12p84glyjC+R1RuOJ7cd05RXHXlgf7c+MZnckXSRHS+5ok/LzxX60oNS4jaeO/FB8XVOuiHe
iScjkwdk3jthnulx4PBa/rWye/st/+FPm5vBoXAkvnh7wZE52Glem9oRwG2542ZbAcvuhW5Yp9nU
qLbYErv45UajdgDcBcVcSZjilNdl/A6PK9E9DDa3jSacsddFevo4bNXrLTTRRcu69B29qsGYncPs
29aKc5dwXpdn1tNlrOHeM0QXdwR4agACsSmAQoNAoNAgECg0CAQKDQKBQoNAnENQ7ZOSPygn3+o/
YWqJ9k4MysevtPOLXZVTKnCCHqERGrIxPm4mtV/aRnZ13QkCzTNjGxF8N4GC1ntcegzKCwrmIdvS
8bcb+LVEhFHTqFsHfzqW7lgv9Y18LYQh7ToCrVPNV/pGOX7BFWFjIsD8nBpVmyU1Qm8qEDxmD2Gl
aYzGvPGGGmVp0wqNcrolAlFTaKjmMAZSTau0c1je7uZLcUCDsG2egcn5M5XDiClU0TybzCzDo1wQ
1TWNbGoJR2UrZrzaAtNZY+Kh2u3tjNueIh7lgpCA/jSIrh9ObjTzDIFAoNAgECg0CAQKDQKBQoNA
oNAgEOcu1Os0lCj/117ZhLRzU7kXf7RkTNxSlBUQ6aVuGUheN5ISMXNskXjXuwPp11bEPQ7EInV5
a6Yh3xoGifyjyqsZUzrHH7pRfC8Q9QhN0yDGe2q64cbY4OVwRP/A4DljujxP9SGpWVTTrkAdiWjE
0yRIZWu3vBG8Sra0jj/CP5SZTWye6T1q1C4zlIpONSqPGnUwJbyenuKLQ6qoKpXwKQ1f2phArShQ
c8Wjk2RT1hpa5ScGbWqeLRSSc0fTGD1qlEv+H+g8apSumEgGjolRRJRWpmwEJZZ2EBh3iMrWn5EC
sWzV6nNCibJ3zjR1bROntUWKp1UtWzVlG7HxhYbaM7zUbiXErCXpG4eZ2w2xSkc/sjKSIfZVhG6U
VeFcJx7EZMhV54cRajEl7uOjuH1tswmNPHZWSY+lHFGwJ252XjdlKjVPkFj61bWaFf1MCWITTQTY
aEOkjsZJLYfuxGY/btbWaBON3EbcOhk0iWW0ztC9YBMLDVSdeabmYwCisvStdA2tLmbUZDBArL4/
QBqVFd1InjSgpCz1BeqRc1VoNB41FWtdvJR8bLTeJao7atLLKnFM+1opNj+qlq406yD2HVkUQmYP
LJJXyFvOCFdjsKa5VaEvRkep2vhoyJ+GkmZetyqZ1hOqN0GKy5Xriy4t3LoXN2t/Z3LjNqM6Fx9R
XlDTIBCoaewAN2wiECg0CAQKDQKBQoNAbGRYn0+jHYvVt8Bg2C5CDUsU6g2cUN3Dhii+KWJM+04v
gLvxEespNNUWHZpsetX2XNlyYFF2Jtt3ehGDodQg2mGeUZWPjOQ8o3OtAYvTaozn1MhEdB45outN
XSLZiB8pArG+mkbXZau9E3WuNVDltBptY9V45qj9b9SuKNXsNIMI1OH0Iu/7QeFBrLfQ6Eynas+0
vjPE9n5FYiYPdbTtmk4vtJa9iUC0VGik7tv+B7+p6aXxnrbKjKoeQ94firWLaJvQkNoTA1Zt2OA5
U8dZadVNLVJHHBQXRAfMM7suhsQ41KBV27vRmZmSJpp6Na8cNM0QbRMaxXFGM7Vr6UEDWqcbjc+K
JpLKI0egK33iwmTVxeDAYiKmFmwrcQzeNQhES7Dxdjk34vSC2JjAXc4tQp2O9igzCBSaOsc+KDMI
FBoEAoUGgUChQSBQaBAIBAoNAoFCg0Cg0CAQKDQIBAoNAoFCg0AgUGgQCBQaBAKFBoFAoUEgUGgQ
CAQKDaLrkT/a64vu8QVJhus21vBQJ0S3gQsMFAqFxeiieBtd3Or86CH3AgoNAmGCeH7/J3MJ81du
l8ub6DbzjAqQ7477VC+En7Ab8gHqCnIwIoYsO0MA10tSd9xLaTDPh/WEu7VKRpxiTq6l+tw2jpjP
Sa/P8+aEi1Hj/E5ncE4bws+ejwRctCcP+R7qDIwIxsf1Tv4qRD8O8JHD9SToE5keCTj58j5+LaXe
uFR9KvoSP8e9TurPSzEzfur0i6mLmZd4b0k5NF03mf6ea+no+IdmLARjYXbqzEmn5/r+TL7TvLoC
lctAIAukcntnqnKZBf6Suy2QC03v9kzsfv7x5KAnEAAPWS7nJ9Ji27mtf/mRM9ECC/v5I4kD3Sk0
j83zOZn94gj7CQQC2+mNbzVNM1ec/saxaIF1PxyjevfsoG/ioZxaqEqz7PnXZraQiS350PSQd/IJ
FhhCL2/1Tj6Z/8/wvfLsh56soysuzgm1wVOMTAzk/uGHF878pbMk1BIBhb7EzyPFSOxMVHwAPfMX
vfXJx4s8U3Sbm1WgxHtArODOjV5imYDjs4Xkys+jGckis/pdXP1pspDr9d75wxfu6FwjM5kI6GWd
pfCNf8jf5KJe2X7blfDAFHDjcAcUwC/IfiIBJCi+XQUuQkmWv9y/MNSlul9szP6yZDovR3/UPNFC
aXAUZlnNv0cQIaBjkFW/P1kURAfGx2CNvRkbB0EvrPFXeXhloQwX9tSR3GhZbmlwegwykCGJS5VK
VOhL/BRKiTd57sRHZMEHeZFNr5r3DopLf6/XnRpL5s4yiQBYjIKd38Tcx8Yuc/iC4cxIpzWNpFLK
Zwd8E35e64D/rbSbuktiR+RI5V3BTAb2zwccKZfjT1519c7cn/jMtCjw5XT+gERiav9HXutOqXn2
AT4ntzy7X8jQvTP3P9kSsvcl4yXo5ZKMKsfa8f5AWfXy5n/mU1vJ3H0gGyg7+J95ocj5q2smnbF3
vP7dH9bRZ0ZSOVEtXDkqUARwT22Z+5xUeSr6Ij8ydwqr107ytZ5y/8rZs5+T33ZC0yx+JR18z9RU
cnmVN1UyDfyllpOFe/r+95vB6QMdFxp3mu69p7fMX5de6Ht9NS1p71ImCP6Vh3f9AwTeN7tGno0W
+j4b/IIz++zAGt9tw90yiU/uf7PcjSITSz8o5GTkgPDDPVDef7AVdCPjMJA9/vw8TzWy8s4P0Iy6
TF8TUuNNpWwmIPyIxi5/tVjuG/vDP5i7K9+3ZluxuaQW/m8iRYDEQ9Mn35IqT6Ev8QNw+D7GnYrV
246wX7c/8rHDfCyB944IzQ2Peotr402T6en9ec+nXB03z8oQuRzEwVjosvu/q3k3vXX5f8b2wnNF
D29bLJdO/0Ly872/INofldn0CCS6UWZgZVlze8G/91zeElm8BM5PwntTws3y4Acze2PGQHsFixxi
qmu+t4Vl8leZQDqy2mjaoiA8pr4X6Uv8wPE/5rmTZwKWYNdHhK6tuPDbfCzG+65kZ2rjcm45M1He
PbRjMCqWRt1/8R3nv9Fb/BcH5+n8mMYBHCfZxSmYvVTRp0wsImultYRke/GSMfS6J+F5hb/zws/k
gBzEulJo5rJU/Xn2NLSksPPcqWEmjbOnBOKeLMm+YvJ97B8Bl2dlLZTtpKDhgRsRSnnYs8CPDevG
AIxwGlmp1J1AX+Jn5GrHcKWvyPe++9tLaonLX3xqeKmTVRLhkqvZ0kW7AzfGhfEKvzJj4zfmCu+6
cK2wunyVpyNsG4UmAENDTI3sZY3/SviZMqbfBn3go/GjcAQ8zuO7YacwiQl74w7+bRDexxEqTFP3
wR93pdAQojl1qghnW0G131GgCnGvc5YsmgzsPXAiDj7ww/AJ1ttQyq6H3yeMxleD8Iuz9fYyjMDf
wXuHGT3vntgw3FmZ3a7Ql/i5BqYoyIsG4Xe/+WHxxktjJ1jg/lcLXTDZDAvc6nOF8ht9Oz4h6V+5
lzb5HRgMh08W846lhKdzDBvHNHPwj+5oHlL0/uKtRw+7lkEa0wSTrzycik48teUgvPjooZmdEwfg
+CMr8LuPx3mDPP0PT99CdyzzFneMzmS7cyJANt6Fn0UItoJkdILLZrMBiWoq8Pe5LUljovMHH5zZ
vuRajU88QY4dZE9Wbzie3HbsIETe/QbAZ3vX6ssD+7v1icnkjqSL7HjJFX1afq7Qlx6UErfx3IkP
iq9z0g3xTjwZmTwg897hKWcBBw6v5V8ru7ff8h/+tLkpGgpH4ou3FxyZg53m1f6OAC4eSNkKeNdf
nI0Aot2odmh97OKXG43aAXAXFHMlYYVY2kkT8zs8ri4aKNexjSayYm8p1tdDsQl3QGiii5Z16Tt6
VYMxO4fZt60V5y7hvC7PrKfLWMO9Z4gu7gjwfBoEYlMAhQaBQKFBIFBoEAgUGgQChQaBOIeg2icl
ra7Is3zKdF+tib/2TgxSiUnaxkNohRxSwGNvETqhIRvj/HCp/dI2sqvrThBonhnbCBV2yFLQeo9L
j0F5QcE8ZFs6/naDoswgDJpG3TooIexH05urb+RrIYwh5GZrvpRQSd+g3CBqTQSYtBHWflRtltQI
valACMFNdQhzTWM05o031ChLm1ZopE4CtQzCjtBQohYPUk2rtHNY3u7mS3FAg7BtnhlUCq9PKuMa
qKJ5NplZBmRzZxHRrKaRTS1+iA+KGa+2wHTWmBCyzfZL21MkOBGAEIH+NIiuH05uNPMMgUCg0CAQ
KDQIBAoNAoFCg9ioI/EOxOz+LKDQIBB1Qr1OI07w2fejMYom0cYx3VJv4pairIBIL3XLQPK6kZSI
mWOLxLveHUi/tiLucSAWqctbM4lJn0O0vPA/qryaMaVz/KEbxfcCUY/QNA1ivKemG26MDV4OR/QP
DJ4zpsvzVB+SmkU17QrUkYhGPE2CVLZ2yxvBq2RL6/gj/EOZ2cRCI3akQkVLTb9yyfeYtNJ/8j1s
pecV7mglvKGnlpuP9cK6dm+kSvMRqu6sDRQooZYPVOpAbNm6lkua6x0U1wkTShtRSGg3DWpoR2lQ
i0p3W7VdrZ+McilKj+5FpSsmcmslVqqk0vmatliNOaXfISpbf0YKxLJVq5qyJPcV12WjlUiMJVa1
1fO0qmWrlpLrSpDWcNySvLaCyDpkwW1PJrWOM7RaP02MVoiZ2w2xSkc/sjKSIfZVhG6UVeFcJx7E
ZMhV54cRajEl7uOjuH1ts5ln8thZJT20JVrcroZseYsi9gJZ+dW1mhX9TAliE41pbLShegYG1HLo
TuxqRpO2Rpto5Dbi1smgSSxaa+SF2ExCA1Vnnqn5GICoLH0rXUOrixk1GQwQq+8PkEZlxWIkXw95
S32xyfQI6UDMFhNZhyy4LexvxaOmYq2Ll5KPjda7RHVHTXpZJY5pX0sqk2vylWYdxL4ji0LI7IFF
8gp5yxnhagzWNLcq9MXoG0GqzJal7DNuiN3RiYAGv1anXo8zoCF/GkrWO6stpWObUL0J0s25XGlY
lqork8bYTTR40qFGpJ0xtm2eNS65G7cZ1bn4eM6M6RvMKGk6WdqdrLtbXxIta0rtJ0TqJ3tOCE5n
PL1Jt7LuBgTCRvNt3MzZfKzjLmdE+1T+JmEdhQbRdYOhbmcdhQZhZ1ywUWVmXVh3ED19802G9c3+
GbaLUMMShXoDJ1T3sCGKb4oY077TC+Bu/IYHz5TUWK6oFZs2bR+1Zp2m0VVwYm+dhlrtbq+Te4M3
Gqm+47emA4tafOW9zjXjNMQ6AtHImEY6a0Y5pkZ9BA2V/bvMTqsxnlMjE1G/lOnSujqURvxIEYh1
gOX5NBrvRJ1rDVQ5rUbbWDWeOWr/G7UrSjU7zSACdTi9yPt+UHgQ6y00KpAaz7S+M8S2+UjM5KGe
rRpQY2mxYpOiwCDaaJ4R+ycCqkKammdWLxs2owj/JX/rt1RUj1i7GwhcJ2g2mKjbWg/Y76iJ1hyz
1Cmk9oyFpalF6oiD4tJmND9PBu+wru46qStx31Er6EBjtojbMmFb1IhxqEGrtnfjjBYlTTT1al45
aJq1D80X9eukVdSJLZoCzpKGOHeaWjfCt4zEn4oQyPfGO9U1oZSY0NITFulKx79SajDbpJBUnyoA
WO58NcSRH6DstAvHPU5XGM6LQ9wLeZ/Tl1fmV8tuiFDqPiyEy7tdrFJGWIgR9urjbmdYnE0NuVg0
6s+bU495nE4CHoG6HFemfh6j7vRk5F6bp3lUoJn3C/RY+ntGWLqqexqRp3BVzw7byqcroL4TbwKB
gPIjXSv3clDlhfoNuwqA9E/zKqAmXAkoPAtIz9WMVCiq0xGQDUDANCvGOMJPNoCteb0hlfFpmg5f
Olkor3mcuV5/ps9dEN6wv+zXDx2YGXKEv1XiwwUDwZUSfI2FOJSH7Ojsf709EMgSyH738wdCzzze
681rK026ya24w0vlzx9d897+vBxXoj747wfelc+Er5iUgvM03yHQDI19SaD39UOffGTte9/Kyffx
mUfGxEQDIKcZn3n03kCDmqbbLYH6dkagomnLoEawFb7HAT0CvjXIPQe5MRjLKQE+GIHB7OG3CqKm
GU+wnn2Nhciyu8nIr0qB3hWBzLtgLGNOvRAAugihHGRDQtw1JcBYBEJrkbderjyo0MwMQjIrpM/E
4o6Fyv1ERGlGcpoTEZsTA3gSGqIFMiO2onw0VzxLuHjRkzd+LQ/yfbOxVEA7sNWt3okPnSXT/SKM
emm+KvXvX6Uajyvf6BMd07nfeJlpPuVeSVSVpr0uFjdsIlqGYKknDBDxhtxsBMIBFxWejkhvPdly
sE+4igo9Oh8ipifBXll1971LgTOMuufjbnVcTqHee7UxUrSyOhEJhbzqe1tpotAg1hm/HHgrzX58
Z/wA3t0w7GMN8kXuGumtOxJxLQhX+4ZjrOH7LhBCyBDbrf8EDFuMK+a2nLqAp/4pnroUl3CPSG+v
IRFXQh+Fg8AshKVEfnDmaVDfVxINnIChAAoNoiPYR+Mu9rMQPQVwLE0zxwD6r47JqxrfW3aODQtX
X0pRpnKWbnBmvl+Je6ND+Fn6DM0kzakPi9QTwKgvp4S4w2OOT0tvP5Sip3brYjCayf9BV4+KdwkI
gfqeYVDQVsm9NJusJ584pkEg6oRTM0dhXDGpfOWv6pxVnRNa0gQ7BdqIjxDVJUlrpmSWH6x6RKNQ
7QioNnnQ6olb0sx3jeuKhpoUsY6aRq1yKj/V/WmUr6VXPGWoLrTU3Vd0CpX3AWh8bLSXGopUmxqo
VmpUHOpiKwlSPSk1K6hvEM1pGnVHXpc/DajnvJU743tQvGBB62NjvNS74ICJA476PDLTk3R0zGnf
4B4bROs0TXXbxvREAaK5IFUJkRopEfOAZsfMmLw2PyeGGAIgEC3UNBVVUK2BEdq6LyBWG9Gb80Is
T96oZ7YCjTNEy4TGlj9Nq2wbYkuvEVtfXaf1BUCdg2ileUZr9cO6GV9q3XtT/WNqV9lQa16IpVYy
n1Km5qygskG0RtMoB9Fozgc3PZFGPvNF/KqZ6gQY0/dgPCTGeACO8oLoeaG69NUc6lJSf2ZNy5ya
FVQ2iAbQ8h0BplZU+yap0GsTse74/6z19ucRPV0uAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2013-05-09 15:04:40 +1000" MODIFIED_BY="Mohammed Mustafa" NO="5" REF_ID="CMP-001.11" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Psychological intervention versus usual practice, outcome: 1.11 Profile of Mood States (full version) at 10 to 12 months.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0cAAADgCAMAAAD/le16AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2013-05-09 15:04:53 +1000" MODIFIED_BY="Mohammed Mustafa" NO="6" REF_ID="CMP-001.13" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:NO;SHOW_RAW_DATA_COLUMNS:YES;SHOW_MORE_DECIMALS:NO;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Psychological intervention versus usual practice, outcome: 1.13 Pain at one year.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA00AAADgCAMAAADot32zAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-05-08 22:07:49 +1000" MODIFIED_BY="Mohammed Mustafa">
<APPENDIX ID="APP-01" MODIFIED="2013-05-08 22:07:49 +1000" MODIFIED_BY="Mohammed Mustafa" NO="1">
<TITLE MODIFIED="2012-07-03 06:44:22 +1000" MODIFIED_BY="Mohammed Mustafa">Search strategy - MEDLINE (OvidSP) (1966 to June 2011)</TITLE>
<APPENDIX_BODY MODIFIED="2013-05-08 22:07:49 +1000" MODIFIED_BY="Mohammed Mustafa">
<OL>
<LI>breast neoplasm.mp. or exp Breast Neoplasms/</LI>
<LI>breast cancer.mp.</LI>
<LI>(breast adj5 carcinoma*).ti,ab.</LI>
<LI>(breast adj5 cancer*).ti,ab.</LI>
<LI>(breast adj5 neoplasm*).ti,ab.</LI>
<LI>(breast adj5 tumour*).ti,ab.</LI>
<LI>(breast adj5 tumor*).ti,ab.</LI>
<LI>(breast adj5 (cancer* or tumor* or tumour* or carcinoma* or neoplasm* or carcinogen* or malignan* or metasta* or recur* or relaps*)).tw,ot.</LI>
<LI>(advanced adj3 (cancer* or tumor* or tumour* or carcinoma* or neoplasm* or carcinogen* or malignan* or metasta* or recur* or relaps*)).tw,ot.</LI>
<LI>(advanced adj5 (cancer* or tumor* or tumour* or carcinoma* or neoplasm* or carcinogen* or malignan* or metasta* or recur* or relaps*)).tw,ot.</LI>
<LI>psychotherapy.mp. or exp Psychotherapy/ or exp Psychotherapy, Group/</LI>
<LI>supportive expressive group therapy.mp.</LI>
<LI>exp Cognitive Therapy/ or cognitive behavioural therapy.mp.</LI>
<LI>group support*.mp.</LI>
<LI>group intervention*.mp.</LI>
<LI>exp Self-Help Groups/ or self-help group*.mp.</LI>
<LI>Counseling/ or counsel.mp.</LI>
<LI>counsel*.ti,ab.</LI>
<LI>expressive writing.mp.</LI>
<LI>psychotherapeutic*.mp. or Psychotherapy/</LI>
<LI>randomized controlled trial.pt.</LI>
<LI>controlled clinical trial.pt.</LI>
<LI>randomized.ab.</LI>
<LI>placebo.ab.</LI>
<LI>clinical trials as topic.sh.</LI>
<LI>randomly.ab.</LI>
<LI>trial.ti.</LI>
<LI>21 or 22 or 23 or 24 or 25 or 26 or 27</LI>
<LI>exp animals/ not humans.sh.</LI>
<LI>28 not 29</LI>
<LI>exp Survival/ or survival.tw.</LI>
<LI>quality of life.tw. or exp "Quality of Life"/</LI>
<LI>adaptation, psychological/</LI>
<LI>31 or 32 or 33</LI>
<LI>1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10</LI>
<LI>11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20</LI>
<LI>35 and 36 and 30</LI>
<LI>35 and 34 and 30</LI>
<LI>37 and 38</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-05-07 21:05:12 +1000" MODIFIED_BY="Mohammed Mustafa" NO="2">
<TITLE MODIFIED="2013-05-07 21:05:12 +1000" MODIFIED_BY="Mohammed Mustafa">Search strategy - EMBASE (OvidSP) (1980 to June 2011)</TITLE>
<APPENDIX_BODY MODIFIED="2012-07-10 23:32:35 +1000" MODIFIED_BY="Mohammed Mustafa">
<OL>
<LI>breast neoplasm.mp. or exp Breast Neoplasms/</LI>
<LI>breast cancer.mp.</LI>
<LI>(breast adj5 carcinoma*).ti,ab.</LI>
<LI>(breast adj5 cancer*).ti,ab.</LI>
<LI>(breast adj5 neoplasm*).ti,ab.</LI>
<LI>(breast adj5 tumour*).ti,ab.</LI>
<LI>(breast adj5 tumor*).ti,ab.</LI>
<LI>(breast adj5 (cancer* or tumor* or tumour* or carcinoma* or neoplasm* or carcinogen* or malignan* or metasta* or recur* or relaps*)).tw,ot.</LI>
<LI>(advanced adj3 (cancer* or tumor* or tumour* or carcinoma* or neoplasm* or carcinogen* or malignan* or metasta* or recur* or relaps*)).tw,ot.</LI>
<LI>(advanced adj5 (cancer* or tumor* or tumour* or carcinoma* or neoplasm* or carcinogen* or malignan* or metasta* or recur* or relaps*)).tw,ot.</LI>
<LI>psychotherapy.mp. or exp Psychotherapy/ or exp Psychotherapy, Group/</LI>
<LI>supportive expressive group therapy.mp.</LI>
<LI>exp Cognitive Therapy/ or cognitive behavioural therapy.mp.</LI>
<LI>group support*.mp.</LI>
<LI>group intervention*.mp.</LI>
<LI>exp Self-Help Groups/ or self-help group*.mp.</LI>
<LI>Counseling/ or counsel.mp.</LI>
<LI>counsel*.ti,ab.</LI>
<LI>expressive writing.mp.</LI>
<LI>psychotherapeutic*.mp. or Psychotherapy/</LI>
<LI>exp Survival/ or survival.tw.</LI>
<LI>quality of life.tw. or exp "Quality of Life"/</LI>
<LI>adaptation, psychological/</LI>
<LI>Clinical trial/</LI>
<LI>Randomized controlled trial/</LI>
<LI>Randomization/</LI>
<LI>Single blind procedure/</LI>
<LI>Double blind procedure/</LI>
<LI>Crossover procedure/</LI>
<LI>Placebo/</LI>
<LI>Randomi?ed controlled trial$.tw.</LI>
<LI>Rct.tw.</LI>
<LI>Random allocation.tw.</LI>
<LI>Randomly allocated.tw.</LI>
<LI>Allocated randomly.tw.</LI>
<LI>(allocated adj2 random).tw.</LI>
<LI>Single blind$.tw.</LI>
<LI>Double blind$.tw.</LI>
<LI>((treble or triple) adj blind$).tw.</LI>
<LI>Placebo$.tw.</LI>
<LI>Prospective study/</LI>
<LI>or/24-41</LI>
<LI>Case study/</LI>
<LI>Case report.tw.</LI>
<LI>Abstract report/ or letter/</LI>
<LI>or/43-45</LI>
<LI>42 not 46</LI>
<LI>1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10</LI>
<LI>11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20</LI>
<LI>21 or 22 or 23</LI>
<LI>47 and 48 and 49</LI>
<LI>47 and 48 and 50</LI>
<LI>51 and 52</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2013-05-07 21:03:35 +1000" MODIFIED_BY="Mohammed Mustafa" NO="3">
<TITLE MODIFIED="2013-05-07 21:03:35 +1000" MODIFIED_BY="Mohammed Mustafa">Search strategy - PsycINFO (OvidSP) (1974 to June 2011)</TITLE>
<APPENDIX_BODY MODIFIED="2012-07-10 23:28:58 +1000" MODIFIED_BY="Mohammed Mustafa">
<OL>
<LI>breast neoplasm.mp. or exp Breast Neoplasms/</LI>
<LI>breast cancer.mp.</LI>
<LI>(breast adj5 carcinoma*).ti,ab.</LI>
<LI>(breast adj5 cancer*).ti,ab.</LI>
<LI>(breast adj5 neoplasm*).ti,ab.</LI>
<LI>(breast adj5 tumour*).ti,ab.</LI>
<LI>(breast adj5 tumor*).ti,ab.</LI>
<LI>(breast adj5 (cancer* or tumor* or tumour* or carcinoma* or neoplasm* or carcinogen* or malignan* or metasta* or recur* or relaps*)).tw,ot.</LI>
<LI>(advanced adj3 (cancer* or tumor* or tumour* or carcinoma* or neoplasm* or carcinogen* or malignan* or metasta* or recur* or relaps*)).tw,ot.</LI>
<LI>(advanced adj5 (cancer* or tumor* or tumour* or carcinoma* or neoplasm* or carcinogen* or malignan* or metasta* or recur* or relaps*)).tw,ot.</LI>
<LI>psychotherapy.mp. or exp Psychotherapy/ or exp Psychotherapy, Group/</LI>
<LI>supportive expressive group therapy.mp.</LI>
<LI>exp Cognitive Therapy/ or cognitive behavioural therapy.mp.</LI>
<LI>group support*.mp.</LI>
<LI>group intervention*.mp.</LI>
<LI>exp Self-Help Groups/ or self-help group*.mp.</LI>
<LI>Counseling/ or counsel.mp.</LI>
<LI>counsel*.ti,ab.</LI>
<LI>expressive writing.mp.</LI>
<LI>psychotherapeutic*.mp. or Psychotherapy/</LI>
<LI>exp Survival/ or survival.tw.</LI>
<LI>quality of life.tw. or exp "Quality of Life"/</LI>
<LI>exp Adaptation/ or adaptation.mp.</LI>
<LI>double-blind.tw.</LI>
<LI>randomized.tw.</LI>
<LI>randomly assigned.tw.</LI>
<LI>24 or 25 or 26</LI>
<LI>1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10</LI>
<LI>11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20</LI>
<LI>21 or 22 or 23</LI>
<LI>27 and 28 and 29</LI>
<LI>27 and 28 and 30</LI>
<LI>31 and 32</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2013-05-07 21:03:53 +1000" MODIFIED_BY="Mohammed Mustafa" NO="4">
<TITLE MODIFIED="2013-05-07 21:03:53 +1000" MODIFIED_BY="Mohammed Mustafa">Search strategy - CINAHL (EBSCO) (1982 to June 2011)</TITLE>
<APPENDIX_BODY MODIFIED="2012-05-04 19:34:35 +1000" MODIFIED_BY="Mohammed Mustafa">
<P>S1. (MH "Clinical Trials+")</P>
<P>S2. PT Clinical trial</P>
<P>S3. TX clinic* n1 trial*</P>
<P>S4. TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) )</P>
<P>S5. TX randomi* control* trial*</P>
<P>S6. (MH "Random Assignment")</P>
<P>S7. TX random* allocat*</P>
<P>S8. TX placebo*</P>
<P>S9. (MH "Placebos")</P>
<P>S10. (MH "Quantitative Studies")</P>
<P>S11. TX allocat* random*</P>
<P>S12. S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11</P>
<P>S13. (MH "Breast Neoplasms+") OR "breast neoplasm"</P>
<P>S14. "breast cancer"</P>
<P>S15. "breast carcinoma"</P>
<P>S16. "breast tumour"</P>
<P>S17. "breast tumor"</P>
<P>S18. "metastatic breast cancer"</P>
<P>S19. "metastatic breast neoplasm"</P>
<P>S20. "metastatic breast carcinoma"</P>
<P>S21. "metastatic breast tumor"</P>
<P>S22. "metastatic breast tumour"</P>
<P>S23. "advanced cancer"</P>
<P>S24. "advanced breast cancer"</P>
<P>S25. "advanced breast carcinoma"</P>
<P>S26. "advanced breast tumour"</P>
<P>S27. "advanced breast tumor"</P>
<P>S28. "advanced neoplasm"</P>
<P>S29. "advanced carcinoma"</P>
<P>S30. "advanced tumour"</P>
<P>S31. "advanced tumor"</P>
<P>S32. "recurrent breast cancer"</P>
<P>S33. "recurrent breast neoplasm"</P>
<P>S34. "recurrent breast carcinoma"</P>
<P>S35. "recurrent breast tumour"</P>
<P>S36. "recurrent breast tumor"</P>
<P>S37. "recurrent cancer"</P>
<P>S38. "recurrent neoplasm"</P>
<P>S39. "recurrent carcinoma"</P>
<P>S40. "recurrent tumour"</P>
<P>S41. "recurrent tumor"</P>
<P>S42. (MH "Psychotherapy+") OR "psychotherapy" OR (MM "Psychotherapy, Brief") OR (MH "Psychotherapy, Group+")</P>
<P>S43. "supportive expressive group therapy"</P>
<P>S44. (MM "Cognitive Therapy") OR "cognitive therapy" OR (MH "Cognitive Therapy (Iowa NIC) (Non-Cinahl)+")</P>
<P>S45. (MH "Support Groups+") OR (MM "Support Group (Iowa NIC)") OR "group support"</P>
<P>S46. "group intervention"</P>
<P>S47. "self-help groups"</P>
<P>S48. (MH "Counseling+") OR "counseling"</P>
<P>S49. "counsel"</P>
<P>S50. "expressive writing"</P>
<P>S51. (MH "Psychotherapeutic Processes+") OR "psychotherapeutic"</P>
<P>S52. (MM "Survival") OR "survival"</P>
<P>S53. (MH "Quality of Life+") OR "quality of life"</P>
<P>S54. (MH "Adaptation, Psychological+")</P>
<P>S55. S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32 or S33 or S34 or S35 or S36 or S37 or S38 or S39 or S40 or S41</P>
<P>S56. S42 or S43 or S44 or S45 or S46 or S47 or S48 or S49 or S50 or S51</P>
<P>S57. S52 or S53 or S54</P>
<P>S58. S12 and S55 and S56</P>
<P>S59. S12 and S55 and S57</P>
<P>S60. S58 and S59</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2013-05-08 22:07:24 +1000" MODIFIED_BY="mohammed mustafa" NO="5">
<TITLE MODIFIED="2012-08-01 21:21:32 +1000" MODIFIED_BY="mohammed mustafa">Search Strategy - ClinicalTrials.gov (July 2011)</TITLE>
<APPENDIX_BODY MODIFIED="2013-05-08 22:07:24 +1000" MODIFIED_BY="mohammed mustafa">
<P>
<B>Basic search </B>
</P>
<OL>
<LI>(breast cancer AND metastatic) AND (psychological AND intervention)</LI>
<LI>(breast cancer AND metastases) AND (psychological AND intervention)</LI>
<LI>breast cancer AND advance) AND (psychological AND intervention)</LI>
<LI>(breast cancer AND advanced) AND (psychological AND intervention)</LI>
<LI>(breast cancer AND metastatic) AND (psychology AND intervention)</LI>
<LI>(breast cancer AND metastases) AND (psychology AND intervention)</LI>
<LI>(breast cancer AND advance) AND (psychology AND intervention)</LI>
<LI>(breast cancer AND advanced) AND (psychology AND intervention)</LI>
<LI>(breast cancer AND metastatic) AND (psychosocial AND intervention)</LI>
<LI>(breast cancer AND metastases) AND (psychosocial AND intervention)</LI>
<LI>breast cancer AND advance) AND (psychosocial AND intervention)</LI>
<LI>(breast cancer AND advanced) AND (psychosocial AND intervention)</LI>
<LI>(breast carcinoma AND metastatic) AND (psychological AND intervention)</LI>
<LI>(breast carcinoma AND metastases) AND (psychological AND intervention)</LI>
<LI>breast carcinoma AND advance) AND (psychological AND intervention)</LI>
<LI>(breast carcinomaAND advanced) AND (psychological AND intervention)</LI>
<LI>(breast carcinoma AND metastatic) AND (psychology AND intervention)</LI>
<LI>(breast carcinoma AND metastases) AND (psychology AND intervention)</LI>
<LI>(breast carcinoma AND advance) AND (psychology AND intervention)</LI>
<LI>(breast carcinoma AND advanced) AND (psychology AND intervention)</LI>
<LI>(breast carcinoma AND metastatic) AND (psychosocial AND intervention)</LI>
<LI>(breast carcinoma AND metastases) AND (psychosocial AND intervention)</LI>
<LI>breast carcinoma AND advance) AND (psychosocial AND intervention)</LI>
<LI>(breast carcinoma AND advanced) AND (psychosocial AND intervention)</LI>
</OL>
<SUBSECTION>
<HEADING LEVEL="5">Each basic search combined with each of the following advanced searches</HEADING>
<P>
<I>Advanced search 1</I>
</P>
<UL>
<LI>Recruitment: all studies</LI>
<LI>Study results: studies with results</LI>
<LI>Study type: interventional studies</LI>
<LI>Condition: breast cancer AND (advanced or metastatic)</LI>
<LI>Intervention: psychological AND (education or therapy or intervention)</LI>
<LI>Outcome: survival OR psychological</LI>
<LI>Gender: studies with female participants</LI>
</UL>
<P>
<I>Advanced search 2</I>
</P>
<UL>
<LI>Recruitment: all studies</LI>
<LI>Study results: studies with results</LI>
<LI>Study type: interventional studies</LI>
<LI>Condition: breast cancer AND (advanced or metastatic)</LI>
<LI>Intervention: psychosocial AND (education or therapy or intervention)</LI>
<LI>Outcome: survival OR psychological</LI>
<LI>Gender: studies with female participants</LI>
</UL>
<P>
<I>Advanced search 3</I>
</P>
<UL>
<LI>Recruitment: all studies</LI>
<LI>Study results: studies with results</LI>
<LI>Study type: interventional studies</LI>
<LI>Condition: breast cancer AND (advanced or metastatic)</LI>
<LI>Intervention: psychiatric AND (education or therapy or intervention)</LI>
<LI>Outcome: survival OR psychological</LI>
<LI>Gender: studies with female participants</LI>
</UL>
<P>
<I>Advanced search 4</I>
</P>
<UL>
<LI>Recruitment: all studies</LI>
<LI>Study results: studies with results</LI>
<LI>Study type: interventional studies</LI>
<LI>Condition: breast cancer AND (advanced or metastatic)</LI>
<LI>Intervention: psychotherapeutic OR group intervention OR group support OR cognitive behaviour OR supportive expressive OR individual psychotherapy</LI>
<LI>Outcome: survival OR psychological</LI>
<LI>Gender: studies with female participants</LI>
</UL>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2013-05-08 22:05:40 +1000" MODIFIED_BY="mohammed mustafa" NO="6">
<TITLE MODIFIED="2013-05-08 22:05:40 +1000" MODIFIED_BY="mohammed mustafa">Search strategy Controlled Trials (July 2011)</TITLE>
<APPENDIX_BODY MODIFIED="2012-07-10 23:26:14 +1000" MODIFIED_BY="mohammed mustafa">
<OL>
<LI>(breast cancer AND metastatic) AND (psychological AND intervention)</LI>
<LI>(breast cancer AND metastases) AND (psychological AND intervention)</LI>
<LI>breast cancer AND advance) AND (psychological AND intervention)</LI>
<LI>(breast cancer AND advanced) AND (psychological AND intervention)</LI>
<LI>(breast cancer AND metastatic) AND (psychology AND intervention)</LI>
<LI>(breast cancer AND metastases) AND (psychology AND intervention)</LI>
<LI>(breast cancer AND advance) AND (psychology AND intervention)</LI>
<LI>(breast cancer AND advanced) AND (psychology AND intervention)</LI>
<LI>(breast cancer AND metastatic) AND (psychosocial AND intervention)</LI>
<LI>(breast cancer AND metastases) AND (psychosocial AND intervention)</LI>
<LI>breast cancer AND advance) AND (psychosocial AND intervention)</LI>
<LI>(breast cancer AND advanced) AND (psychosocial AND intervention)</LI>
<LI>(breast carcinoma AND metastatic) AND (psychological AND intervention)</LI>
<LI>(breast carcinoma AND metastases) AND (psychological AND intervention)</LI>
<LI>breast carcinoma AND advance) AND (psychological AND intervention)</LI>
<LI>(breast carcinoma AND advanced) AND (psychological AND intervention)</LI>
<LI>(breast carcinoma AND metastatic) AND (psychology AND intervention)</LI>
<LI>(breast carcinoma AND metastases) AND (psychology AND intervention)</LI>
<LI>(breast carcinoma AND advance) AND (psychology AND intervention)</LI>
<LI>(breast carcinoma AND advanced) AND (psychology AND intervention)</LI>
<LI>(breast carcinoma AND metastatic) AND (psychosocial AND intervention)</LI>
<LI>(breast carcinoma AND metastases) AND (psychosocial AND intervention)</LI>
<LI>breast carcinoma AND advance) AND (psychosocial AND intervention)</LI>
<LI>(breast carcinoma AND advanced) AND (psychosocial AND intervention)</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-07" MODIFIED="2013-05-08 22:06:14 +1000" MODIFIED_BY="mohammed mustafa" NO="7">
<TITLE MODIFIED="2013-05-08 22:06:00 +1000" MODIFIED_BY="mohammed mustafa">Search strategy WHO ICTRP (July 2011)</TITLE>
<APPENDIX_BODY MODIFIED="2013-05-08 22:06:14 +1000" MODIFIED_BY="mohammed mustafa">
<P>
<B>Basic search</B>
</P>
<OL>
<LI>(breast cancer AND advance*) AND (psycholog* AND intervention*)</LI>
<LI>(breast cancer AND metasta*) AND (psycholog* AND intervention*)</LI>
<LI>(breast cancer AND advance*) AND (psychosocial AND intervention*)</LI>
<LI>(breast cancer AND metasta*) AND (psychosocial AND intervention*)</LI>
<LI>(breast cancer AND advance*) AND psychotherap*</LI>
<LI>(breast cancer AND metasta*) AND psychotherap*</LI>
</OL>
<P>
<B>Advanced search</B>
</P>
<P>
<I>Advanced search 1</I>
</P>
<UL>
<LI>Condition: breast cancer% AND (advance% OR metasta%)</LI>
<LI>Intervention: psycholog% AND (education% OR therap% OR intervention%)</LI>
<LI>Recruitment Status: ALL</LI>
</UL>
<P>
<I>Advanced search 2</I>
</P>
<UL>
<LI>Condition: breast cancer% AND (advance% OR metasta%)</LI>
<LI>Intervention: psychosocial AND (education% OR therap% OR intervention%)</LI>
<LI>Recruitment Status: ALL</LI>
</UL>
<P>
<I>Advanced search 3</I>
</P>
<UL>
<LI>Condition: breast cancer% AND (advance% OR metasta%)</LI>
<LI>Intervention: psychiatric% AND (education% OR therap% OR intervention%)</LI>
<LI>Recruitment Status: ALL</LI>
</UL>
<P>
<I>Advanced search 4</I>
</P>
<UL>
<LI>Condition: breast cancer% AND (advance% OR metasta%)</LI>
<LI>Intervention: psychotherap% OR group intervention% OR group support% OR support group% OR cognitive behavio% train% OR cognitive behavio% therap% OR individual psychotherapy%</LI>
<LI>Recruitment Status: ALL</LI>
</UL>
<P>
<I>Advanced search 5</I>
</P>
<UL>
<LI>Title: Psychological interventions for women with metastatic breast cancer</LI>
<LI>Recruitment Status: ALL</LI>
</UL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-08" MODIFIED="2012-07-10 22:54:23 +1000" MODIFIED_BY="[Empty name]" NO="8">
<TITLE MODIFIED="2012-06-26 19:54:00 +1000" MODIFIED_BY="[Empty name]">Data Extraction Sheet</TITLE>
<APPENDIX_BODY MODIFIED="2012-07-03 06:25:56 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>DATE FORM COMPLETED</B>:</P>
<P>
<B>REVIEWER ID</B>:</P>
<P>
<B>STUDY ID</B>: (surname/year)</P>
<P>
<B>NOTES</B>:</P>
<P>
<B>
<U>STUDY</U>
</B>:</P>
<P>
<B>Title</B>:</P>
<P>
<B>Aim</B>:</P>
<P>
<B>Year</B>:</P>
<P>
<B>Citation</B>:</P>
<P>
<B>Country of origin</B>:</P>
<P>
<B>Funding</B>:</P>
<P>
<B>Ethics approved</B> (yes/no/unclear):</P>
<P>
<B>Duration</B>:</P>
<P>
<U>
<B>ELIGIBILITY</B>
</U>:</P>
<TABLE COLS="3" ROWS="9">
<TR>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>Y/N</P>
</TD>
<TD VALIGN="TOP">
<P>Comment</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>RCT?</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Women with Metastatic Breast Cancer</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Psychological Intervention type:</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>-  Educational</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>-  Individual psychotherapy</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>-  Cognitive behavioural therapy</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>-  Group</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Other factors?</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>
<U>
<B>PARTICIPANTS</B>
</U>:</P>
<P>
<B>Patient group involved</B>:                                                <B>Age</B>:                                       <B>Ethnicity</B>:</P>
<P> </P>
<P>
<B>How were participants recruited?</B>:</P>
<P>
<B>Inclusion criteria</B>:</P>
<P>
<B>Exclusion criteria</B>:</P>
<P>
<B>Other social/demographic details</B>:</P>
<P>
<B>Numbers</B>:           </P>
<TABLE COLS="3" ROWS="11">
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Total eligible</P>
</TD>
<TD VALIGN="TOP">
<P>  </P>
</TD>
</TR>
<TR>
<TD ROWSPAN="3">
<P>Pre-randomised</P>
</TD>
<TD VALIGN="TOP">
<P>Excluded</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Refused</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Other</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Randomised</P>
</TD>
<TD VALIGN="TOP">
<P>INT</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>CTRL</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD ROWSPAN="4">
<P>Post-randomised</P>
</TD>
<TD VALIGN="TOP">
<P>Withdrew</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Died</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Lost to FU</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Other</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
</TABLE>
<TABLE COLS="2" ROWS="4">
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Included in analysis</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Total</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Control</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Intervention</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
</TR>
</TABLE>
<P> </P>
<P>
<B>Any differences in baseline risk?</B>:</P>
<P>
<B>Other comments</B>:</P>
<P>
<U>
<B>INTERVENTIONS</B>
</U>
<B>:</B>
</P>
<P>
<B>Intervention type &amp; detail</B>:        </P>
<P>
<B>Education [ ]</B> :</P>
<P>                <B>Individual Psychotherapy [ ]</B> :</P>
<P>                <B>Cognitive Behavioural Training [ ]</B> :</P>
<P>                <B>Group Interventions [ ]</B> :</P>
<P>                <B>Other [ ] Comments</B>:</P>
<P>
<B>Intervention delivery (e.g. frequency, duration)</B>:</P>
<P>
<B>Intervention setting</B>:</P>
<P>
<B>Details of control group intervention</B>:</P>
<P>
<B>Details of providers</B>:                                     </P>
<P>
<B>Intervention quality</B>:</P>
<P>
<B>Other</B>:</P>
<P>
<U>
<B>OUTCOMES</B>
</U>
<B>:</B>
</P>
<P>
<B>Authors outcome measures</B>;</P>
<P>
<B>Primary</B>:</P>
<P>
<B>Secondary</B>:</P>
<P>
<B>Others</B>:</P>
<P>
<B>Method of assessing outcome</B>:</P>
<P>
<B>Timing of outcome assessment (e.g. frequency, length of FU)</B>:</P>
<P>
<B>Method of follow up for non-responders </B>:</P>
<P>
<B>Adverse events</B>:</P>
<P>
<B>Any data regarding the validity of outcome measurement tools?</B>:</P>
<P>
<U>
<B>RESULTS</B>
</U>
<B>:</B>
</P>
<TABLE COLS="9" ROWS="8">
<TR>
<TD COLSPAN="9">
<P>Continuous outcomes</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Outcome</P>
</TD>
<TD ROWSPAN="2">
<P>Timing of Outcome Assessment</P>
</TD>
<TD COLSPAN="3">
<P>Intervention Group</P>
</TD>
<TD COLSPAN="3">
<P>Control Group</P>
</TD>
<TD ROWSPAN="2">
<P>Notes</P>
</TD>
</TR>
<TR>
<TD>
<P>Mean/mean change</P>
</TD>
<TD>
<P>Standard deviation</P>
</TD>
<TD>
<P>N</P>
</TD>
<TD>
<P>Mean/mean change</P>
</TD>
<TD>
<P>Standard deviation</P>
</TD>
<TD>
<P>N</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
</TABLE>
<P/>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>Dichotomous outcomes</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Outcome</P>
</TD>
<TD ROWSPAN="2">
<P>Timing of Outcome assessment</P>
</TD>
<TD COLSPAN="2">
<P>Intervention group</P>
</TD>
<TD COLSPAN="2">
<P>Control Group</P>
</TD>
<TD ROWSPAN="2">
<P>Notes</P>
</TD>
</TR>
<TR>
<TD>
<P>Observed (n)</P>
</TD>
<TD>
<P>Total (N)</P>
</TD>
<TD>
<P>Observed (n)</P>
</TD>
<TD>
<P>Total (N)</P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;7 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;18 articles (10 studies) included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;45 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;100 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;862 records screened&lt;/p&gt;" WIDTH="200">
<FLOWCHARTBOX TEXT="&lt;p&gt;860 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;2 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;762 records excluded&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;55 duplicate records removed&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;27 full-text articles excluded, with reasons&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>